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ABSTRACT 
Insulating oils are rich in polycyclic aromatic hydrocarbons (PAHs) which act as 
inhibitors of oil breakdown, but are believed to be the main source of oil mutagenicity 
when converted to their epoxide form by mammalian enzymes. The current industry- 
recognised measurement of oil risk, the IP 346 method, measures total aromatic 
content and therefore cannot be directly related to PAH risk. This thesis describes 
efforts made to establish the contribution of PAH species alone to total oil 
mutagenicity. 
The aromatic fraction of the oil was successfully extracted with the Grimmer and 
Blackburn methods. When tested with 80% v/v S-9 (activation enzymes), the Ames 
test results of these extracts correlated with IP346 data in that oil 4 (low IP346 value) 
gave no indirect mutagenicity, whilst Nytro-10GBN (intermediate IP346 value) gave a 
40% increase in revertants and oil 8a 40-50% increase (high IP346 value). In the 
absence of S-9 however, both methods produced -800-1000 revertants for all oil 
samples. This indicated an additional threat from direct mutagens in these oils. 
However the source of mutagenicity remained inconclusive due to extract complexity. 
A new extraction that was specific to PAHs was therefore developed using solid phase 
extraction as a rapid, safer, more repeatable system with potential for automation. 
The efficiency of the new C 18/Silica/Isolute PAH HC extraction method was 68-84% 
for the carcinogenic EPA priority PAHs and 21-67% for non-mutagenic priority PAHs, 
with the most volatile PAHs being lost during the evaporation step. The GC-MS of 
these extracts was successfully used to identify and quantify these compounds in the 
oil by total peak area integration, offering an alternative to the IP 346 method. Ames 
test studies showed indirect (essentially PAH) mutagenicity (-70-100 revertants) only 
for the C 18/Silica/Isolute PAH HC extracts indicating that the extracts were PAH 
specific. Artificial ageing of the oil was found to alter PAH composition, although no 
change in oil mutagenicity was observed. 
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CHAPTER 1.0 
INTRODUCTION AND LITERATURE 
REVIEW 
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1.1 TRANSFORMERS AND TRANSFORMER OIL 
Electricity is transferred from the source of production to homes and industries at high 
voltage. This is to avoid losses in power due to the resistance that occurs over long 
distances. Transfer across the country is via cables, which are situated either 
underground or overhead. In order to reduce the danger from high voltages as the 
electricity gets closer to residential areas, the voltage is minimised. This is achieved 
with the use of a transformer. To minimise heat loss from transformers and to stop 
conduction, a variety of mineral oils are used. The oil must allow the transformer to 
withstand lightning, over-voltage and overload stresses. The oil also prevents water 
entering the transformer, therefore reducing corrosion. Up to 100 000 litres of oil is 
required to fill a transformer and the quality of the oil is crucial in determining the 
efficiency and lifetime of a transformer (National Grid Company Plc, 2002). 
1.1.1 Composition of Transformer Oil 
The mineral oils most commonly used in transformers are naphthenic, which refers to 
the high contents of cyclic compounds present including aromatic compounds such as 
polycyclic aromatic hydrocarbons (PAHs). The oil also contains minor components 
such as oxygen, sulphur, nitrogen, metals and water, which vary according to the 
degree of refining performed. As the working life of a transformer is so dependent on 
the oil's properties, the main problems that occur in a transformer are related to the 
inconsistent nature of the oil. Grades of oil have been engineered according to the 
amount of power that will pass through the transformer. This is not the only way that 
composition will vary however, as it will also alter with the origins of the crude oil raw 
material used (Nynas, 1999). 
Oil has many functions in a transformer. In addition to reducing the stress from 
changes in voltage, it can indicate the condition of the transformer if measured 
according to strict standards. The colour and general appearance of the oil are 
characteristics that can be assessed by an experienced person. For example, a 
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darkening of the oil indicates deterioration, while debris in the oil might suggest 
breakdown of fibres or cellulose from insulation paper in the transformer. Water is also 
an indication of problems in the transformer. The water may originate from the 
insulation paper or from the oxidation of the oil and leads to more rapid 
decomposition. Furthermore, oxidation leads to increased acidity which can have a 
corrosive effect on the transformer (Mynas, 2001) 
Transformer oil has now been used for a 100 years, but ensuring dryness and reducing 
air contact during the lifetime of the transformer is a problem that keeps the industry 
searching for alternatives to oil insulation. As the oil works so effectively however, 
alternatives that are as economically viable are unlikely to be found in the near future 
(Lindroth, 1995). 
1.1.2 The Breakdown of Oil 
One problem with transformer oil is that it readily breaks down in the presence of 
0.05-0.25% oxygen. Even with degassing processes the oil naturally contains this 
small amount of oxygen. Heat, UV light, mechanical shear or high electrical fields will 
cause the production of free radicals that will react with oxygen and produce further 
radicals which are unstable. In this way the chain reaction of oxidation is perpetuated 
(Nynas, 2001). 
PAHs decompose peroxide into stable compounds and absorb hydrogen gas (produced 
by electric discharges in the oil) by taking up hydrogen on the unsaturated aromatic 
rings and therefore stopping more free radicals forming (Mynas, 2001). In this way, 
PAHs are natural inhibitors in the oil, although oils that contain only naturally 
occurring inhibitors are classed as non-inhibited. Inhibited oils are those that have 
phenol added in addition, which further stabilises the oil by donating a hydrogen to 
free radicals produced during oxidation. Most oils have an inhibitor added at various 
quantities, but naturally occurring PAHs remain important in prolonging the lifetime of 
the oil. 
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1.1.3 Carcinogenicity of the Oil 
Epidemiological studies for many years have identified links between oils and cancer, 
which is believed to be the primary hazard from exposure to oil (Järvholm and Easton, 
1990; Hewstone, 1994). These studies looked at a number of different occupations 
where workers were commonly exposed to mineral oils. Particular links were made 
with skin and bladder cancer, but other cancers of the stomach, colon, rectum, 
pancreas, larynx and prostate were also observed (Tolbert P. E, 1997). The type of 
exposure played an important role in which cancers resulted, although such studies 
draw no conclusive classification. 
1.1.3.1 PAH Mutagenicity Versus Aromatic Mutagenicity 
The mutagenicity of oil is attributed to the polyaromatic (PAH) fraction of the oil 
(McKee et al., 1989; Järvholm and Easton, 1990; Brooks et al., 1995; Granella et al., 
1995) as PAHs are one of the few known mutagens to have been identified in the oil 
(Grimmer, 1983). Oils that have had the polyaromatic content extracted by polar 
solvents have been shown to lose their carcinogenic properties (IARC, 2002). 
The oil industry uses a liquid-liquid extraction called the IP 346 method (BS2000 Part 
346,1996) (Section 1.5.2) to measure the carcinogenic threat of polyaromatics from 
the oil. The method uses the weight of the oil before and after extraction to give a 
percentage value of polyaromatic content. However, the IP 346 % w/w method (and 
other liquid-liquid extractions) is known to remove all oil components soluble in 
dimethyl sulphoxide (DMSO) which may include simple aromatics and other polar 
components. Therefore the IP346 % w/w method, in addition to alternative liquid- 
liquid extractions involving DMSO, over estimates polyaromatic content (Stang, 1993; 
1999). For this reason the fraction of polyaromatic and aromatic compounds extracted 
by liquid-liquid extractions will be referred to as the aromatic content, although it is 
the polyaromatics (PAHs) that is estimated by these methods. 
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Nevertheless the IP 346 % w/w method is used to measure carcinogenic risk from the 
oils, as 1P 346 % w/w data correlates with skin painting experiments and this 
carcinogenicity is attributed to PAHs (Grimmer, 1983). An IP 346 aromatic fraction of 
more than 3% has been chosen by the Oil Companies' European Organisation for 
Environmental and Health Protection (CONCAWE) as oils containing a lower IP 346 
content showed no carcinogenicity (Nynas, 1999). Oils that contain more than 3% 
must be labelled as hazardous (Jansson, 1992; Hewstone, 1994; Granella et al., 1995). 
Such concerns over the health impacts of PAHs could be removed by refining the oil 
further thus removing the PAH content. However, removing the PAHs without 
extracting other aromatic components of the oil is difficult and such refining would 
change the properties of the oil, making it unsuitable for use in transformers. It would 
also increase the requirement for artificial inhibitors like phenol, which is corrosive, 
mutagenic and highly toxic when heated. For this reason, the National Grid Company 
Plc requested a mutagenic study of PAHs in transformer oil, which forms the basis of 
this work. 
1.2 POLYCYCLIC AROMATIC HYDROCARBONS 
Polycyclic aromatic hydrocarbons (PAHs) are found naturally in oils but they are also 
commonly found in the open environment, as the combustion or pyrolysis of almost all 
organic compounds will lead to small amounts of PAHs being produced (Moret and 
Conte, 2000, Wang et al., 2000). Alternative sources therefore include the combustion 
of fossil fuels, vehicle emissions and cigarette smoke. Of these sources Grimmer et al., 
(1991) states that over 75% of the carcinogenicity seen in animal experiments was due 
to PAHs with 4 rings or more. PAHs are so hazardous that they have been included by 
the Environmental Protection Agency (EPA) in the USA on the list of priority 
pollutants (EPA, 2002). 
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Polycyclic aromatic hydrocarbons have been given many names including polyarenes. 
polyaromatic compounds and polynuclear aromatic hydrocarbons. For the purpose of 
this work, these molecular structures will be mainly referred to as PAHs or 
polyaromatics when discussing a mixture of unknowns, such as that extracted by 
liquid-liquid methods. 
1.2.1 PAH Structure 
PAHs are based on benzene rings, which are unsaturated six-membered hydrocarbon 
rings (Figure 1.1). PAHs, like benzene are far more stable than the alkenes although 
the presence of double bonds would suggest that it should be similar. The explanation 
for this extra stability lies in the distribution of electrons in the molecular orbitals of 
the cyclic structure. All six carbons are sp 2 hybridised and all carbons have equivalent 
p-orbitals perpendicular to the plane of the ring. These p-orbitals overlap with 
neighbouring p-orbitals, becoming degenerate and therefore more stable, forming a 
cloud of electrons above and below the plane of the carbon ring. If a molecule exhibits 
this characteristic, it is considered aromatic (Fessenden and Fessenden, 1994). 
4 
Naphthalene 
1ý51- 
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FIGURE 1.1. Examples of PAH structures. 
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-6- 
1.2.2 Carcinogenic and Mutagenic PAH s 
Carcinogens are chemical agents that act on the body and cause cancer. 
Carcinogenicity is irreversible; the repair mechanisms of the body may reverse some 
of the effects but this is not well understood and is believed not to be significant 
(Alberts et al., 1989). 
It has been determined that cancers can be initiated by a change in DNA sequence 
called a mutation. A mutation does not always lead to a cancerous tumour growth 
however, as cancer is usually the result of a number of independent incidents in a cell, 
which have a cumulative effect (Alberts et al., 1989). PAHs are mutagenic initiators of 
cancer (Yuspa and Bethesda, 1986). They bind to the DNA in an activated form 
(Section 1.2.3) which disrupts the strand, and causes an altered transcription of the 
strand. Once the cells have been exposed to a tumour promoter above a threshold level, 
tumour production can take place no matter how much time has passed since exposure 
to the mutagenic initiator (Alberts, et al., 1989). 
Links between cancer and hydrocarbons were first observed in 1775 when scrotal 
cancer in chimney sweeps was linked to occupational exposure to soot. It was not until 
1915 however, that experimentation in Japan provided direct evidence of hydrocarbon 
carcinogenicity by applying coal tar directly to the skin of animals, which was 
followed by the identification of specific carcinogenic PAHs (Harvey, 1991). The 3 to 
7 ring PAHs in mineral oil are believed to be the source of carcinogenicity in mouse 
skin painting assays (Roy et al., 1996). 0 
1.2.3 PAH Activation 
PAHs must be activated before they can demonstrate mutagenic activity and are 
therefore known as indirect mutagens (as opposed to direct mutagens that do not 
require activation). Activation occurs in mammals as a method of making xenobiotics 
more soluble and therefore facilitating removal (excretion) from the body. Metabolic 
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I 
activation occurs in two phases. Phase I uses a multi-step pathway involving 
cytochrome P450; particularly form 1A1 (Bauer et al., 1995) to introduce a functional 
group such as a hydroxyl group. Phase II reactions connect this functional group to an 
endogenous species (e. g. glucuronic acid) to create a hydrophilic molecule that can be 
easily excreted. In the case of many xenobiotics, including PAHs, metabolic 
intermediates produced after phase I are mutagenic. 
The phase I cytochrome P450 oxidises the PAH to an epoxide and then an epoxide 
hydrase converts this to a dihydrodiol. This is then oxidised by another P450 and 
produces the dihydrodiol epoxide that will react with DNA (Figure 1.2) (Josephy et al., 
1997). 
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FIGURE 1.2. Bioactivation of Benzo[a]pyrene by mammalian liver enzymes Adapted 
from Weaver and Hedrick (1995). Benzo[a]pyrene (A) is an epoxide by cytochrome 
P450 (B) and then an epoxide hydrase (C) converts it to a dihydrodiol. This is then 
oxidised by another P450 (D) and produces the dihydrodiol epoxide (E) that will react 
with DNA. 
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FIGURE 1.3. Interaction of an carcinogenic epoxide (E) from Figure 1.2 with and 
guanine (F) on a DNA stand to form a DNA adduct (G). Adapted from Weaver and 
Hedrick (1995). 
The dihydrodiol epoxide shown in Figure 1.2 has the ability to interact with bases in 
the DNA, as shown in Figure 1.3. The epoxide on the PAH metabolite is drawn to 
negative charges on DNA, such as the electron rich centre of guanine, and forms a 
covalent bond which disrupts the DNA structure (Weaver and Hedrick, 1995). The 
techniques that are used to study DNA disruptions include gas or liquid 
chromatography, which detects adducts and as PAHs are fluorescent, fluorescence 
spectroscopy may also be used (Lodovoci et al., 1998). 
A structural indication of mutagenicity has been established and studied. When a dial 
epoxide is formed in the bay region of a PAH (shown in Figure 1.4) containing 4 to 5 
rings, the resulting structure is likely to be a mutagen (Buening et al., 1979; Glucker er 
al., 1999). When a methyl group is present in the bay region, many PAHs will exhibit 
an enhancement of mutagenicity (Harvey, 1991). However, the presence of the bay 
region does not indicate that a PAH will be carcinogenic (Zeiger, 2001). 
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Bay Region Bay Region 
iB 
FIGURE 1.4. The bay region of benzo[a]pyrene (A) and dibenzo[a, i]pyrene, thought 
to be the site of reactivity with DNA when activated by oxygenation. Adapted from 
Glucker et al. (1999). 
1.2.4 IARC Classification of PAHS 
Not all PAHs are thought to be carcinogenic, and of those that are, some are more 
carcinogenic than others. The International Agency for Research on Cancer (IARC, 
2002) has reviewed all the literature available on PAHs and has created a classification 
of carcinogenicity which is as follows: 
Class 1: Carcinogenic to humans 
Class 2A: Probably carcinogenic to humans 
Class 2B: Possibly carcinogenic to humans 
Class 3: Not classifiable 
Class 4: Probably not carcinogenic to humans 
In addition to this classification system, there are three degrees of evidence that give 
rise to these classifications; sufficient, limited and inadequate. Such general 
classification, in addition to differing levels of evidence, makes it difficult to establish 
any definite conclusions (Hewstone, 1994). 
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Mineral oils are defined in classes according to refinement (Bingham, 1988). 
Unrefined mineral oils fall into Class 1, whereas mildly refined oils are considered 2A 
or 2B. With no definition of what `mildly refined' is, it is difficult to use such a 
classification. Highly refined oils that contain little or no PAHs are considered class 4, 
but it must be noted that they are classed as such due to inadequate data on 
carcinogenicity. There are 15 PAHs that are classed as having sufficient evidence of 
carcinogenicity in animals and they are listed in Table 1.1. 
TABLE I. I. IARC 15 carcinogenic PAHs. 
PAHs Classed as Having Sufficient Evidence for Carcinogenicity by the IARC 
Benz[a]anthracene 7-H-Dibenzo[c, g]carbazole Indenol[l, 2,3-cd]pyrene 
Benzo[b]fluoranthene Dibenzo[a, e]pyrene 5-Methylchrysene 
Benzo[j]fluoranthene Dibenzo[a, h]pyrene Dibenzo[a, h]acridine 
Benzo[k]fluoranthene Dibenzo[a, i]pyrene Dibenzo[a, j]acridine 
Benzo[b]pyrene Dibenzo[a, i]pyrene Dibenzo[a, h]anthracene 
TABLE 1.2. EPA 16 priority PAHs. 
PAHs Classed as Priority Pollutants by the EPA 
Naphthalene Fluoranthene Benzo[a]pyrene 
Acenaphthylene Pyrene Indeno[ 1,2,3-c, d]pyrene 
Acenaphthene Benzo[a]anthracene Dibenz[a, h]anthracene 
Fluorene Chrysene Benzo[g, h, i]perylene 
Phenanthrene Benzo'[b]fluoranthene 
Anthracene Benzo[k]fluoranthene 
Some of these PAHs have been included on the EPA's list of 16 PAH priority 
pollutants (EPA, 2002), in addition to non-mutagenic PAHs that are hazardous due to 
their abundance in the environment. These are listed in Table 1.2. 
1.3 TESTS FOR CARCINOGENICITY 
The first tests used to identify carcinogenic behaviour of chemicals were performed on 
mammals because they are most closely related to humans. Almost all forms of cancer 
found in humans can be reproduced in an animal model by the use of chemical 
carcinogens and in some cases, the additional application of a tumour promoter. All the 
major organs of the animal are exposed in these experiments to determine where the 
greatest damage is caused. The results of any animal test however, will differ 
according to many factors so it is important to reduce as many variables as possible. 
These factors may be animal specific such as, species, age, gender or diet. It may also 
depend on the techniques used, such as, solvent selection, hair removal method, 
amount and concentration of each dose, frequency and duration of treatment or which 
end point is employed (Grimmer, 1983). 
PAHs are of most concern to the general public through contamination of food 
(Phillips, 1999) so most experimental animals are exposed to PAHs orally. However, 
skin carcinogenicity is the most relevant type of testing to companies such as the 
National Grid Company Plc as this is the most likely means of employee exposure to 
oil. Skin is one of the easiest models to study as it is clearly visible and resulting local 
changes can be recorded using photographs (Grimmer, 1983). The drawback to this 
type of testing is that the skin is not uniform in its composition and may contain higher 
levels of enzymes in certain areas. As PAHs require metabolism before they have 
effect, the potency of carcinogenicity will differ depending on which part of the skin is 
used. Skin tests will also be affected by the condition of the skin (Grimmer, 1983). 
As the skin provides a barrier between the body and the outside world, much of the 
carcinogen will remain on the skin surface and cause tumours locally. However, 
subcutaneous injections have shown that without such a barrier, the tumours are still 
mainly observed on the skin, illustrating that PAHs are local carcinogens (Grimmer, 
1983). Each different site of administration will give different rates of metabolism and 
elimination from the body. However, as all types of delivery will lead to the 
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elimination of PAHs via the liver and gall bladder, all administration has the potential 
to cause tumours in these organs (Grimmer, 1983). 
Although animal models are the closest to humans, it can take time for the cancer to 
develop and therefore great expense is incurred for the up-keep of the animals. 
Mendelsohn quoted the price of an animal test in 1988 to be $1 million per chemical 
tested. In addition, cancer is commonly a result of several types of exposures, so 
quantifying the carcinogenic effect of one particular substance is extremely difficult 
even under controlled conditions (Boffetta, 1993). Often cancer is subject to the 
susceptibility of the patient in terms of their genetic make up, which is difficult to 
quantify (Alberts, et al., 1989). 
1.3.1 Mutagenicity as a Measure of Carcinogenicity 
Due to the expensive and time consuming nature of animal tests, as well as the 
associated ethical debate, bacteria offer an alternative to animals. However, bacterial 
tests, such as the Ames test (Section 1.5.1) have two drawbacks. The first is that 
bacteria are prokaryotic cells that do not relate well to human eukaryotic cells. The 
second is that a bacterial test detects the mutagenic properties of a chemical, which 
does not always correlate with carcinogenicity (Watson et al., 1985; Zeiger, 2001). 
The literature often provides conflicting correlations between mutagenicity and 
carcinogenicity. A 91% correlation between carcinogenicity and mutagenicity was 
observed by Purchase et al. (1978) using 58 carcinogens and 62 non-carcinogens 
whereas Andrews et al. (1978) identified a correlation of only 58% when testing 25 
PAHs. 
Studies have been conducted to test the mutagenicity of 54 PAHs (Coombs et al., 
1976). Carcinogenicity data had already been made available for these PAHs, some 
from skin painting experiments on mice and others from injection experiments on rats, 
the results of which were compared with the bacterial data. Thirty-seven of the PAHs 
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were carcinogenic in animal experiments while all 54 exhibited mutagenic activity. In 
some cases the weakest carcinogens proved to be the most mutagenic. 
Although this suggests that a measure of mutagenicity cannot determine if exposure to 
a chemical will lead to cancer, mutagenicity can still illustrate a hazardous property of 
a chemical. Mutagenicity, unlike carcinogenicity can be measured directly and rapidly 
as it is not a multi-step process and does not have a long latency period. It can indicate 
the ability of a chemical to initiate cancer, so is a valid measurement to investigate as a 
screening process for potential carcinogens. It will not of course detect non-mutagenic 
carcinogens (Haroun and Ames, 1981) but as PAHs have been identified as mutagenic, 
their impact in oil carcinogenicity can be measured with a mutagenicity test. For this 
reason, bacterial mutagenicity testing was used in this work. 
1.3.2 PAH Toxicity 
Like most substances, PAHs are toxic when in a large enough dose (Wong and Wang, 
2001). Toxic effects can be split into two types, cytostatic and cytocidal toxicity. 
While cytocidal agents are lethal, cytostatic agents inhibit and slow growth rather than 
kill the cell. 
Toxicity in addition to carcinogenicity has been difficult to assess due to the problems 
associated with the extrapolation of toxicity data from other species to humans. For 
this reason it is often not clear, particularly in mixtures, what level of PAHs constitute 
a threat to human health (Moret and Conte, 2000). PAH carcinogenicity is of greater 
concern in oil than toxicity, as carcinogenicity will generally be of threat before toxic 
effects are observed (Haroun and Ames, 1981). However, if any PAH shows great 
toxicity, it is possible that it would effect mutagenicity testing by killing or inhibiting 
the bacteria. 
Cytocidal or cytostatic toxicity may be visible in mutagenicity tests by a reduction or 
complete absence of bacteria (such as the absence of a background bacterial lawn). 
However, such toxicity if not acute, may not be as visible and may mask mutagenic 
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effects by reducing the number of viable cells that can be mutated. This would lead to 
reduced numbers of revertants, even in the presence of a highly mutagenic chemical. If 
toxicity were found to significantly reduce the number of viable cells, a ratio of the 
viable cell number to revertant number would have to be measured to determine the 
reversion frequency. For example, if the number of revertants was reduced by 50% on 
plate 2 compared to plate 1, but the viable cell count on plate 2 showed 50% less cells 
present, the mutagenicity on plate 1 and 2 would be equivalent. Toxicity will be 
investigated therefore by growing the S. typhimurium culture with the test samples in 
nutrient growth to establish whether the test chemical has toxic properties that reduce 
the number of viable cells and therefore affects Ames testing (Section 5.8). 
1.4 AIMS OF THESIS 
Many studies have been performed investigating the PAH mutagenicity of oils 
(Herman et al., 1981; Blackburn et al., 1984,1986; Ingram et al., 1994; Granella et al., 
1991,1995; Brooks et al., 1995). The majority of oil mutagenicity testing centres on a 
liquid-liquid extraction step that recovers the aromatic fraction from the oil. 
Transformer oils contain a highly complex mixture of aromatics including PAHs, some 
of which may be mutagenic. Studying the mutagenicity of such extracts simplified the 
oil matrix, but attributing the mutagenicity of such extracts solely to PAHs was not 
possible. As the main concern for transformer oil hazard labelling legislation by 
CONCAWE was PAH mutagenicity, the work here centres on the isolation and 
measurement of PAH mutagenicity. 
The aims of the work were as follows: 
" Establish the extent to which PAHs contribute to total oil mutagenicity and 
therefore the risk they present to National Grid Company Plc employees. The 
mutagenicity of PAHs were compared to the mutagenicity of the aromatic fraction 
of the oil (extracted by liquid-liquid extractions) and the whole oil. This was to 
establish if the removal of PAHs from the oil removed the mutagenic threat 
significantly enough to warrant the loss of beneficial properties (reducing oil 
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breakdown) from the oil. Mutagenicity testing must include an investigation into 
possible antagonistic or synergistic effects that could interfere with measurements, 
including toxicity. 
" Identification and quantification of the main PAHs present in the oil, particularly 
PAHs classed as priority pollutants by the Environmental Protection Agency 
(EPA). This involved the development of an extraction method to isolate PAHs 
from the rest of the oil matrix. 
9 Relate carcinogenic PAH content to total PAH content to determine if measuring 
total PAH (as in the IP 346 % w/w method) is a valid method of determining 
carcinogenic risk. This involved the use of immunoassay kits that are available for 
measuring both total PAH content and carcinogenic PAH content. 
" Investigation of possible changes in PAH composition (and therefore PAH 
mutagenicity) with oil ageing. PAH composition is believed to increase with usage 
(Wong and Wang, 2001) which would improve oil oxidation stability but may 
increase oil mutagenicity and therefore increase the threat to the end-user over 
time. As used oils were not available for testing, artificially aged oil was tested for 
mutagenicity and PAH content as a measure of oxidation stability and health risk 
changes in used oil. 
1.4.1. Constraints of Work 
There were a number of considerations that controlled the manner in which the work 
was performed. The main factors that were noted at the beginning of the work are 
briefly considered here. 
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1.4.1.1 The End-User's Requirements 
As the National Grid Company Plc and indeed any other concerned end-user may wish 
to repeat this work for new oils coming onto the market, it was specified that all 
methods used should minimise the financial cost of testing and the risk to the health of 
the user. This included substituting solvents for less hazardous ones. This was 
exemplified by the move towards a solid phase extraction method for sample 
preparation, as opposed to the current liquid-liquid extraction method, in order to 
reduced solvent consumption. This consideration was also a prime reason as to why 
the Ames test was the most appropriate choice for mutagenicity testing, rather than 
other commercially available tests (discussed further in Section 1.5.1.3). The Ames test 
can be set up easily and does not require expensive equipment. The strain of 
Salmonella typhimurium can be used on the bench and does not provided risk to health 
if handled correctly. 
1.4.1.2 Oil Extracts for Both PAH Mutagenicity and Analysis 
Although many methods are available in the literature for analysing PAHs in oil, such 
as chromatographic techniques or supercritical fluid extraction (section 1.5.3.4), they 
do not produce a sufficient mass of extract to allow mutagenicity testing. Furthermore, 
current liquid-liquid extraction methods used to measure oil mutagenicity are not 
amenable to quantitative analysis, as they extract total aromatic content rather than 
PAHs solely and are therefore too complex. The same extraction method should be 
used for mutagenicity testing and analysis in order to conclude that the identified 
PAHs are present in the extracts tested for mutagenicity. For this reason, liquid-liquid 
and solid phase extraction methods was developed, as they produce extracts in 
sufficient quantity to allow both analysis and mutagenicity testing. 
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1.4.1.3 Regulatory Concerns 
In order to meet the regulatory standards governing the Ames test, four strains of S. 
typhimurium (TA98, TA100, TA1535 and TA1537) should be used to test the samples 
(Gollapudi and Krishna, 2000). However, this work was concerned with the review 
and development of improved ways to determine PAH mutagenicity, and is not 
required to meet such regulatory standards. For this reason only TA98 (shown to be the 
most susceptible strain to PAH mutagenicity by Hermann et al, (1980)) was used. 
1.4.1.4 Variation in PAH Content with Oil Origin and Age 
For users of transformer oils, the problem of determining the risk arising from PAHs is 
complicated by the fact that there is no guarantee that all oils will have a similar PAH 
content and composition. Gases produced as a result of oil deterioration during in- 
service usage react with naturally occurring PAHs and other components of the oil to 
alter the PAH composition (Moret and Conte, 2000). This is further complicated 
should the oil be mixed with those from another source and can have detrimental 
effects on transformer performance (Nynas, 2001). For these reasons, it is also highly 
desirable to find a way of monitoring the PAH composition of in-service oil that is 
quick and cheap. Ideally, an analysis method that is easy to perform on site rather than 
in the laboratory where testing is currently slow and requires large, expensive 
equipment and trained staff, would be beneficial. 
1.4.1.5 PAH Mixtures in a Complex Matrix 
The initial problem that occurs when beginning mutagenicity testing on PAH species 
in oil is that there is no agreement in the literature as to the mutagenic effect of PAHs 
mixtures. It is often assumed that toxic substances will show the sum of their toxic 
effects when in a mixture (White, 2002). This cannot always be true due to the 
synergistic and antagonistic effects known to occur in any chemical mixtures 
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(Manahan, 1994). This has led to a limited understanding of the underlying biological 
effects of toxic mixtures (Randerath et al., 1999). Information concerning the 
mutagenic effects of PAH mixtures upon animals has been gathered, but shows widely 
differing results according to the route of exposure (Schneider et al., 2002). 
The mixture of PAHs that have been identified in oil (Pahlavanpour and Wilson, 1999) 
will have antagonistic and synergistic effects, which may increase or decrease the risk 
from PAHs in complex oil samples. Other components in the complex oil matrix are 
also likely to have antagonistic and synergistic effects, which must be investigated. 
These interferences may also have their own mutagenic properties, which ideally must 
be subtracted from the PAH mutagenicity in order to determine if PAHs present the 
greater risk to human health. 
1.4.1.6 Volume of f Oil for Testing 
Another consideration when testing oil for mutagenicity was the quantity of oil to use. 
The carcinogenic PAHs may only make up a small percentage of the oil, but as 100 
000 litres of oil are used in a single transformer, the risk becomes proportionally 
significant (National Grid Company Plc, 2002). For this reason, it is not unreasonable 
to suggest that the quantity of oil tested may have a significant impact on the final 
conclusion of the study. 
As there are limits to the amount of oil that can be immobilised on the surface of an 
agar plate with the bacteria, PAHs will have to be concentrated to allow greater doses 
to be tested. The polyaromatic content of the oils provided by the National Grid 
Company Plc varies from 1-9% according to the IP346 % w/w method (Table 2.1) 
suggesting that a range of doses must be tested. The literature suggests typical oil 
volumes of 2-6 mL for subsequent Ames testing is sufficient to elicit a mutagenic 
response (Herman et al., 1981; Blackburn et al., 1984,1986; Ingram et al., 
1994; 
Granella et al., 1991,1995; Brooks et al., 1995). An oil volume of up to 
6 mL will mix 
relatively well with 1 mL DMSO, a minimum volume required 
for conventional petri 
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dish based mutagenicity testing. When adding the extract of more than a6 mL volume 
of oil to lmL DMSO, the sample is not completely soluble. In addition, extracting 
more than 6 mL becomes more hazardous, as it requires more solvent to be used 
during the extraction method, which is detrimental to the end-user. 
1.5 INTRODUCTION TO METHODOLOGIES 
The following section provides an introduction to the methods used in this work. This 
includes the Ames test which is used for mutagenicity testing, liquid-liquid and solid 
phase extraction methods used to determine the PAH content of the oils and 
immunoassay and GCMS employed to detect and analyse the PAH composition. 
1.5.1 The Ames Test for Mutagenicity 
In the 1970s, Bruce Ames developed a test utilising Salmonella typhimurium that has 
become a standard test for the preliminary screening of potentially carcinogenic 
chemicals (Ames et al., 1975). 
The Ames test consists of a specially constructed Salmonella typhimurium auxotrophic 
histidine mutant strain incorporated into top agar and grown on a minimal glucose agar 
plate. Each mutant strain contains an alteration in one of the 8 genes of the histidine 
operon. With each mutation an enzyme will be inactivated, leading to incomplete 
histidine production so that only a trace of histidine present in the top agar keeps the 
bacteria alive. More detail is given in Section 1.5.1.2. 
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FIGURE 1.5. The principle of the Ames test. An auxotrophic histidine mutant of S. 
typhimurium, on the addition of a mutagen, will revert to wildtype, which leads to 
growth in the absence on histidine. Without the addition of a mutagen, the strain 
remains auxotrophic and no significant growth is observed. 
Of the many new mutations that can occur on the addition of a mutagenic chemical to 
the mutant S. typhimurium, a small percentage will occur that compensate for the 
original mutation (Figure 1.5). As the Ames test incorporates a dense population of S. 
typhimurium cells, the small percentage of cells that undergo a compensatory mutation 
is significant and can be visualised as a greater number of colonies on the plate. These 
colonies are counted after incubation at 37°C for 2-3 days. The colony numbers are 
compared to negative control plates containing everything but the test chemical and 
positive control plates containing a strong mutagen such as benzo[a]pyrene (Plate 1.1). 
The negative control plates will have a small number of revertant colonies growing on 
them due to spontaneous reversions at the genes encoding histidine synthesis. If the 
test plate contains at least a doubling of the number of revertants found on the negative 
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control plate at two consecutive doses (as with the positive control plate) the test 
chemical is considered mutagenic (Maron and Ames, 1983). 
AB 
PLATE 1.1. Colony revertants on negative (A) and positive (B) control plates in the 
Ames test. S. typhimurium TA98 on the addition of non-mutagenic DMSO carrier 
solvent (negative control) and 5 pg mL-1 mutagenic benzo[a]pyrene (positive control). 
1.5.1.1 Bioactivation of Chemical Carcinogens in the Ames Test 
In order to incorporate the phase I metabolic activation enzymes required for PAH 
mutagenicity into an in vitro experiment, a 9000 Xg centrifugation supernatant of a rat 
liver extract called S-9 is used (Tauc et al., 1984) along with the addition of 
nicotinamide adenine dinucleotide phosphate (NADP) as a co-enzyme. Aroclor-1254- 
induced rat enzymes were shown to be more effective than induced hamster S-9 
(Rainen et al., 1981) and were most readily available. Aroclor-1254-induced rat liver 
S-9 was described in De Flora et al. (1984) as being effective at activating 
carcinogenic PAHs in the Ames test. There are drawbacks to using this method 
however, as the enzymes are susceptible to changes in temperature and pH, which 
means that controls must be used to ensure the enzyme activity is optimised (Tauc et 
al., 1984). 
II 
The activity of these enzymes has been shown to differ among mammalian species and 
even primate species, therefore creating problems in the extrapolation of results from 
animals S-9 to humans. For example, mouse cytochrome P450 1A1 metabolises 
Benzo[a]pyrene at a much greater rate that the human form (Shou et al, 1994). Human 
S-9 can be gained during autopsy therefore reducing extrapolation problems, but 
sources are limited and the enzyme activity may be reduced from this source (Josephy 
et al, 1997). 
1.5.1.2 Key Factors and Modifications of the Ames Test 
The Ames test relies on the fact that there are many available mutant alleles in the 
Salmonella typhimurium his operon, which are sensitive to mutagens. Many different 
sequence changes in the his operon will lead to a reversion to the wildtype (histidine 
producing). Such test strains were also modified to achieve greater cell permeability, 
as well as inactivating the DNA repair system so that damage was maximised. Each S. 
typhimurium tester strain used in the Ames test contains a different type of mutation in 
the his operon. For example, Strains such as TA1538 and TA98 have a frameshift 
mutation in the hisD gene (hisD3052) that encodes histidinol dehydrogenase (Maron 
and Ames, 1983). 
The S. typhimurium strain found to be most sensitive to hydrocarbons was TA98 
(Hermann et al, 1980). TA98 specifically includes mutation rfa (rough deep character) 
that causes partial loss of the lipopolysaccharide barrier that coats the surface of 
bacteria and increases permeability so that large molecules are able to enter. It also has 
the addition of a plasmid pKM101. The plasmid infers ampicillin resistance as a 
marker of the plasmid's stability (Maron and Ames, 1983) and encodes genes involved 
in error-prone DNA repair. There is a danger however, that by enhancing the 
mutagenicity, one may produce a false positive result. It is more dangerous to get a 
false negative result however, and for this reason enhancing mutagenicity remains an 
important tool (Josephy et al, 1997). 
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Blackburn et al. (1984,1986) developed the Ames test into the form that is now known 
as the `modified Ames test' and that has improved the sensitivity of the Ames test with 
respect to measuring the mutagenicity of the aromatic portion in oils. The 
modifications include an eight-fold increase in the concentration of S-9 and a two-fold 
increase in co-enzyme (NADP) to increase the probability of activation. The aromatic 
content of oil is also extracted using dimethylsulphoxide (DMSO), to concentrate the 
mutagens in the oil. 
1.5.1.3 Alternative Mutagenicity Tests 
Greater deviation from the Ames test is seen in the use of luminescent bacteria. One 
photobacterium bioassay commercially available is called the MutatoxTM test. Vibrio 
fisheri M169 will show an increase in luminescence on the addition of genotoxic 
chemical (Johnson, 1992; Bekaert et al, 1999). Commercially available tests such as 
MutatoxTM are expensive to both set up and use as they rely on a supplier to provide 
specialised components. Newer tests use genetically modified organisms, such as yeast 
(a eukaryote) with a green fluorescent jellyfish protein reporter plasmid added 
(Walmsley et al, 1997). However, all new tests must be validated using the Ames test 
as a standard. For these reasons, the Ames test was chosen for initial mutagenicity 
testing, especially with the modified method (Blackburn et al., 1986). The Ames test 
can be set up in any hazard II microbiological laboratory, without great expense or 
specialised equipment. The test can also be performed on the bench and all 
components of the test can be prepared in-house. 
1.5.2 Liquid-Liquid Extraction 
Liquid-liquid extractions (LLE) are the main method of removing the aromatics from 
oil matrices and are either used solely or following a solid phase extraction (Paschke et 
al., 1992; Moret and Conte, 2000, Wang et al., 2000). The most commonly used LLE 
is the IP 346 method (BS2000 Part 346,1996) which is the industry standard for the 
estimation of polyaromatic content in transformer oil, although it tends to overestimate 
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by measuring total aromatic content (Section 1.1.3.1). Oil aromatic content estimated 
by IP 346 is believed to correlate well with animal painting tests (Stang, 1993; 1999; 
2000). 
The general mechanism of LLE can be illustrated by the IP 346 % w/w extraction 
where an organic non-polar solvent (cyclohexane) is added to an aqueous polar solvent 
(DMSO and water) and the oil and its components are partitioned between the 
immiscible layers. As PAHs are polar they will prefer the DMSO layer, while the 
aliphatics prefer the organic layer. The mixture is shaken and left to separate, then 
more DMSO is added to ensure complete separation of the aromatics from the 
aliphatics. The aromatics can be collected in the DMSO layer or removed to a fresh 
organic layer by disrupting the DMSO layer with the addition of a salt solution. The 
method is outlined in Appendix B. 
LLE has also been used with the Ames test to determine the mutagenicity of mineral 
oil (Blackburn et al., 1986). Again, it was the aromatics that were removed, not just the 
PAHs, therefore mutagenicity measured by this extraction method may not 
automatically be attributed to PAHs. 
1.5.3 Solid Phase Extraction 
Solid phase extraction (SPE) is another sample preparation method. It has two main 
functions, to purify and concentrate an analyte. It was designed in the 1970's as an 
alternative to LLE as it has the benefits of better separation (due to no emulsion 
formation) and automation. SPE columns come in different formats, such as disks, for 
small quantities of sample (10-20 µL), cartridges for larger quantities (20-100 µL) 
which are most commonly used (shown in Plate 1.2) and finally barrels, which come 
in 
a large variety of sizes (Henry, 2000). The majority of formats are available 
in 
polypropylene with a matching frit. If platicizers are likely to 
interfere with the 
analysis, glass barrels with Teflon frits can be used. 
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When studying one compound in a sample, studies can be conducted to predict the 
extraction efficiency of an analyte according to its chemical properties. Such 
information can be used to determine the best sorbent to use. As oil is a complex 
mixture of compounds, however, prediction of such properties is unrealistic. Only a 
practical application of SPE will determine the best way to extract PAHs from oil. 
r 
law 
A 
PLATE 1.2. SPE cartridges for solid phase extraction. The cartridges are shown in 
consecutive use with an adaptor (in red) to join the cartridges together. The top clear 
column is an unfilled filtration tube used as a solvent reservoir. 
1.5.3.1 Types of SPE 
Two types of SPE were used, normal and reverse phase. The most commonly used 
SPE for the extraction of components from oils is normal phase extraction. Normal 
phase extraction uses a polar sorbent to retain polar components within the column, 
therefore washing out non-polar alkane components. Washing is achieved by using a 
non-polar solvent. Most importantly, once the unwanted components have passed 
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through the column, the polar components can be removed using a suitable polar 
solvent (Moret and Conte, 2000). The ability of a solvent to remove the polar 
components from the column is measured as an eluotropic strength (E). Choosing the 
correct solvent for elution will ensure effective extraction in the smallest possible 
volume, therefore ensuring a concentrated sample (Wells, 2000). Solvent eluotropic 
strength is taken from Thurman and Mills (1998) and shown in Table 1.3. An 
eluotropic strength of >0.6 was considered to be the most appropriate to elute 
moderately polar components from silica. An eluotropic strength of <0.38 was most 
appropriate for a washing solvent. However, as there were a number of polar 
components present in the oil, altering the solvent according to eluotropic strength 
allowed the separation of compounds with similar polarity. PAHs were found to only 
require a0 of -0.43-0.45 for effective elution, as anything higher produced the 
elution of additional polar components including column bleed, which occurred with 
methanol (Section 4.2.2.1). 
TABLE 1.3 Solvent eluotropic values. Adapted from Thurman and Mills (1998). 
Solvent I Eluotropic Strength (EO) Polarity 
Methanol 0.73 6.6 
2-Propanol 0.63 4.3 
Ethyl acetate 0.45 4.3 
Acetone 0.43 5.4 
Cyclohexane 0.03 0.0 
n-Hexane 0.00 0.06 
The most common normal phase sorbent used is silica (Si02). When SiO2 is used to 
interact with the analyte, it does so with hydrogen bonding through a Si-OH bond. The 
silica gel can be modified by the addition of functional groups to produce sorbents 
with different properties including reverse phase extraction. 
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Reverse phase is literally the reverse of normal phase, using a non-polar sorbent, 
usually C 18 (Silica with (CH2)17CH3 groups attached). Bonding to the sorbent occurs 
through Van der Waals interactions. The advantages of the bonded silica sorbents are 
that they are stable in organic solvents, have good flow characteristics, and are easily 
wet with polar or non-polar solvents. Most importantly, a wide range of functional 
groups are available for various applications (Thurman and Mills, 1998). 
1.5.3.2 Effects of Length and Width on SPE Columns 
One important factor in effective SPE is the shape and size of the sorbent column. 
Plate theory is used in all chromatographic methods and relates the length and width of 
a column to its efficiency by describing the columns in terms of smaller sections called 
plates. As in all chromatographic methods, the sample slowly moves through the 
column with the solvent and will equilibrate with a small section of sorbent at a time. 
Plate theory was used for chromatography by Martin and Synge (1941) to predict the 
movement of an analyte. The primary finding was that the greater the number of plates 
in a column, the better the separation (Thurman and Mills, 1998). 
As SPE columns are small in length compared to a column used in separation 
techniques such as gas chromatography, they will contain a small number of plates and 
therefore will not be efficient at separating analytes according to the distribution 
coefficient. However, they can still be used for isolation of analytes and the greater the 
number of theoretical plates present, the less dispersion that can occur and a lesser 
volume of solvent is required for elution. Increasing the amount of sorbent used 
however, will increase the volume of eluent required although when used in a thin 
column, this will also increase the plate number and therefore the efficiency of 
extraction (Thurman and Mills, 1998). The volume of sample added will also effect 
extraction efficiency. If too much sample is used, the column may become saturated 
and separation will not be complete. However, if too little is added, the analyte may 
interact more strongly with the unsaturated sorbent (if the analyte contains more than 
one binding site) and more solvent is required to remove it from the column. With 
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more analyte the interactions are shared between more molecules, and become easier 
to break. 
An extension of plate theory, known as `rate' theory is now used that acknowledges 
the contribution of elution rate on separation efficiency. Rate of elution will differ 
according to the analytes affinity for the column, the path through the stationary phase 
it takes (which may vary in length) and the extent of analyte diffusion (longitudinal 
diffusion) along a plate. Rate theory therefore illustrates the importance of constant 
flow rate as well as column length during chromatographic separations. 
1.5.3.3 Sample Breakthrough 
Another important factor in the development of SPE is the point at which the analyte 
begins to be lost (breakthrough) from the column. PAH breakthrough was easily 
determined as PAHs fluoresce. This allowed the monitoring of PAHs with an Ultra 
Violet (UV) lamp, and reduced the need for breakthrough experiments. However 
breakthrough during washing can be determined by continuous washing and analysis 
of the wash solvent after it is recovered from the column. Additionally, overloading of 
the column can also be established by running an extraction with different volumes of 
sample, and determining which produces the cleanest extract by gas chromatography 
(Simpson, 2000). 
1.5.4 Gas Chromatography Mass Spectroscopy (GC-MS) 
Quantitative analysis of oil is usually performed with techniques such as high pressure 
liquid chromatography (HPLC) and gas chromatography with mass spectroscopy (GC- 
MS), although earlier quantification was achieved only partially by the use of thin 
layer chromatography (TLC) with ultra-violet (UV) detection or fluorescence 
spectroscopy (Moret and Conte, 2000). HPLC in particular can determine the many 
isomers of PAHs and is used by the oil manufacturer Nynas for this purpose (Kroon, 
1989). In the Nynas method the whole oil is dissolved in hexane and injected onto a 
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HPLC column of nitrile-substituted silica, which adsorbs aromatic rings with the 
compound with the greatest number of rings (most polar) adsorbing most strongly. The 
large PAHs stick so efficiently that backflushing is employed to remove them once the 
smaller PAHs are removed. 
Recently, work has been performed with supercritical fluid extraction (SFE) as it 
removes the need for hazardous solvents and has a short analysis time. Much 
development of this technique is under way in the literature, and for PAH analysis it 
has been most effective after SPE (Marce and Borrull, 2000). However, due to the 
limited availability of the HPLC and SFE equipment, the chosen analysis technique 
was GC-MS. GC-MS has proven to be particularly useful for PAH analysis as PAHs 
are thermally stable. The combination of the techniques (GC and MS) in particular, has 
the advantage of selective monitoring, which allows target compounds to be monitored 
with greater sensitivity even in complex mixtures. This may be of particular benefit for 
PAHs in oil, where the PAHs make up an extremely small fraction of the total 
components. 
1.5.4.1 Gas Chromatogram (GC) 
GC is a method for the separation of analytes in a gaseous mobile phase using a 
stationary phase. In the same way as SPE, the analytes interact with both phases, but 
are separated according to volatility. Volatile components spend little time on the solid 
phase and are therefore eluted quickly and said to have a short retention time. Only 
thermally stable analytes such as PAHs can be separated this way as the operating 
temperature ranges from 50-300°C, which would destroy many analytes and make 
detection impossible (McNair and Miller, 1998; Purdue University, 2002). 
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FIGURE 1.6. The principle components of a Gas Chromatogram (GC') (Purdue 
University, 2002). 
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FIGURE 1.7. A GC slit/slitless injector (Polytechnic University, 2002). 
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A GC is composed of a number of parts crucial to the analysis of samples and are 
outlined in Figure 1.6. The first is the injection port, where sample is added. For 
efficiency, the sample should be added in low quantities (usually 0.1-2 µL) and as 
rapidly as possible to reduce peak broadening and improve resolution (Polytechnic 
University, 2002). The sample is made up in a volatile solvent such as methanol or 
acetone and injected with a syringe through a septum, which will seal once the needle 
is withdrawn. Unfortunately the septum can be the source of bleed as the needle cores 
some fragments into the column. The sample can also accumulate at the septum, so the 
septum must be changed regularly. A diagram of the injector is shown in Figure 1.7. 
Two methods, split or splitless injection, can be used to inject the sample. The same 
injector is used in both cases and contains a glass liner with glass wool to increase the 
surface area allowing complete volatilisation. In split injection the sample is 
evaporated in the vaporisation chamber after injection and joins the carrier gas stream. 
Most of the sample is vented leaving 0.1-10% to enter the column. This method is used 
with simple mixtures, especially where the less volatile components are required for 
analysis, as highly volatile components tend to be vented. With such a small amount of 
sample entering the column, split injection is not reliable for quantitative analysis. 
Alternatively, splitless injection allows up to 5 gL of sample to be added and is 
achieved by keeping the split valve closed and the column cooler than the boiling point 
of the solvent. The sample is injected slowly and allowed to evaporate for up to 60 
seconds. Only then is the split valve opened to purge the injector port. The splitless 
method is useful with dirty samples as the glass liner can easily be replaced. As larger 
quantities of sample are used splitless injection is better for the quantification of trace 
components (Purdue University, 2002) such as PAHs in oil. 
The second component of the GC is the column, which is the stationary phase. 
Columns can work at a range of 40-350°C. Capillary columns are hollow tubes with 
methylpolysiloxane (5% phenyl) coated onto the walls and are both flexible and 
inert. 
A smaller diameter and greater length is best due to a greater number of theoretical 
plates (Kitson et al., 1996). 
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The third component is the carrier gas, which is the mobile phase. The carrier gas must 
be inert and preferably of no risk to health so helium, hydrogen or nitrogen are most 
often used (helium in this case). The carrier gas mixes with the sample in the injection 
chamber and carries it through the column. The flow rate must be kept constant 
irrespective of the temperature for effective separation and repeatability (Purdue 
University, 2002). 
The oven and other temperature control devices make up the forth important 
component. Without such heating devices the sample would not volatilise. Without 
correct heating at every part of the system the sample would condense, leading to poor 
separation and contamination of the system. The injector temperature is usually around 
50°C higher than the boiling point of the least volatile component of the sample 
(Polytechnic University, 2002). 
Controlling the column oven temperature allows effective separation of sample 
components. The column is usually maintained for a short time at a low temperature at 
the start of an analysis to allow the highly volatile components to elute effectively. If 
the temperature were too high at this point, all the volatiles would elute together giving 
poor resolution. The temperature is then ramped to up to 40°C min' to allow 
volatilisation of the less volatile components. The higher the temperature, the faster the 
elution, but by carefully ramping the temperature the separation and resolution of a 
mixture is not compromised (Purdue University, 2002). 
In GC, the column would enter a detector and recorder to collect the data. However, in 
GC-MS the capillary column exit is inserted into the ion source of the mass 
spectrometer. 
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1.5.4.2 Mass Spectrometer (MS) 
When the sample leaves the GC column it enters the ion source of the MS, which is 
under vacuum. The ion source used here converts the sample into gaseous ions by 
bombardment of the analyte with electrons (electron impact, EI). The electrons have a 
kinetic energy of -70 eV which allows it to knock electrons out of the analyte 
molecules. This leads to the formation of cations, which are accelerated towards a 
mass analyser by a potential (a few volts), which separates the ions according to their 
mass/charge (m/z) ratios (West Virginia University, 2002). 
The mass analyser used in this work was a quadrupole, a group of four electromagnets, 
and is shown in Figure 1.8. The electrically charged poles create a magnetic field that 
aligns the ions. Masses can be selected by sweeping a radiofrequency signal. With 
each frequency a different m/z ratio can escape the quadrupole and hit the detector. 
Sweeping across a range, from high to low, releases the range of m/z ratios 
individually, to produce a spectrum, by plotting mlz ratio against intensity 
(abundance). When GC is combined with MS, a measure of time vs. intensity vs. m/z 
ratio is achieved which allows each separated GC peak to be identified by its specific 
MS spectrum. A total ion chromatogram (TIC) is produced when all the raw signals 
are plotted against time. Alternatively, ions of interest can be selected and plotted 
against time in a selective ion chromatogram (SIC) (Niessen, 2001). 
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FIGURE 1.8. The principle components of a Mass Spectrometer (MS) (Polytechnic 
University, 2002). The inlet is where the GC column enters the ion source and the 
analyser is a quadrupole. 
1.5.5 Immunoassay 
Immunoassays use antibodies in the detection or isolation of an analyte. As antibodies 
are specific to antigens, the analyte is injected into an animal, such as a sheep or rabbit 
to elicit a response from the animal's immune system. The antibodies produced are 
isolated and used, in this case with a labelled analogue as a measure of the PAH 
present. Most work conducted using antibodies to detect PAHs has been performed in 
water and soil samples using commercially available kits (Barce16 et al., 1998; Chuang 
et al., 1998). Commercial kits are easier to use, although costly, as setting up and 
optimising an immunoassay can take years of research. 
A commercial kit was used as an additional PAH detection method. Although there 
were concerns about how it would perform in a complex oil matrix it had been 
successfully used during previous studies at Cranfield University by Kim et al. (2001) 
with great dilution of the oil matrix. The mechanism involved in the immunoassay 
method is summarized in Figure 1.9. More detail on the test is outlined in Section 2.1.6 
and 2.2.13. 
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FIGURE 1.9. Outline of the competitive PAH immunoassay kit. (1) Mixing of the 
sample with the antibody/magnetic particle and colour labelled analyte analogue. (2) 
Incubation, the analyte and analogue compete for binding sites of the antibody. (3) 
Washing of unbound analyte and analogue while the antibody/magnetic particle is held 
with a magnet. (4) Coloured label is read by absorbance at 450 nm. Absorbance is 
inversely proportional to analyte. 
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CHAPTER 2.0 
MATERIALS AND METHODS 
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2.1 MATERIALS 
The materials and preparation steps for the techniques used in this work are set out 
below. The method for each technique is outlined in detail in Section 2.2. 
2.1.1 Oils Samples 
All oils were supplied by the National Grid Company Plc. Supplied were: 
" Twelve oils, with varying aromatic content from three different manufacturers 
(details in Table 2.1) 
" Nytro-lOGBN (NlOGBN), the most commonly used transformer oil by the 
National Grid Company Plc 
"A sample of Castrol BS 148 which was artificially aged for three weeks 
" The highly refined `white' oil serving as a PAH-free control. However, it differed 
from transformer oil in its composition due to the extensive refining process. 
The aged oil was provided to determine how PAH composition changes with use. 
Changes in PAH composition may affect oil oxidation stability and mutagenicity. The 
original oil will be referred to as `ALT 0'. ALT 0 oil was artificially aged using a 
method recognised by the electrical power transmission industry (BS EN 61125,1993) 
for the National Grid Company Plc at the Glasgow Caledonian University. Aluminium 
electrodes were immersed in the oil and the voltage increased until electrical 
discharges were observed. This voltage was applied for 1 week (ALT 1) 2 weeks (ALT 
2) and 3 weeks (ALT 3) producing a total of 3 aged oils for comparison with ALT 0. 
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TABLE 2.1. Details of the transformer oil samples 1-12 and Nytro-1 OGBN. All oils 
were provided by the National Grid Company Plc 
Oil Identification Number I IP 346 (% v/v) Manufacturer 
1 1.8 Nynas 
2 2.1 Carless 
3 3.3 Nynas 
4 <1.0 Carless 
5 2.6 Carless 
6 1.8 Carless 
7 1.0 Nynas 
8 8.9 Carless 
9 2.2 Carless 
10 4.5 Carless 
11 <1.0 Nynas 
12 3.7 Castrol 
Nytro- I OGBN 1.75-2.64* Nynas 
* IP 346 value measured in house 
Oil 8 contained the greatest amount of PAH according to the IP 346 % w/w data and 
was therefore chosen for initial testing. In addition oil 4, which had a particularly low 
PAH content according to IP 346 % w/w data, was tested along with Nytro-10GBN 
which was tested due to its abundant use. White oil was also used in experiments to 
give a background `blank' reading. 
2.1.2 The Ames Test 
All components of the Ames test were purchased from Sigma-Aldrich (Poole, UK) 
unless otherwise stated. The procedure was slightly modified from that described 
in 
Maron and Ames (1983) to simplify preparation and was performed in a Hazard 
II 
safety cabinet. Dimethyl sulphoxide (DMSO, 99+% ACS reagent) was purchased 
from 
Fisher Scientific Ltd (Manchester, UK). 
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2.1.2.1 Inoculation of Bacteria Bacteria from Original Freeze Dried Sample 
Nutrient broth was prepared using Nutrient Broth No. 2 BP pH 7.3 (2.5g) purchased 
from Lab M (owned by IDG Ltd, Bury, UK) in deionised water (100 mL). After 
autoclave sterilisation it was inoculated with a freeze dried Salmonella typhimurium 
TA98 strain (Public Health Laboratory Services Culture Collection, London, UK). The 
culture was shaken at 30°C in a 100 mL conical flask and grown up for 16 hours. A 
small quantity of this culture was propagated on a nutrient agar plate until the liquid 
culture was deemed satisfactory. If the liquid culture was contaminated, a colony from 
the agar plate could be used to produce a new culture, by inoculation into fresh 
sterilised broth. 
Frozen 1 mL vials of culture were prepared for future use by adding 90 µL of DMSO 
per 1 mL of culture to the original nutrient broth culture. Each aliquot was stored in a 
microtube (BDH, Poole, UK) and frozen at -80°C. To make a fresh culture from a 
frozen vial, fresh nutrient broth (100 mL) was inoculated with the thawed culture and 
shaken for 16 hours at 30°C in a sterilised conical flask. The fresh culture was kept in 
the fridge for up to 5 days. 
Routine checks to ensure the desired phenotypes (discussed in Section 1.5.1.2) are 
intact (ampicillin resistance, histidine requirement) were performed on nutrient agar 
plates, once every 3 months or whenever the bacteria demonstrated an unexpected 
characteristic, as described in Maron and Ames (1983) (Appendix A). 
2.1.2.2 Preparation of Minimal Glucose Vogel Bonner (VB) Plates 
The Vogel Bonner (VB) solution (a minimal glucose, high salt composition) was made 
up as outlined in Appendix A (Maron and Ames, 1983). The plates were prepared in 
100 mm x 15 mm petri dishes (BDH) and contained 30 mL of minimal glucose VB 
agar medium. The medium was prepared by adding 7.5 g agar to a1L Duran bottle 
(BDH), with 490 mL de-ionised water and the 10 mL VB solution. This was 
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autoclaved for twenty minutes at 121 °C and within 10 minutes of cooling, 10 g 
glucose was added directly to the solution and mixed slowly by swirling the bottle by 
hand to minimise foaming. The plates were stored at 4°C for up to a month before use. 
2.1.2.3 Preparation of the S-9 Mix 
Phosphate buffer solution (pH 7.4) was prepared as outlined in Appendix A (Maron 
and Ames, 1983). The amounts of each component per 10 mL of the S-9 mix (10% 
v/v) were as follows: 
5.0 mL Phosphate buffer (pH 7.4; 0.2 M) 
4 mL De-ionised Water 
1 mL Rat liver S9 (Aroclor-1254-induced) 
14.1 mg Glucose-6-phosphate 
31 mg Nicotinamide adenine dinucleotide phosphate (NADP) 
Rat liver S-9 homogenate was purchased from ICN (Basingstoke, UK). The phosphate 
buffer and distilled water for the S-9 mix were sterilised by autoclaving for 20 minutes 
at 121 °C. NADP and glucose-6-phophate were added to the buffer water mixture 
almost immediately after autoclaving. The S-9 was added once the solution had cooled 
to 40°C. 
For the "Modified Ames Test" described by Blackburn et al. (1984), twice as much 
NADP (62 mg) and glucose-6-phosphate (28.2 mg) were used and 8 mL of S-9 was 
added, replacing both water and buffer. This ensured optimum activation of the 
PAHs 
in the oil sample by the enzymes. The volume was made up to 10 mL 
by the addition 
of 2 mL of buffer. The S-9 mix was freshly prepared each 
day and kept on ice before 
use. 
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S-9 free solution was also prepared to determine the tent of sample mutaQeniýity 
without enzyme activation (direct mutagenicirv). This buffer «-as prepared in the same 
way as the 10% `- %, S-9 mix. with de-ionised water replacing the S-9. 
2.1.1.4 Preparation of Top Agar 
The 0. 
-; m-%i 
histidine and biotin solution used in the top agar was prepared as described 
by Aaron and Ames (1983) and outlined in Appendix A. 
The top agar was prepared as follows: 
0.6 a Haar 
0.5 g Sodium chloride 
90 mL Distilled water 
10 mL Histidine Biotin solution (O. SnLv1) 
The top agar was autoclaved for 20 minutes at 121°C prior to use and stored in a water 
bath at 45 3C until required. 
2.1.3 Liquid-Liquid Extractions 
All solvents (99-0 o ACS reagent) were purchased from Fisher Scientific Ltd and all 
separating funnels were from BDH. Evaporation was achieved using a rotary 
evaporator (BUCHI Rotovapor R-110). 
2.1.4 Solid Phase Extraction 
Spiking experiments N,,, -ere performed using a standard containing, 10 uQ mUl of each 
of the EPA 16 priority PAHs in cv clohexane supplied by Qmx Laboratories (Esscv 
UK). The Camag Ultra Violet (UV) lamp used to track the PAH fluorescence (at 366 
nm) was purchased from BDH. 
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Silica gel (60A) and Aluminium oxide (neutral alumina) was purchased from Sigma- 
Aldrich (Poole, UK). The 900 mg Cyanopropyl and 900 mg C18 cartridges were 
purchased from Machery-Nagel (Oxon, UK). The 1g PAH HC Isolute SPE columns 
were purchased from Jones Chromatography (Hengoed, UK). Polypropylene filtration 
tubes (1 cm diameter, 3 mL length) with matching polyethylene frits were supplied by 
Supelco (Bellefonte, USA). 
The 20 mm x 200 mm glass chromatography columns briefly used to assess the effects 
of column thickness (Section 4.2.2.3) were purchased from BDH. The preferred 10 
mm x 460 mm glass Ace chromatography column used in Section 4.3.1 with fitted 
disc was purchased from Sigma-Aldrich as was the larger 50 mm x 600 mm glass 
chromatography column used to extract 20 g of oil in Section 3.6. 
Quickfit glass adaptors were used to attach a syringe or a compressed air tap to the 
columns, to increase pressure and therefore increase solvent elution rate. The size of 
the adaptor varied depending on the column used but all quickfit adaptors were 
purchased from BDH except for the large scale extraction column, the adaptor for 
which was purchased from Sigma-Aldrich. The adaptors used with the small scale 
polyethylene columns were PTFE column adaptors purchased from Jones 
Chromatography. 
2.1.5 Toxicity Measurements 
Sterile, flat bottomed 96 well microtitre plate and microwell sealing tape were 
purchased from BDH. A computer controlled Dynex Technologies Ltd MRX plate 
reader (Billingshurst, UK) was used to read absorbance at 600 nm. 
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2.1.6 Immunoassay 
Two RaPID assay PAH test kits were purchased from Strategic Diagnostics Inc 
(Newark, DE USA). One was for total PAH measurement and the other favoured the 
detection of carcinogenic PAHs. All reagents were supplied with the kits and are listed 
in Appendix A. 
Polystyrene test tubes were also included, and all reagents contained stabilisers and 
preservatives to increase the shelf life of the kits. The oils were diluted in methanol 
(Sigma-Aldrich) before testing. 
Paramagnetic beads were separated from the sample solutions using a magnetic 
separation rack (Strategic Diagnostics Inc). Colour development was measured using a 
plate reader (Dynex Technologies Ltd). 
2.2 METHODS 
In this section, the methods used in this work are outlined in detail. The materials used 
in this section have been discussed in Section 2.1. 
2.2.1 Ames Test Sample Preparation 
The samples were usually tested over 5 doses (10 fold dilution in each case) to test for 
mutagenicity over a wide range (Organisation for Economic Co-operation and 
Development (OECD), 1983). A dose response, particularly with a doubling of the 
reversion number observed on the negative control plates (at 2 consecutive dilutions) 
indicated mutagenicity (Jackson and Pertel, 1986). A doubling observed at only one 
dilution was justified by additional testing over a smaller dose range. This standard of 
mutagenicity was difficult to adhere to for the liquid-liquid extracts of oil, as the 
highest dose available for testing, was the only dose that produced a mutagenic 
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response. If a higher dose could not be achieved for mutagenicity testing, the results 
were validated by comparison with the mutagenicity data of alternative extracts of the 
same oil. In addition, testing over 5 doses was occasionally limited to a smaller range 
when the S-9 concentration was increased to 80% v/v, due to limits in S-9 availability. 
Indirect mutagenicity (activation required) was measured with the S-9 solution 
(Section 2.1.2.4), while direct mutagenicity (no activation required) was measured 
using a S-9 free solution (OECD guidelines, 1983). Each dose of samples was tested 
for direct and indirect mutagenicity in triplicate (6 plates in total). 
Controls were included to ensure that the test bacteria were growing as expected. 
Positive control plates included a known mutagen (50 µg mL' benzo[a]pyrene or 20 
µg mL-' 2-amino anthracene) to indicate a mutagenic response. For a negative control, 
plates were run with only DMSO to indicate the background spontaneous revertants 
produced irrespective of sample. Both positive and negative plates were run with and 
without S-9 as indicated in Table 2.2. If these plates did not produce the excepted 
number of revertants, the accompanying test samples would be repeated. 
TABLE 2.2. The contents of the negative (non-mutagen) and positive (mutagen with 
10% v/v S-9) control plates incorporated into top agar in the Ames test. The presence 
of each component is indicated with a cross. 
Plate Number Type of Control S-9 DMSO B[aJp 2-aa Revertant Number 
1 to 3 Negative x 20-40 
4 to 6 Negative xX 20-40 
7 to 9 Positive xX 200-300 
10 to 12 Positive xX 400-600 
Where reversion numbers were to be directly compared e. g. oil 8 with Nytro- I OGBN, 
white oil and oil 4, all Ames tests were performed using the same 
batch of S. 
typhimurium culture to minimise the problem of inter-batch variability. 
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2.2.2 The Ames Test Procedure 
The Ames test was performed in a Hazard II safety cabinet. Up to 70 sterilised 
universals were set out in rows of six at one time. The caps of the universals were 
unscrewed but kept on to prevent contamination. All samples were run with and 
without S-9 in triplicate. Each set of experiments was then repeated on another day, to 
check inter-batch variability. 
To each universal the following was added: 
0.1 mL a 16 hour nutrient broth culture of S. typhimurium 
0.1 mL sample to be tested, in DMSO 
0.5 mL S-9 mix, or buffer 
The contents of each universal was gently shaken by hand and left for 20 minutes to 
allow activation to begin. A2 mL volume of molten top agar, kept at 45°C in a water 
bath was added to the first three universals and shaken gently by hand. 
The contents of the first three universals were individually poured from the universals 
onto VB minimal glucose plates. The lids were replaced and distribution of the top 
agar onto the surface of the plate was made uniform by tilting and rotating and placing 
the plate on a flat surface until solid. The addition of top agar and plating was then 
repeated for all plates, three at a time. 
When all the plates were poured, they were inverted and stored in sterile plastic bags. 
They were then incubated at 37°C within 1 hour of plating. Growth occurred over 48 
hours. After 48 hours the colonies (revertants) in both control and test plates were 
counted and the presence of the light background lawn of growth (due to the trace of 
histidine present in the media) confirmed. 
The dose is reported as milligrams of oil extracted rather than milligrams of oil extract 
and is plotted against the mean number of revertants per plate, as is the convention 
in 
the literature (Herman et al., 1981; Granella et al., 1991,1995; Brooks et al., 1995). 
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This allowed a simpler comparison of whole oil mutagenicity results with oil extract 
results. 
2.2.3 Liquid-Liquid Extractions 
2.2.3.1 IP 346 
The gravimetric IP 346 % w/w procedure was executed as described in method 
BS2000 Part 346 (1996). The method is outlined in Appendix B. Oil 8,4 and Nytro- 
IOGBN were extracted, 2.5 g of oil was used per extraction. Cyclohexane, dimethyl 
sulphoxide and a NaCl solution (4% v/v) were used to extract the aromatic fraction. 
For safety reasons, only 2-3 g of oil could be extracted at one time due to the large 
quantities of solvent required. The method was repeated four times for each oil to 
determine repeatability. The oil was weighed before and after extraction to establish 
the percentage aromatic fraction remaining (% w/w). The oil extracts were evaporated 
to dryness with a rotary evaporator. The residue from 2 extractions per oil was 
combined for Ames testing in 1 mL of DMSO. 
2.2.3.2 The Grimmer Method 
The Grimmer method is a liquid-liquid extraction modified from the method described 
by Grimmer et al. (1981). A sample of 5g of oil, 18 mL DMSO, 2 mL cyclohexane 
and 2 mL de-ionised water was added to a 100 mL separating funnel. This was shaken 
vigorously for 1 minute and left to stand until the two immiscible layers had 
completely separated. The time taken to separate depended on the purity of the oil. The 
lower aqueous layer was removed and added to a second 250 mL capacity separating 
funnel containing 50 mL cyclohexane and 25 mL deionised water. The funnel was 
shaken for 1 minute and the layers left to separate. The lower aqueous layer was 
discarded while the upper organic layer was evaporated to 10 mL by a rotary 
evaporator, then further evaporated to 1 mL at room temperature in a fume cupboard. 
The extract was reconstituted in 1 mL of DMSO for subsequent Ames testing. 
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2.2.3.3 The Blackburn Extraction 
The extraction method was performed as described by Blackburn et al. (1986) but 
scaled up to extract 6 mL (-5 g) of oil instead of 2 mL. The extraction mixes 6 mL of 
oil with 9 mL of cyclohexane and 30 mL of DMSO. The mixture was shaken 
vigorously by hand for 20 seconds every five minutes, for at total of 30 minutes and 
the DMSO layer was recovered for mutagenicity testing. 
2.2.4 Solid Phase Extraction 
The initial preparative methods used to extract PAHs using solid phase extraction 
(SPE) was based on the approach by Wang et al. (2000). However, since hexane and 
dichloromethane were considered too hazardous, cyclohexane and ethyl acetate 
replaced them respectively. Silica sorbent was used as it was polar and would interact 
with PAHs allowing them to be collected after the removal of unwanted, less polar oil 
components. Three extraction approaches were evaluated. (1) a 10 mm x 46 cm 
column containing 15 g of sorbent used to fractionate liquid-liquid extracts (Section 
3.7) or to test sorbent extraction efficiency (Section 4.3.1), (2) a 50 mm x 600 mm 
glass column with 182 g of sorbent used to extract large quantities of oil and therefore 
allow a greater range of doses to be tested (section 3.6) and (3) small scale cartridges 
or columns containing 09-1.2 g of sorbent for extraction development (Section 4.5). 
2.2.4.1 SPE with 15 g Columns 
A sorbent weight of 15 g of silica (Si02) or alumina (A1203) was added to the 10 mm x 
46 cm glass column and gently rotated in the palms of the hands to ensure even 
column packing. A weight of 1g of oil or the extract of 1g of oil (from a previous 
extraction) was added to the top of the silica column after conditioning with 20 mL 
cyclohexane. A 60 mL volume of cyclohexane was used to displace the extract down 
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the column and removed many unwanted components. Using an UV lamp at 366 nm, 
the fluorescence of the PAHs was tracked down the column to ensure that significant 
quantities of PAHs were not eluted during washing. If PAH elution was suspected the 
cyclohexane volume was reduced accordingly. All cyclohexane washes were discarded 
after use. Smooth elution was enhanced using a 20 mL syringe attached by plastic 
tubing to a quickfit adaptor to give a flow rate of approximately 2-3 mL min-'. 
Typically 2 bands of fluorescence formed on the silica, both fluorescing at 366 nm. 
These bands were eluted separately by using 2x 30 mL ethyl acetate or acetone. The 
UV lamp was once again used to ensure complete band elution. The syringe method 
was used to ensure a flow rate of approximately 3-4 mL min 1. The eluted fractions 
were evaporated to 10 mL using a rotary evaporator then evaporated to dryness in a 
fume hood at room temperature. The sample was then reconstituted in 1 mL DMSO for 
subsequent Ames testing. 
2.2.4.2 SPE with 182 g Columns 
A 50 mm x 600 mm glass column was used to extract 20 g of oil. Approximately 182 g 
of dry silica was poured into the column and gently rotated to ensure even column 
packing. Further removal of voids was achieved by tapping the column with a piece of 
plastic tubing. The column was conditioned with 50 mL cyclohexane and the 20 g oil 
sample was added to the top of the silica. A 800 mL volume of cyclohexane was used 
to wash the non-polar components of the oil from the column. The flow rate was 
maintained at 3-4 mL min' by the addition of the appropriate quickfit adaptor to the 
top of the column, attached by plastic tubing to a compressed air tap. All cyclohexane 
was discarded after use. Two bands of aromatic components, fluorescing strongly at 
366 nm were observed when an UV lamp was used. A2x 60 mL volume of ethyl 
acetate eluted the two aromatic bands from the column. The flow rate was 
approximately 4-5 mL min 1. The solvent was evaporated to 10 mL using a rotary 
evaporator and then to dryness in a fume hood at room temperature. The sample was 
then reconstituted in 1 mL DMSO for subsequent Ames testing. 
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2.2.4.3 SPE with 1g Columns 
Filtration tubes (1 cm diameter, 3 mL length) pre-prepared with base frits, were filled 
with silica (1.2g; equivalent to 2.5 mL) and conditioned with 8 mL cyclohexane. A 100 
µL volume of oil was used unless otherwise stated. Cyclohexane was used to elute 
non-polar interference (flow rate 2-3 mL min-') followed by 6 mL acetone to elute the 
aromatic fractions (flow rate 4-5 mL mini). An empty filtration tube was attached to 
the top of the column, to act as a reservoir for solvent, and flow rate was controlled by 
the addition of a 10 mL syringe linked to the top of the solvent reservoir by an adaptor. 
The acetone eluent was evaporated to a final volume of 1 mL at room temperature in a 
fume cupboard prior to GC-MS analysis. A rotary evaporator was not used due to 
minimal solvent. 
2.2.5 Investigation of Oil Interference with Liquid Media Ames Test 
A volume of 0.1 mL S. typhimurium culture, 0.1 mL DMSO and 0.5 mL S-9 mix (10% 
v/v) was placed in sterile universals (numbered 1-6). Instead of adding a top agar 
media that was plated onto a solid VB plate, a3 mL VB/top agar mix in liquid form 
was added. 
The VB solution was comprised of the following: 
2 mL VB salt solution used in the Ames test (Appendix A) 
4g Glucose 
10 mL histidine/biotin solution (0.5 mM) (Appendix A), 
De-ionised water to make a volume of 100 mL 
A 100 mL of VB solution (without glucose) was autoclaved in a 250 mL Duran bottle 
at 120°C for 20 minutes and cooled to <40°C. Glucose was added -10 minutes after 
autoclaving by swirling the Duran by hand. To universals 1 and 2,50 gL Nytro- 
l OGBN oil was added and the universals were incubated for 24 hr at 37°C. 
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After incubation, 0.5 mL of the mixture in universal 1-6 was added to fresh VB liquid 
media (4.5 mL) and aliquots (200 µL) were placed in 2 rows of wells in a sterile 
microtitre plate (16 repeats). Oil Nytro- l OGBN was added to universals 3 and 4 (50 
µL) after transfer to the microtitre plate. The microtitre plate were sealed with 
microwell sealing tape and placed in the incubator at 370 C for 24 hours. 
Finally, Nytro- I OGBN oil was added to the wells that originated from universals 1 and 
2 (currently oil free) and 5 and 6 immediately prior to reading the absorbance at 600 
nm on the plate reader. This final addition of oil ensured that any oil affects on 
absorbance readings were taken into account. 
2.2.6 GC-MS Analysis 
2.2.6.1 Perkin Elmer System 
SPE extracts were analysed using a Perkin-Elmer Turbomass GC mass spectrometer 
with NIST library (Buckinghamshire, UK) unless otherwise stated. The column used 
was a Perkin-Elmer Elite series 5MS (30 in x 0.25 mm, 25 gm film thickness) with 
splitless injection. The injection volume was I gL and the injector and GC-MS 
interface temperatures were both 300°C. The oven temperature was held at 55°C for 2 
minutes then ramped (30°C min-) to 180°C. Finally the temperature was ramped to 
310°C at a rate of 5°C min"' and held for 5 minutes. The mass spectroscopy was 
performed in electron ionisation (EI) mode (70eV) with source temperature at 230°C 
and scanned from 30-350 atomic mass units for a scan time of 0.2 sec-1 in total ion 
chromatogram (TIC) mode. 
Selective ion chromatograms (SIC) were collected for quantification of the EPA 16 
priority PAHs with a dwell time of 0.1 seconds. Mass and retention times programmed 
for SIC are shown in Table 2.3. All GC parameters for SIC were the same as those for 
TIC. Initial quantitative data was determined with the Turbomass quantitative 
software, which created a calibration curve from the standards run and automatically 
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determines the amount of each PAH present in the sample. Linear calibration curves 
were obtained for each of the 16 EPA priority PAHs across a 5-point calibration range 
0-2 µg mL-1. The software did not calculate the error related to linear regression. 
Therefore, once the final solid phase extraction was developed, quantitative data was 
obtained by manual integration of peaks so that the calibration curve and linear 
regression analysis could be determined. 
2.2.6.2 Hewlett Packard System 
A Hewlett Packard GC5890 series II with a HP MSD 5971A detector was also used in 
this work. The column was a HP5-MS (30 in x 0.25 mm, 25 gm film thickness) with 
splitless injection. The GC and MS programmes for TIC and SIC were as outlined for 
the PE Turbomass (Section 2.2.6.1). All quantification on the HP GC-MS was 
performed by manually integrating peaks, drawing a 5-point calibration curve 0.05-1 
ggmL-1 and calculating the concentration of unknown samples using spreadsheets 
created in Microsoft Excel. 
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TABLE 2.3. GC-MS retention windows for the selective ion chromatogram (SIC) of 
the EPA 16 priority PAHs 
Name of PAH I Mass Retention Window 
Naphthalene 128 4.61-7.84 
Acenaphthylene 152 7.38-7.57 
Acenaphthene 154 7.62-7.76 
Fluorene 166 7.83-9.19 
Phenanthrene 178 10.04-10.72 
Anthracene 178 10.04-10.72 
Fluoranthene 202 13.58-15.18 
Pyrene 202 13.58-15.18 
Benzo(a)anthracene 228 18.38-21.19 
Chrysene 228 18.38-21.19 
Benzo(b)fluoranthene 252 22.10-27.91 
Benzo(k)fluoranthene 252 22.10-27.91 
Benzo(a)pyrene 252 22.10-27.91 
Indeno(1,2,3-c, d)pyrene 276 25.05-31.95 
Dibenz(a, h)anthracene 278 25.05-31.95 
Benzo(g, h, i)perylene 276 25.05-31.95 
2.2.7 The Isolute PAH HC Protocol 
The Isolute PAH PC protocol was designed for the removal of PAHs from soil samples 
(Jones Chromatography). The method was therefore modified to accommodate oil 
matrix effects. 
2.2.7.1 Manufacturer's Method 
A 100 µL volume of oil was added to the column after conditioning with 
8 mL hexane 
and allowed to pass through by gravity flow. A3 mL volume of pentane was added to 
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remove unwanted components using gravity flow followed by 6 mL hexane 
(containing 3.4% v/v isopropanol) to elute the PAHs from the column. 
2.2.7.2 Modified Method 
The oil sample was added to the column in 0.5 mL cyclohexane after column 
conditioning with 10 mL cyclohexane. A2 mL volume of pentane was then added to 
wash out further unwanted components under a slight positive pressure (flow rate 1 
mL min-) and the eluent discarded. PAHs were eluted with 6 mL acetone under 
pressure (flow rate 2 mL min-) and concentrated to 1 mL by evaporation at room 
temperature in a fume cupboard. 
2.2.8 The Mineral Insulating Oil Fingerprinting Technique 
The method used is described by Wilson and Pahlavanpour (2000) but modifications 
were made after discussions with the authors, to improve repeatability. For this reason 
the liquid-liquid extraction procedure is outlined in Appendix B. 
2.2.9 C 18/Silica/Isolute PAH HC Extraction 
The extraction process is outlined in Figure 2.1. Silica (Si02) columns were prepared 
in-house by placing the accompanying frit in the base of the 3 mL filtration tube and 
adding dry silica gel (1.3 g, equivalent to 2.5 mL). The tip of the column was placed on 
a vortex at its highest speed for 10 seconds to reduce void formation. 
Commercial silica columns of this sorbent weight usually come in a6 mL column, 2 
cm in diameter. In order to increase the plate number while still using only 1g of 
sorbent, a narrower (1 cm diameter) 3 mL filtration column was used. This also 
prevented drying out of the column, as it reduced the sorbent surface area exposed to 
the air at the top of the column. 
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The column was conditioned with 4mL cyclohexane (4-5 mL min-') and then placed 
below the C18 cartridge. The C18/Si02 columns were then conditioned with 8 mL 
cyclohexane, which was discarded after use. A 100 µL aliquot of transformer oil was 
loaded onto the C 18 column and allowed to interact with the sorbent for 1 minute. The 
C 18 cartridge was covered to prevent the sorbent drying out. Samples were eluted 
onto the Si02 column with 3 mL cyclohexane (1-2 mL min-1). 
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FIGURE 2.1. Outline of the C18/Silica/Isolute extraction of PAHs from transformer 
Oil. (1) Cyclohexane washes the oil sample through the C18 sorbent into the silica 
column. (2) C18 is removed and cyclohexane washes the fluorescence through the 
silica. (3) Acetone elutes the fluorescence, which is concentrated to I mL. 
(4) The 
fluorescent residue is added to an Isolute PAH HC column, washed with pentane and 
eluted with acetone for further analysis. 
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Migration of fluorescent species (including PAHs) was observed using a 366 nm UV 
light source. The C 18 cartridge was discarded and the Si02 column washed with 5 mL 
cyclohexane, which was then discarded. Columns were eluted with 6 mL acetone (3-4 
mL min-) and the eluent evaporated to dryness in a fume cupboard at room 
temperature. Samples were re-dissolved in 1 mL cyclohexane and applied to a PAH 
HC Isolute column, preconditioned with 8 mL cyclohexane. The column was washed 
with 3 mL of pentane, which was discarded, and the final extract was eluted with 6 mL 
of acetone (3-4 mL min-) and analysed using GC-MS. All tests were performed 6 
times. 
2.2.10 Large Scale C 18/Silica/Isolute PAH HC 
Bakerbond C18 and Silica (10 g) polyethylene columns were purchased from Fisher 
Scientific Ltd. The C18/ Si02 columns were conditioned with cyclohexane (60 mL), 
which was discarded after use. A weight of 2.5 g transformer oil was loaded onto the 
C 18 column and allowed to penetrate the sorbent for 3 minutes. The C 18 column was 
topped up with 1 mL of cyclohexane as required to prevent drying out of the sorbent. 
Samples were eluted onto the Si02 column with 50 mL cyclohexane under gravity. The 
C18 column was discarded and the Si02 column washed with 60 mL cyclohexane. 
The Si02 column was eluted with 100 mL acetone and the eluent evaporated to 10 mL 
in a rotary evaporator. As the Isolute PAH HC sorbent was only available as 1g 
columns, the sample was split into 1 mL fractions and added to 10 PAH HC Isolute 
columns preconditioned with 8 mL cyclohexane. Each column was washed with 3 mL 
pentane (which was discarded) and the final extracts eluted with 6mL acetone (3-4 mL 
min-'). These extracts were combined into one sample and evaporated with a rotary 
evaporator to 25 mL. A small quantity (0.1 mL) was removed for GC-MS analysis 
whilst the rest of the extract was evaporated to dryness at room temperature in a fume 
cupboard and reconstituted in 0.5 mL DMSO. This extraction method was repeated 
twice for each oil and the extract in DMSO combined to give 1 mL of extract from 5g 
oil for Ames testing. 
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2.2.11 Toxicity Testing of Oils and Oil Extracts with S. Typhimurium 
A 10 µL volume (per well) of a 16 hour S. typhimurium culture (Section 2.1.2.1) was 
added to the wells of a sterile microwell plate along with 250 µL fresh sterile nutrient 
broth. A 10 µL sample of oil or oil extract was then added. The oil extracts were 
diluted in DMSO to test for toxicity over a range of doses (3 wells per dose). The 
microplates were sealed with microwell tape and the S. typhimurium was grown for 16 
hours at 37°C before absorbance readings were taken at 600 nm with the plate reader. 
2.2.12 The Miniscreen Mutagenicity Assay 
The miniscreen assay used the same materials and principles as the Ames test, but with 
smaller multiwell plates with 25 x 100 mm2 flat bottomed wells instead of petri dishes 
and therefore used less material and sample. 
The procedure was performed as described by Brooks (1995) then carried out with the 
modifications described by Burke et al. (1996). These modifications include the use of 
a 10 hour culture rather than an overnight culture, a maximum of 10% v/v S-9, and a 
three day incubation period instead of two days. 
A 100 gL volume of 10% v/v S-9 was added directly onto the VB agar plate, along 
with the 20 µL sample to be tested. The S. typhimurium culture was added directly to 
the top agar and made up 5% v/v of the final top agar solution, which was kept at 
42°C. Each well had 0.5 mL of top agar added, the lid replaced and the top agar was 
allowed to harden before inversion and incubation at 37°C. After 48 hours of growth 
the colonies were counted as in the Ames test. 
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2.2.13 Immunoassay Rapid Assay PAH Test Kit 
The instructions for the use of both the total and carcinogenic PAH test kits were 
supplied with the kits, but is briefly outlined below: 
1. The oils were diluted in methanol by 10 000 times for the total PAH kit, and by 
100 000 for the carcinogenic kit. Further dilution was required for some oils that 
yielded values at the extreme ends of the dynamic range of the kit. The final 
dilution was always made in diluent (buffered saline supplied with the kit) so that 
the final concentration was in 10% v/v methanol. 
2. The 250 µL samples were placed in duplicate, in test tubes in the top part of the 
magnetic rack. The standards were also repeated in duplicate along with a blank 
(diluent only) and the control solution. The controls and standards were repeated 
each time the test was performed. 
3. A 250 gL volume of PAH analogue labelled with horseradish peroxidase (HRP) 
(enzyme conjugate) was added to each test tube, followed by 500 µL of magnetic 
particles coated in anti-PAH antibodies. 
4. The test tubes were vortexed, avoiding foaming and incubated for 30 minutes at 
room temperature. The kit for carcinogenic PAHs was incubated for 20 minutes at 
room temperature. 
5. The bottom part of the rack, which contained the magnets, was added and the test 
tubes were left for 2 minutes so that the magnetic particles settled to the bottom. 
The contents was then poured out onto absorbent paper, ensuring the bottom part 
of the rack was still attached so that the particles remained in the test tubes. 
6. The particles were washed with 1 mL de-ionised water/detergent mixture, vortexed 
and left for 2 minutes, allowing the particles to settle to the 
bottom of the test 
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tubes. The contents was then poured onto absorbent paper, ensuring the bottom 
part of the rack was again attached and the particles remained in the test tubes. This 
washing test was then repeated. 
7. The bottom of the rack was removed and 500 µL hydrogen peroxide and 3,3', 5,5'- 
tetramethylbenzidine solution (colour solution) was added. The test tubes were 
vortexed and incubated for 20 minutes at room temperature. 
S. A 500 µL volume of sulphuric acid solution was then added to stop the reaction 
and 200 µL of each test tube was added to the wells of a microtitre plate in 
duplicate. The microtitre plate was read in a plate reader at 450 mit within 15 
minutes of adding the stop solution. 
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CHAPTER 3.0 
RESULTS 
MEASURING MUTAGENICITY OF 
POLYCYLIC AROMATIC HYDROCARBONS 
IN OILS AND OIL EXTRACTS 
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3.1 INTRODUCTION 
Mutagenicity of transformer oils was determined using the Ames test. The Ames test 
was chosen as it has been used extensively in the literature and has been recognised by 
regulatory authorities and the oil industry as a valid mutagenicity test (OECD, 1983; 
Nynas, 1999). 
The aim of the work described in this chapter was to determine the mutagenicity of the 
oil sample, and also oil aromatic fractions, thought to be the source of most risk 
(Tolbert, 1997). By comparing oil and aromatic mutagenicity, the aromatic 
contribution (and more specifically PAH contribution) to whole oil mutagenicity can 
be ascertained. A transformer may contain up to 100 000 litres of oil and therefore the 
health risk to National Grid Company Plc employees, and the environmental risk 
through leakage is significant. A measure of whole oil and PAH mutagenicity would 
indicate whether certain oils should be avoided to reduce the risk. It would also 
ascertain whether removing PAHs would be a suitable measure, considering the 
beneficial properties PAHs bring to the oil (Section 1.1.2). 
In order to measure oil mutagenicity, a number of issues required consideration. The 
hydrophobic properties of the oil did not lend themselves to testing in the aqueous 
environment of the Ames test. As oil is a complex mix of components, mutagenicity 
may be increased or decreased by synergistic or antagonistic effects from other 
components. This may affect the bacteria and the activation enzymes present in the 
Ames test. Oil interference effects were therefore investigated. 
The aromatic fraction of the oil was extracted by various liquid-liquid and solid phase 
extractions in order to determine the optimum method of oil preparation and hence 
compatibility with the Ames test. As stated by Stang (1993) the fraction extracted by 
liquid-liquid methods contains all DMSO soluble components of the oil and will 
contain substances other than polyaromatic components (PAHs). Results were 
therefore analysed in order to distinguish PAH mutagenicity from other potentially 
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mutagenic sources. The dose of oil extract for Ames testing was given as milligrams of 
oil extracted (as opposed to milligrams of oil extract) per plate, as is the convention in 
the literature (Herman et al., 1981; Granella et al., 1991,1995; Brooks et al., 1995) to 
allow a better comparison of whole oil mutagenicity results with oil extract results. 
Four oils were tested to determine how mutagenicity differed with PAH content. White 
oil, a highly refined mineral oil, was used as a `blank' as it contained little or no PAHs 
along with transformer oil 4, thought to contain a low PAH level according to IP 346 
% w/w data. Oil 8 was used as the high PAH content oil, and Nytro-1 OGBN 
(NIOGBN) was tested as it was thought to have an intermediate PAH level and is the 
most widely used oil in transformers by the National Grid Company Plc. 
3.2 AMES TESTING OF EPA 16 PRIORITY PAH STANDARD 
Before the oils could be tested for mutagenicity, the Salmonella typhimurium strain 
TA98 had to be tested with PAH standards to ensure it was the correct strain to use for 
PAH mutagenicity. Although this strain has been used in the literature for determining 
PAH mutagenicity in oil (Blackburn et al., 1984; 1986; Brooks et al., 1995; Granella et 
al., 1991; 1995) the available EPA 16 priority PAHs were tested to ensure that the 
results obtained agreed with the findings in the literature. As the International Agency 
for Research on Cancer (IARC, 2002) has the most comprehensive data collection on 
PAH mutagenicity, their findings were used for comparison. 
3.2.1 Effects of DMSO on S. Typhimurium 
In order to assess the oil or oil extracts with the Ames test, the oil was added to a polar 
solvent that was miscible with the oil but not toxic to S. typhimurium. Dimethyl 
sulphoxide (DMSO) was the solvent used by Maron and Ames (1983) as most other 
organic solvents are toxic to S. typhimurium (Salamone et al., 1979). However, it was 
important to establish the amount of DMSO that could be added without interfering 
with the assay, as the more that could be added, the greater the amount of sample that 
-62- 
could be tested. Increased quantities of DMSO were added to the S. typhimurium assay 
to determine the toxic effects of DMSO. 
TABLE 3.1. Effect of increased volume of DMSO as a solvent carrier in the Ames 
test. 
DMSO 0 mL 0.1 mL 0.2 mL 0.3m1 0.5m1 
Mean Number of Revertants 43 
±SD 3.5 
43 24 40 
1.5 2.3 2.7 0 
It was clear from the results in Table 3.1 that 0.1 mL DMSO would be appropriate for 
Ames testing as all other quantities lead to a reduction in revertant number. This meant 
that the limiting factor in testing oil samples or extracts was the amount of test 
substance that was soluble in 0.6 mL of DMSO (the volume required for testing each 
sample with and without S-9). For the purpose of repeat testing, the test substances 
were reconstituted in 1 mL DMSO, leaving an extra 0.4 mL for diluting to lesser 
doses. 
3.2.1.1 Mutagenicity of Individual EPA 16 Priority PAHs 
PAHs, considered to be priority pollutants by the EPA, were tested over a range of 5 
doses. Each dose was diluted 10-fold to ensure that a large dose range was assessed. 
As mutagenicity of the control mutagen benzo[a]pyrene was observed at 5 µg plate-', 
and 2-amino anthracene at 2 gg plate-1, PAHs showing a doubling of revertants at 
similar doses were considered mutagenic (Jackson, 1986). However, the range of doses 
tested extended from 0.5 to 5000 µg plate-' to ensure that less potent mutagens were 
also noted (OECD, 1983). Not all of the EPA 16 priority PAHs were tested. Those that 
were well documented as carcinogens and were unlikely to be present 
in the oil 
according to National Grid Company Plc analysis (Pahlavanpour, and Wilson, 1999) 
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were not tested. These were benzo[b]fluoranthene, dibenz[a, h]anthracene and 
indeno[1,2,3-c, d]pyrene. 
Results are summarised in Table 3.2. Each sample was tested with and without 10% 
v/v S-9 in triplicate on 2 separate occasions to ensure repeatability (total of 12 plates 
per sample). Only the results on addition of S-9 are shown since no mutagenicity was 
observed for any of the PAHs in the absence of S-9. Toxic effects, observed as a lack 
of background bacterial lawn or a reduction in revertant number compared to the 
spontaneous background rate, were also recorded. 
TABLE 3.2. Mutagenicity of PAH standards tested with the Ames test. Up to 5 mg 
plate-' was used. A minus sign denotes no mutagenic/toxic effect; a plus sign denotes 
mutagenic/toxic effect. 
Name of PAH Mutagenicity Mutagenicity with Toxicity from the 
according to the 10% v/v S-9 from the Ames test 
findings of the IARC Ames test 
(1983) 
Naphthalene - - - 
Acenaphthylene - - - 
Acenaphthene - - + 
Fluorene - - - 
Phenanthrene - - + 
Anthracene - - - 
Fluoranthene - - + 
Pyrene - - - 
Benzo(a)anthracene + + + 
Chrysene + - - 
Benzo(b)fluoranthene + N/A N/A 
Benzo(k)fluoranthene + + - 
Benzo(a)pyrene + + - 
Indeno(1,2,3-c, d)pyrene + N/A N/A 
Dibenz(a, h)anthracene + N/A N/A 
Benzo(g, h, i)perylene - + - 
N/A = not IARC recognised carcinogen, not tested 
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The findings of the Ames test agree with those compiled by the IARC except for 
chrysene, which was found to be non-mutagenic in the Ames test, but classed as a 
mutagen by the IARC. The mutagenic dose response for chrysene is shown in Figure 
3.1. Although no doubling of the spontaneous revertants was observed even at the 
highest dose (5 mg plate-') there was still an increase in the number of revertants 
compared to the response at 0 mg plate-'. According to the protocols published since 
the development of this test in 1975, mutagenicity is only established if at least a 
doubling of revertants is observed with a dose-related response (Jackson and Pertel, 
1986). For this reason, chrysene cannot be classed as a mutagen on the results of the 
Ames test. However, it cannot be considered a non-mutagen, due to the borderline 
results obtained and the conclusion of the IARC. However, such discrepancies for 
chrysene have been found in the literature (Basler et al, 1977; McCann et al, 1975) and 
are discussed further in Section 7.2.1. Therefore, strain TA98 was deemed appropriate 
for testing PAHs. 
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FIGURE 3.1. Ames test revertants on the addition of chrysene in the absence and 
presence of 10% v/v S-9 solution (n = 3). %CV ranges from 
5-40%. 
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3.2.1.2 Mutagenicity of EPA 16 Priority PAH Mixture 
In addition to testing the EPA 16 priority PAHs separately, a mixture composed of the 
same amount of each PAH was tested over a range of 5 doses. In accordance with the 
work of Blackburn et al. (1984) a greater amount of S-9 (80% v/v) was used. The 
highest dose added was 2 mg plate-' (per PAH) due to availability limits of the EPA 16 
priority PAHs. Results are shown in Figure 3.2. 
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FIGURE 3.2. Ames test revertants on the addition of a mixture of the EPA 16 priority 
PAHs in the absence and presence of 10% v/v S-9 solution (n = 3). %CV ranges from 
10-96%. 
Mutagenicity was not observed for the EPA 16 priority PAHs. However, a toxic effect 
was evident in the form of a reduced number of revertants compared to the negative 
control (0 mg plate-'), on the plates without S-9. The number of revertants observed 
with S-9 present was not as reduced, indicating that a mutagenic increase 
in revertants 
was counteracting the toxic decrease in revertants (Haroun and Ames, 
1981). Up to a 
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dose of 2 µg plate-' the number of revertants increases suggesting an increase in 
mutagenicity. However, at 20 µg plate-' and above, the toxicity overcomes any 
mutagenic effects and a decrease in revertant number is prevalent. 
These results illustrated that a mixture of PAHs presents a complex interplay of 
mutagenic and toxic effects. The toxicity of the oils must therefore be established to 
ensure it was not interfering with mutagenicity measurements. Toxicity is further 
discussed in Section 5.8. 
3.3 AMES TESTING OF WHOLE OIL 
The first stage of testing transformer oil for mutagenicity was to test the oil directly 
with the Ames test, to determine whole oil mutagenicity. In early papers reporting 
studies of oil mutagenicity with the Ames test, the oil was either (a) added to the 
bacteria directly or (b) added with a detergent present (Tween 80) to make the oil more 
soluble (Hermann et al., 1980). A 10% v/v S-9 solution was used in each case. 
Differences in response, with and without S-9 would indicate whether PAHs were the 
only mutagens present in the oil. If PAHs were the only mutagens, a positive response 
would only be evident in the presence of S-9 (indirect mutagenicity). Both methods 
were examined. 
3.3.1 Direct Addition of Oil 
The main concern with directly adding the oil to the Ames test was that the oil was 
predominantly hydrophobic and therefore may not mix well with the aqueous 
components of the Ames test, thus giving inconsistent results. 
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TABLE 3.3. Ames test revertants on the addition of pure oil (0.1 mL) in the presence 
and absence of 10% v/v S-9 solution (n = 3). 
Components of Ames Test Plate Oil 8 Oil 8 Oil Oil Oil 4 Oil 4 
N1OGBN NIOGBN 
S-9 (10% v/v) (mL) 0.0 0.5 0.0 0.5 0.0 0.5 
Mean No, of Revertants plate-' 40 43 45 41 40 45 
± SD 17 15 13 13 15 13 
%CV 43 34 28 31 37 28 
On adding pure oil to the Ames test, no mutagenicity or toxicity was observed (Table 
3.3). However, the coefficient of variance (%CV) varied between 27-43% for all the 
oils, suggesting incompatibility between the oil and water matrices. The assay was not 
sufficiently repeatable to give conclusive results. Making the oil soluble with Tween 
80 was considered a means of overcoming this problem. 
3.3.2 Oil with Tween 80 
A 200 µL volume of oil was made soluble in 200 µL Tween 80 as described by 
Hermann et al. (1980). De-ionised water was added dropwise while stirring, until a 
final volume of 2 mL was reached (10% v/v Tween 80). The results for oil 8 are shown 
in Table 3.4. 
The addition of Tween 80 improved the repeatability of the method as the %CV values 
were reduced to between 3-28% (as opposed to 27-43% for the pure oil). No doubling 
of the spontaneous reversion rate was observed at any dose and no indication of 
toxicity was observed. Due to the complex mixture of components that make up the oil 
however, it was possible that there were antagonistic components reducing 
mutagenicity that could not as yet be accounted for. Whole oil mutagenicity is 
further 
discussed in Section 7.2.2. 
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TABLE 3.4. Ames test revertants on the addition of oil 8 made soluble with Tween 80 
in the absence and presence of 10% v/v S-9 (n = 3). 
Oil 
(mg plate') 
Oil 8/Tween 80 
without S-9 
f SD %CV Oil 8/Tween 80 
with 10% S-9 
f SD %CV 
0 41 1.4 3 41 1.4 3 
0.000615 38 3.5 9 40 2.6 7 
0.00123 43 9.0 21 44 10.7 24 
0.00615 51 3.2 6 29 2.6 9 
0.0123 39 7.5 19 52 7.2 14 
0.0615 37 4.3 12 58 16.0 28 
0.123 50 14.4 29 53 5.5 10 
0.615 47 6.8 14 54 3.5 6 
1.23 46 11.5 25 52 5.7 11 
6.15 33 8.5 26 28 8.6 30 
12.3 36 5.5 15 32 11.2 35 
By investigating the mutagenicity of the aromatic fraction of the oil, (Section 3.4.1) 
thought to be the source of mutagenicity (McKee et al., 1989; Järvholm and Easton, 
1990; Brooks et al., 1995; Granella et al., 1995) antagonistic effects may be revealed if 
the oil contained mutagens. If no mutagenicity were observed in the aromatic fraction 
however, it would remain unclear if this result were due to a lack of mutagen or an 
antagonistic effect. For this reason further examination was required. By adding oil to 
a known mutagenic PAH such as benzo[a]pyrene and 2-amino anthracene, antagonism 
could be unequivocally established. 
3.3.3 Investigation of Whole Oil Interference on the Ames Test 
To determine if the oil would affect the mutagenicity of PAHs, 0.1 mL whole oil was 
added to the bacteria with 0.1 mL Benzo[a]pyrene (50 µg mU-') or 2-amino 
anthracene (20 µg mL-i). Oil 8 was tested as it had the highest aromatic loading 
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according to IP 346 % w/w data, oil 4 as it contained the lowest and white oil was 
tested as a blank. 
Results in Table 3.5 show that the presence of oil reduced the number of revertants by 
between 16.6-33% for plates with benzo[a]pyrene and 11.5-25% for plates with 2- 
amino anthracene. The %CV of benzo[a]pyrene was -7% and 2-amino anthracene was 
-5% which was low and meant that a reduction of > 7% may be significant. 
TABLE 3.5. Effects on revertant number of adding whole oil to mutagens 
benzo[a]pyrene and 2-amino anthracene with 10% v/v S-9 (n = 3). 
Sample on Plate Mean ± SD %CV Reduction in One-Sided t-Test 
Number Revertants from (t) 
of Mutagen on 
revertants Exposure to Oil 
(0) 
Benzo[a]pyrene (B[a]P) only 196 34.1 17 N/A N/A 
White oil and B[a]P 163 20.8 13 17 -2.7 
Oil 4 and B[a]P 141 15.5 11 28 -6.1 
Oil 8 and B[a]P 131 2.6 2 33 -43 
2-amino anthracene (2-aa) only 729 37.1 5 N/A N/A 
White oil and 2-aa 645 83.3 13 12 -1.7 
Oil 4 and 2-aa 554 47.7 9 24 -6.3 
Oil 8 and 2-aa 547 28.5 5 25 -11 
*Critical Value t3 = -2.35 (P = 0.05) 
A t-test was used to determine significance. The null hypothesis (no) was that there was 
no difference in revertant number on the addition of oil except for that from random 
error. A one-sided t-test was used, and the results in Table 3.5 were given a negative 
value, as only a decrease in revertants was of interest. The critical t-value for three 
repeats (t3) was -2.35 and any t-value of greater negative value was considered 
significant (the null hypothesis was rejected). 
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All values in Table 3.5 showed a significant reduction in the number of revertants 
except for white oil with 2-amino anthracene. White oil with benzo[a]pyrene was 
considered significant at the 95% level, but with a difference of -0.36 which was small 
compared to the other oils, which differed by at least -3.78. 
The largest decrease in revertants was observed with oil 8, spiked with either 
benzo[a]pyrene or 2-amino anthracene whilst the smallest reduction in revertant 
number was observed with white oil (17% for benzo[a]pyrene and 12% for 2-amino 
anthracene). It was therefore possible that the PAHs present in oil 8 interfered with 
benzo[a]pyrene or 2-amino anthracene mutagenicity. The t-value differences also 
increased with the PAH content of the oil, suggesting that the other PAH species may 
play a part in inhibition. This is further discussed in Sections 3.8,5.7 and 7.5.1. 
The inhibition observed here may interfere with borderline or weakly positive Ames 
test results. In the case of oil 8, the number of revertants produced at the highest dose 
with Tween 80 was 36 (Table 3.4). The greatest inhibition of revertants recorded was 
32% for oil 8, but increasing the number of Ames test revertants by 32% yields a value 
of 47.5 which does not constitute a doubling over the zero dose response. It could be 
concluded in this case that inhibition did not lead to a false negative result. It does 
illustrate however, that measuring mutagenicity of a complex sample may prove 
inconclusive until the inhibition from other components in the sample is established. 
The next stage was to determine what part of the Ames test assay was affected by the 
oil matrix components. One possibility was that the oil inhibited the growth of the 
bacteria, or inhibited bacterial uptake of the mutagen. Alternatively, the oil could have 
been affecting enzyme activity, reducing PAH activation. It was also possible that both 
the enzyme and bacteria were being affected. Under the current experimental protocol, 
it was not possible to isolate possible affects on bacteria from the enzyme activity in 
the Ames test since all components were incorporated into the top agar. A completely 
different approach was therefore required. 
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3.3.3.1 The Impact of Oil on S-9 Activity 
To determine if the oil affected enzyme activity, 10% v/v S-9 was incubated for 20 
minutes with various amounts of oil extract and incorporated into the Ames test to 
determine if its activity had been altered. After incubation with the oil, the S-9 was 
removed by centrifuging the mix for 15 minutes. Centrifugation has been suggested as 
a way of removing the activation enzymes from the mix of other proteins in the S-9 
(Brooke et al., 1996). Once the pellet containing the activation enzymes was collected 
it was added to the Ames plates with S. typhimurium and Benzo[a]pyrene. It was 
thought that if component in the oil acted to inactivate the enzyme, it would be 
observed on the Ames plates by a reduction in revertant number. 
However, the centrifuged S-9 controls showed that even without the oil present the 
number of revertants was significantly reduced. It was possible that the centrifugation 
process either interfered with enzymes activity, or more S-9 was required to make up 
for losses incurred due to incomplete separation. However, repeating the experiment 
with more S-9 and with an extended centrifugation period showed no improvement, so 
an alternative method was developed. 
3.3.3.2 The Impact of f Oil on S-9 Activity and S. Typhimurium with Liquid 
Ames Test 
A liquid media version of the Ames test was investigated to alleviate the difficulty of 
determining the oil's affect on bacteria and enzymes separately. No known protocol 
has been reported in the literature since no investigation of this particular problem had 
been performed. The protocol used is outlined in Section 2.2.5. 
The method was performed in 2 stages (1) incubation of the S-9 with the mutagen and 
S. typhimurium, and (2) isolation of the S. typhimurium from the mixture and growth 
in 
fresh media devoid of histidine. If the bacteria had not reverted, no growth would 
be 
observed in the second stage. This would suggest that the oil affected the 
S-9. Oil was 
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then added to the fresh media in the second step to determine if the oil interfered with 
the growth of the S. typhimurium. Controls were run accordingly, to determine changes 
at each stage, and are included in Table 3.6. 
TABLE 3.6. Effects of pure oil on S-9 activity and S. typhimurium growth (n = 12). 
Amount of Oil Amount of Oil Amount of Oil Mean ± SD One-Sided T-Test 
Added During Added During Added After Absorbance (n = 12) (t) 
Incubation of Growth in Growth in 
Bacteria, S9 and Microtitre Plate Microtitre 
B[a]p Plate 
0 0 10 0.87 0.035 - 
0 0 25 0.89 0.034 - 
0 10 0 0.53 0.022 -52 
0 25 0 0.28 0.040 -52 
10 0 10 0.83 0.016 -7 
25 0 25 0.85 0.035 -4 
* Critical Value t12 = -1.78 (P = 0.05) 
§ Oil added at this stage to account for the effect of oil presence on absorbance readings 
It can be seen in Table 3.6 that bacteria growth was most significantly affected. The 
greatest absorbance drop was in samples where oil was added during the second stage 
of testing where only S. typhimurium was present. This result suggests that other 
components in the oil extract were preventing the PAHs from entering the bacterial 
cells. The t-test values suggested however, that oil added during the first stage also 
significantly decreased the observed absorbance, as the t-values were less than the 
critical t value of -1.78. This result was expected, as S. typhimurium was also present 
during this stage. This did not rule out issues concerning enzyme inhibition, but as this 
decrease in absorbance became greater when oil was added to the second stage of 
growth, it at least suggested that S. typhimurium was affected by the presence of oil. 
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The high level of mutagenicity engendered by benzo[a]pyrene and 2-amino anthracene 
even with oil present, suggested that the oil itself does not contain mutagens, as 
naturally occurring mutagens would have been revealed in previous experiments 
(Section 3.3). However, the benzo[a]pyrene and 2-amino anthracene added to the 
Ames test were not intrinsic components of the oil, and it was therefore postulated that 
mutagenicity of PAHs within the oil matrix would be affected differently. 
In addition, it was possible that the oil contained such low amounts of mutagenic PAH 
that a larger volume of oil was required before a mutagenic response was observed. 
More oil could not be added to the test system, as it would significantly hinder 
bacterial growth in an undesirable oily environment. As shown from the previous 
experiment, the presence of the oil seemed to affect bacterial growth, so the effects of 
the oily matrix required reduction. It was postulated that concentrating the sample, 
reducing the oil matrix and hence removing antagonistic effects, could be achieved by 
extracting and testing the aromatic fraction of the oil, thought to contain the mutagens 
(Brooks et al., 1995; Granella et al., 1995). 
3.4 AMES TESTING OF OIL EXTRACTED BY LIQUID-LIQUID 
SEPARATION 
The IP 346 % w/w method is the oil industry standard for the estimation of the 
polyaromatic content of an oil (Section 2.2.3.1) although it is 
known to overestimate 
polyaromatic content (as with all liquid-liquid extractions) 
by extracting all aromatics 
into DMSO (Stang, 1993; 1999). For this reason it was considered pertinent to test 
such extracts for mutagenicity. Since the IP 346 % w/w method 
is a time consuming 
and laborious multi-step method, the simpler Grimmer method was also performed and 
extracts tested for mutagenicity (Section 2.2.3.2). The 
Grimmer method is also a 
liquid-liquid extraction (LLE) method, and can be used 
in the same way as IP 346 to 
estimate PAH content. Both methods were performed 
4 times, to determine 
repeatability (Table 3.7). It was clear that the 
IP 346 % w/w values for oil 4 and 8 were 
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different to those provided by the National Grid Company Plc (Table 2.1). This 
difference may be due to the number of steps involved in the procedure, which lack 
precision due to the crude separation process of LLE. The Grimmer data was closer in 
value to those in Table 2.1 and showed similar trends in PAH content. Lack of 
repeatability may affect Ames test data. For these reasons, the 4 extracts of each oil 
were tested for mutagenicity to determine variation in extraction. 
TABLE 3.7. Percentage PAH extracted using the IP 346 and Grimmer methods 
(n=4). 
OIL Mean IP 346 ± SD %CV Mean Grimmer ± SD %CV 
value value 
0114 4.1 2.1 52 1.9 0.7 38 
Oil 8 4.5 0.8 19 5.7 1.2 21 
N1OGBN 1.7 0.5 29 2.6 1.4 53 
3.4.1 IP 346 Extraction and Grimmer Extraction 
A 10% v/v S-9 mixture was used for preliminary Grimmer and IP 346 extract analysis 
to conserve limited supplies of S-9 and determine if a lower concentration of S-9 
would indicated mutagenicity. Eighty percent S-9 was used when the optimum 
extraction method was established. In both cases up to 5g of oil was tested, as the 
extract of more than 5g was not soluble in 1 mL DMSO for Ames testing (discussed 
in Section 1.4.1.6). The revertant numbers found on individual plates are compiled for 
IP 346 and Grimmer extracts in Appendix C. 
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FIGURE 3.3. Ames test revertants on the addition of liquid-liquid extracts of white oil 
in the absence and presence of 10% v/v S-9 (n = 3). %CV ranges from 2.9-18.7% for 
IP 346 and 2.3-16% for Grimmer extracts. 
White oil (Figure 3.3) and oil 4 (Figure 3.4) showed similar mutagenicity with and 
without S-9 for the Grimmer extracts. This suggested that the addition of S-9 did not 
activate more mutagens and that the mutagenicity of the oil was due to components 
other than PAHs at extract loadings of 50 mg plate-' or greater. The direct mutagens 
may be due to simple aromatic compounds that are known to be extracted along with 
polyaromatics in liquid-liquid extractions (Stang, 1993; 1999). However, no 
mutagenicity was observed for any of the IP 346 extracts with or without S-9, so only 
Grimmer results will be discussed. IP 346 extract mutagenicity is further discussed in 
Section 7.2.3.2. 
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FIGURE 3.4. Ames test revertants on the addition of liquid-liquid extracts of oil 4 in 
the absence and presence of 10% v/v S-9 (n = 3). %CV ranges from 3.2-11.2% for IP 
346 and 3.2-12.5% for Grimmer Extracts. 
Oil Nytro-IOGBN (Figure 3.5) showed direct mutagenicity at 50 mg plate-' or above. 
Indirect mutagenicity was not observed until 500 mg plate-' but again only with the 
Grimmer extract. The number of revertants at 500 mg plate-' increased from 837 
without S-9 to 1037 with S-9, which suggested an accumulation of both direct and 
indirect mutagens. However, as the indirect mutagens were only observed at the 
highest available dose, the Grimmer extract of Nytro- l OGBN was investigated further 
with the use of 80% v/v S-9 (Section 3.4.2). 
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FIGURE 3.5. Ames test revertants on the addition of liquid-liquid extracts of oil 
Nytro-IOGBN in the absence and presence of 10% v/v S-9 (n = 3). %CV ranges from 
1.6-9.5% for IP 346 and 1.7-17.9% for Grimmer Extracts. 
For oil 8 (Figure 3.6), which was known to have the highest aromatic content (IP 346 
% w/w data) only clear evidence of direct mutagenicity (1200 revertants) was observed 
for the Grimmer extract. This might have been due to the presence of an excess of 
PAHs in oil 8 competing for the S-9 enzymes and was therefore investigated further 
using 80% v/v S-9 (section 3.4.2). Results are further discussed in section 7.2.3. 
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FIGURE 3.6. Ames test revertants on the addition of liquid-liquid extracts of oil 8 in 
the absence and presence of 10% v/v S-9 (n =3). %CV ranges from 1.6-12.9% for IP 
346 and 3.2-27.2% for Grimmer Extracts. 
The Grimmer extraction was performed a further 3 times and tested with the Ames test 
on each occasion. LLE proved difficult to repeat with precision but the Ames test 
results did not alter each time a new extract of the same oil was used. The variation in 
aromatic content therefore had no effect on the mutagenicity of the fraction. Hence the 
results suggested that, although the amount of mutagen might vary with extraction, the 
threshold level required for mutagenicity was present in all extracts. 
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3.4.1.1 Total Ion Chromatogram (TIC) of Grimmer and IP 346 Extracts 
It was not possible in the context of this work to determine how the Grimmer and IP 
346 extracts differed in composition as both gave highly complex GC-MS data (Figure 
3.7). It might be that the Grimmer method, due to a reduced number of stages, resulted 
in a more complex extract, and the mutagenicity observed was due to components that 
were not present in the IP 346 extracts. However, it was still not possible to determine 
the source of the mutagenicity due to the remaining complexity of both extracts, and it 
was also not possible to conclusively relate mutagenicity as observed with S-9 to PAH 
content as the extract may contain other species of indirect mutagens. The cause of the 
direct mutagenicity could not be attributed for the same reason. The selective ion 
chromatogram (SIC) of the oil extracts were also performed to specifically quantify 
PAH content, but no PAHs were found other than fluorene and phenanthrene. As the 
%CV values ranged from 59-68% due to the nature of the sample matrix and 
extraction methods, this data was discarded and is not discussed here. 
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FIGURE 3.7. The total ion chromatograms (TIC) of oil 8 before extraction, after 
Grimmer extraction and after IP 346 extraction. 
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3.4.2 The Grimmer Method at 80% S-9 
An 80% v/v S-9 mix was used in the Ames test to increase the activation of PAHs in 
the oil extracts. The number of revertants observed after the addition of 80% v/v S-9 
did not significantly change for the Grimmer extract of white oil when compared to the 
result observed without S-9 (Figure 3.3). This also applied to oil 4 when comparing 
Figure 3.8 with data recorded in the absence of S-9 in Figure 3.4. 
Nytro-IOGBN however, showed a further increase of 133 revertants when 80% v/v S-9 
was used instead of 10% v/v (a total of 1137 revertants). When compared to revertant 
number without S-9 (837) it was further evidence that Nytro-IOGBN contained 
indirect mutagens that might be PAHs. However, the presence of indirect mutagenicity 
was once again only observed at the highest dose. As carrier solvent saturation did not 
allow testing at higher doses, the results were validated by comparing the Grimmer 
extract mutagenicity data (at 500 mg plate-) with the mutagenicity data of other 
extraction methods (Section 3.6,5.2 and 5.5) and indirect mutagenicity was concluded. 
The number of revertants for oil 8 increased from 1228 without S-9 (Figure 3.6) to 
2444 with 80% v/v S-9 (Figure 3.8). This near-doubling in number on the addition of 
S-9 was deemed significant, particularly as it was an increase of over 1000 revertants. 
Since oil 8 was observed to be 3 times richer in aromatics than oil 4 or Nytro-1OGBN 
(IP 346 % w/w data), it was possible that this increase in mutagenicity was due to 
PAHs. However this increase was only observed at loadings of 500 mg plate-1; all 
responses observed at 50 mg plate-' or less were no greater than the response observed 
in the absence of S-9. Once again, issues of saturated carrier solvent meant that these 
results were validated using the mutagenicity data of alternative extracts (Section 3.6, 
5.2 and 5.5) and only then was indirect mutagenicity concluded. Results are further 
discussed in Section 7.2.4 and compared to other extracts in Section 7.4.1 and 7.4.2.1. 
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FIGURE 3.8. The Ames test revertants on the addition of Grimmer oil extracts with 
80% v/v S-9 (n = 3). %CV ranges from 3-33%. 
3.5 AMES TESTING OF AGED OIL GRIMMER EXTRACTS 
In addition to new transformer oils, aged oils (Section 2.1.1) were extracted and tested 
to give an indication of how mutagenicity changed with age. This would indicate if 
mutagenic threat increased over the lifetime of the oil. The oil used was tested before 
ageing (ALT 0) and then tested after ageing for 1 week (ALT 1), 2 weeks (ALT 2) and 
3 weeks (ALT 3). Results showed that the Grimmer extracts of all oils were mutagenic 
with or without 10% v/v S-9 (Figures 3.9,3.10). 
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FIGURE 3.9. The Ames test revertants on the addition of Grimmer extracts of new oil 
ALT 0 and after ageing for I week (ALT 1), 2 weeks (ALT 2) and 3 weeks (ALT 3) 
without S-9 (n = 3). %CV ranges from 1.4-20.7%. 
No significant change in mutagenicity was observed with artificial ageing of up to 3 
weeks. There was an increase in the number of revertants by >200 on the addition of 
10% v/v S-9 for the Grimmer extracts, although this did not constitute a doubling in 
revertant number compared to that observed without S-9. However, it was possible that 
the extra revertants were due to the presence of an indirect mutagen such as PAHs 
(Section 7.2.5). Further measures of aged oil mutagenicity were performed in Section 
5.6 with alternative extracts and concluded that direct and indirect mutagenicity was 
present, but did not change with age. 
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3) with 80% v/v S-9 (n = 3). %CV ranges from 3.7-13.8%. 
3.6 AMES TESTING OF FRACTIONATED SOLID PHASE 
EXTRACTS 
A number of issues were encountered when testing liquid-liquid extracted oils with the 
Ames test. The first issue was that the IP 346 and Grimmer methods gave different 
results. In order to prevent false negative diagnosis, it was considered appropriate to 
use the most mutagenic result, and so the Grimmer extraction method was considered 
more appropriate than the IP 346 method. 
In addition to this, mutagenicity testing proved to be expensive due to the requirement 
for 80% v/v S-9, an important consideration when large numbers of samples require 
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processing by the end-user. The next stage therefore, was to find a different method of 
extraction that correlates with the results of one of the extraction methods already 
used, whilst reducing S-9. It was postulated that by fractionating the aromatic oil 
extract, an overall reduction in S-9 usage was possible. 
Solid phase extraction (SPE) was investigated as an alternative to LLE. It was 
postulated that this extraction method would also remove more unwanted components 
than the LLE methods, therefore allowing improved identification of PAHs in oil. It 
also allowed easy fractionation of PAHs according to their interaction with the sorbent 
so that any synergism or antagonism arising from both the presence of a large mixture 
of PAHs in one fraction and competitive or non-competitive inhibition would be 
overcome. A silica column was used, which was the recommended normal phase 
sorbent for moderately polar components. Due to the preference of the National Grid 
Company Plc for non-hazardous solvents, an investigation into the most appropriate 
low hazardous solvents was undertaken. The literature showed ethyl acetate to be a 
suitable elution solvent, so it was selected over dichloromethane, the preferred solvent 
for PAH analysis (Thurman and Mills, 1998). 
3.6.1 Optimisation of Oil Volume for Silica Column Extraction 
An experiment was performed to determine the most appropriate oil volume for silica 
(Si02) SPE efficiency. The more oil that could be extracted at once, the less time 
consuming the extraction. Consequently loadings of 10 mL and 20 mL were examined. 
Efficiency was determined by spiking the oil with the EPA 16 priority PAHs before 
extraction (Table 3.8). It was found that overall efficiency was improved when more 
oil (20 mL) was added. This may be due to loss of PAHs within the column with lower 
oil loadings, particularly as lower loadings required greater volumes of elution solvent. 
This experiment also gave an indication of efficiency for this large-scale extraction. It 
proved difficult to obtain quantitative data due to the presence of interferents 
illustrated by the high %CV values, and efficiency was found to vary widely 
particularly with respect to the smaller, less polar PAHs. For 20 mL of oil, 14 of the 16 
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PAHs were recovered while only 8/16 were recovered with 10 mL of oil. Extraction 
efficiencies ranged from 24-109% of 20 mL of oil, while 10 mL of oil led to an 
efficiency range of 28-87%. 
TABLE 3.8. Extraction efficiencies of large scale solid phase extraction with 20 mL 
and 10 mL of Nytro-IOGBN oil (n = 3). 
Name of PAH 20 mL Oil Nytro- 
10GBN: 
Efficiency of 
Extraction (%) 
%CV for 20 mL 
Extraction 
10 mL Oil Nytro- 
1OGBN: Efficiency 
of Extraction (%) 
%CV for 10 mL 
Extraction 
Naphthalene 24 35 0 0 
Acenaphthylene 55 17 0 0 
Acenaphthene 91 14 0 0 
Fluorene 65 0 58 20 
Phenanthrene 27 39 30 23 
Anthracene 42 30 28 19 
Fluoranthene 30 18 0.0 0 
Pyrene 62 5 87 43 
Benzo(a)anthracene 0 0 55 16 
Chrysene 0 0 0 0 
Benzo(b)fluoranthene 96 3 0 0 
Benzo(k)fluoranthene 89 10 0 0 
Benzo(a)pyrene 89 33 0 0 
Indeno(1,2,3-c, d)pyrene 99 44 75. 13 
Dibenz(a, h)anthracene 102 44 86 1 
Benzo(g, h, i)perylene 109 31 78 18 
3.6.2 Mutagenicity of Solid Phase Extracts 
The SPE extracts were eluted in two fractions (Section 2.2.4.2) and each fraction was 
tested separately for mutagenicity with 10% v/v S-9. Oil 4 fraction 1 showed direct 
mutagenicity with the number of revertants increasing on addition of S-9 (increase of 
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200 revertants; 2.5 fold). Such mutagenicity had not been observed for the Grimmer 
extract. Fraction 2 proved non-mutagenic with or without S-9 (Figure 3.11). Nytro- 
IOGBN also only showed mutagenicity in fraction 1 with and without S-9. In this case 
the number of revertants increased by just over 100 on the addition of S-9, an increase 
of 75% and therefore not a doubling (Figure 3.12). 
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FIGURE 3.11. Ames test revertants on the addition of two fractions of oil 4 large 
produced by scale solid phase extraction in the absence and presence of 10% v/v S-9 (n 
= 9). %CV ranges from 1.4-42%. 
Direct and indirect mutagenicity for fraction 2 of oil 8 was obtained, but fraction 1 
with S-9 produced further indirect mutagenicity (Figure 3.13). The solid phase 
extraction results suggested that oil 8 contained additional mutagenic PAHs since 
indirect mutagenicity was observed in both fractions. This correlated with Grimmer 
results and IP346 %/ w/w values again, suggesting that oil 8 contained a greater PAHs 
loading than the other oils. This is further discussed in Section 7.2.6. 
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FIGURE 3.12. Ames test revertants on the addition of two fractions of oil Nytro- 
IOGBN produced by scale solid phase extraction in the absence and presence of 10% 
v/v S-9 (n = 9). %CV ranges from 1.8-38%. 
Unfortunately, the solid phase extraction proved less able to remove aliphatic 
compounds than the liquid-liquid extraction method due to immiscibilty with the 
aqueous environment of the Ames test plates. This inability to mix on the plate was 
believed to be the cause of large variations in the Ames test results and makes them 
less conclusive that the Grimmer extract results. Definite trends only became apparent 
when the test was repeated on at least nine plates. Figure 3.14 shows the TIC of the 
two fractions of Nytro-1 OGBN. Again, the complexity of the chromatograms did not 
allow individual PAH species or other possible mutagens to be identified. 
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%CV ranges from 2.7-25%. 
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FIGURE 3.14. Total ion chromatogram of the two PAH fractions of Nytro- l OGBN 
from silica solid phase extraction. 
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However, the results of the solid phase extraction tests have shown that most mutagens 
could be confined to one fraction. This had potential for concentrating the extract and 
removing interferents. In addition, indirect mutagens had been observed in oil 4, that 
had not been observed in the Grimmer extract. Nevertheless, the liquid-liquid 
extraction method did have benefits over the SPE method, in that the former method 
was better at removing aliphatics and was therefore more repeatable. These findings 
suggested that the oil preparation method would benefit from a combination of liquid- 
liquid extraction to remove the aliphatics, followed by solid phase extraction to 
fractionate and isolate the bulk of the mutagenic species. 
3.7 AMES TESTING OF GRIMMER/SPE EXTRACTS 
The Grimmer method was used in conjunction with a small scale solid phase extraction 
to generate two extract fractions and to evaluate if this double extraction method gave 
a cleaner extract than a single extraction method. The Grimmer method LLE was used 
rather than the Blackburn method, as cyclohexane was used as the final solvent and 
hence was compatible with SPE. The final solvent in the Blackburn method was 
DMSO, which was difficult to evaporate without possible analyte losses due to low 
volatility. The results are shown in Figure 3.15. Unlike the Grimmer or SPE methods 
individually, no mutagenicity or toxicity was observed for any of the oil extracts even 
with fractionation at 10% v/v S-9. 
The TIC scan in Figure 3.16 shows than the extracts were still very complex and no 
information on composition could be obtained. Due to the lack of mutagenicity of the 
extracts, the wash material from the solid phase column was tested for mutagenicity. 
The results, also shown on Figure 3.15 indicated no mutagenicity or toxicity. It was not 
fully understood why the extracts no longer exhibited mutagenicity. It was possible 
that a proportion of the PAHs were retained on the silica column or were distributed 
between the cyclohexane wash and the two aromatic fractions so that no single fraction 
contained sufficient PAHs to cause a mutagenic response. In conclusion, as the TIC 
scan shows, this extraction method was no better than the single step methods for 
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cleaning and identifying PAHs, and so was not investigated further. For exploring 
mutagenicity, the liquid-liquid or single step solid phase extractions were superior, 
even though all extraction methods examined thus far did not allow the identification 
of the compounds causing mutagenicity. 
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FIGURE 3.15. Ames test revertants on the addition of Nytro-IOGBN Grimmer/SPE 
extracts in the absence and presence of 10% v/v S-9. Extracts are compared to the 
revertants on the negative (DMSO only) and positive (B[a]p with 10% v/v S-9) control 
plates. 
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FIGURE 3.16. Total ion chromatogram of Nytro-1 OGBN fractionated by the 
Grimmer/SPE extraction. 
3.8 INVESTIGATION OF OIL EXTRACT INTERFERENCE ON 
THE AMES TEST 
Although a mutagenic response had thus far been observed for oil extracts, due to their 
complex nature, it was postulated that extracting the aromatic fraction had not removed 
all antagonistic or synergetic effects. It particular, identifying antagonistic affects on 
PAH mutagenicity was of interest as it was possible that the full extent of PAH 
mutagenicity had not yet been observed. The inhibition of benzo[a]pyrene and 2-amino 
anthracene mutagenicity had previously been detected when in the presence of whole 
oil (Section 3.3.3). It was postulated that these inhibitors of PAH mutagenicity may 
have been extracted with the aromatic fraction of the oil. 
To determine if the oil extracts would alter the mutagenicity of PAHs, 50 mg plate"1 of 
the extracts were added to the bacteria in turn, with benzo[a]pyrene (50 µg mL-) or 2- 
amino anthracene (20 µg mU-'). This amount of oil extract was used as it was the 
highest dose of extract tested that did not produce a mutagenic response, with or 
without S-9. In this way, only the mutagenicity of the benzo[a]pyrene/2-amino 
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anthracene would be observed as it would be difficult to subtract benzo[a]pyrene/2- 
amino anthracene mutagenicity from oil extract mutagenicity, when oil extract 
mutagenicity can have a large standard deviation. Only 10% v/v S-9 was used at this 
stage, as benzo[a]pyrene in the control plates had only required 10% v/v to be 
activated. 
The results in Table 3.9 shows the reduction in benzo[a]pyrene or 2-amino anthracene 
mutagenicity when the Grimmer oil extracts were added. There was an increase in 
inhibition with increasing PAH content, with inhibition no greater than 32%. These 
trends were present with whole oils (Section 3.3.3). The inhibition was significant 
according to the t-test results in Table 3.9 as all extracts gave a value more negative 
than the critical value of -2.35 (n = 3). Such an increase in inhibition when a high 
PAH content oil was used was investigated further in Section 5.7 where S-9 was 
increased to see how it affected inhibition. 
TABLE 3.9. Effects on revertant number of adding Grimmer extracts to mutagens 
(benzo[a]pyrene and 2-amino anthracene). 
Sample on Plate Mean ± SD %CV Reduction in One-Sided T- 
Number (n = 3) Revertants Test (t) 
of from 
revertants Mutagen on 
Exposure 
to Oil (%) 
Benzo[a]pyrene (B[a]PO 196 34 17 0 N/A 
Grimmer extract of White oil and B[a]P 165 9 5 15 -5.7 
Grimmer extract of Oil 4 and B[a]P 157 14 9 20 -4.9 
Grimmer extract of Oil 8 and B[a]P 134 8 6 32 -13.4 
2-amino anthracene (2-aa) 729 37 5 0 N/A 
Grimmer extract of White oil and 2-aa 638 44 7 12 -3.5 
Grimmer extract of Oil 4 and 2-aa 568 94 16 22 -2.9 
Grimmer extract of Oil 8 and 2-aa 498 64 13 32 -6.2 
* Critical Value t3 = -2.35 (P = 0.05) 
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SPE extracts in Table 3.10 again followed the trend, as all oils caused significant 
inhibition according to the t-test values with the greatest inhibition from oil 8 extracts 
(30%) as did the Grimmer/SPE extracts, although the inhibition was up to 43% for oil 
8 (Table 3.11). 
TABLE 3.10. Effects on revertant number of adding solid phase extraction fractions 1 
and 2 to mutagens (benzo[a]pyrene and 2-amino anthracene). 
Sample on Plate Mean 
Number 
of 
revertants 
± SD 
(n = 3) 
%CV Reduction in 
Revertants 
from 
Mutagen on 
Exposure 
to oil C/o) 
One-Sided 
T-Test (t) 
Benzo[a]pyrene (B[a]P) 196 34 17 0 N/A 
SPE Fraction 1 White oil and B[a]P 165 17 10 16 -3.1 
SPE Fraction 1 Oil 4 and B[a]P 159 10 6 19 -6.7 
SPE Fraction 1 Oil 8 and B[a]P 146 19 13 26 -4.5 
2-amino anthracene (2-aa) 729 37 5 0 N/A 
SPE Fraction 1 White oil and 2-aa 622 77 12 15 -6.8 
SPE Fraction 1 Oil 4 and 2-aa 564 64 11 23 -8.6 
SPE Fraction 1 Oil 8 and 2-aa 614 16 3 16 -8.0 
Benzo[a]pyrene (B[a]P) 196 34 17 0 N/A 
SPE Fraction 2 White oil and B[a]P 174 6 3 11 -2.4 
SPE Fraction 2 Oil 4 and B[a]P 153 9 6 22 -4.4 
Grimmer the SPE Fraction 2 Oil 8 and B[a]P 138 12 9 30 -12.5 
2-amino anthracene (2-aa) 729 37 5 0 N/A 
SPE Fraction 2 White oil and 2-aa 634 22 3 13 -7.4 
SPE Fraction 2 Oil 4 and 2-aa 612 53 9 16 -3.8 
SPE Fraction 2 Oil 8 and 2-aa 536 53 10 26 -6.2 
* Critical Value t3 = -2.35 (P = 0.05) 
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TABLE 3.11. Effects on revertant number of adding Grimmer/solid phase extraction 
fractions 1 and 2 to mutagens (benzo[a]pyrene and 2-amino anthracene). 
Sample on Plate Mean 
Number 
of 
revertants 
± SD 
(n = 3) 
%CV Reduction in 
Revertants 
from 
Mutagen on 
Exposure 
to Oil (%) 
One-Sided 
T- Test (t) 
Benzo[a]pyrene (B[a]P) 196 34 17 0 N/A 
Grimmer/SPE Fraction 1 White oil and B[a]P 165 17 10 16 -3.1 
Grimmer/SPE Fraction 1 Oil 4 and B[a]P 159 10 6 19 -6.7 
Grimmer/SPE Fraction 1 Oil 8 and B[a]P 132 4 3 32 -26.3 
2-amino anthracene (2-aa) 729 37 5 0 N/A 
Grimmer/SPE Fraction 1 White oil and 2-aa 555 72 13 24 -9.1 
Grimmer/SPE Fraction 1 Oil 4 and 2-aa 557 68 12 24 -8.6 
Grimmer/SPE Fraction 1 Oil 8 and 2-aa 415 18 4 43 -7.7 
Benzo[a]pyrene (B[a]P) 196 34 17 0 N/A 
Grimmer/SPE Fraction 2 White oil and B[a]P 160 7 4 18 -4.1 
Grimmer/SPE Fraction 2 Oil 4 and B[a]P 153 9 5 22 -4.3 
Grimmer/SPE Fraction 2 Oil 8 and B[a]P 131 14 11 33 -30.9 
2-amino anthracene (2-aa) 729 37 5 0 N/A 
Grimmer/SPE Fraction 2 White oil and 2-aa 568 63 11 22 -4.4 
Grimmer/SPE Fraction 2 Oil 4 and 2-aa 512 53 10 30 -7.1 
Grimmer/SPE Fraction 2 Oil 8 and 2-aa 432 42 10 41 -12.3 
* Critical Value t3 = -2.35 (P = 0.05) 
In order for inhibition to change an Ames test result, it would have to reduce 
mutagenicity by 50% (therefore disguising a doubling in revertant number). Inhibition 
of up to -30-40% observed here would only be significant if the Ames test had 
produced an intermediate (inconclusive) result, as in the case of chrysene (Section 
3.2.1.1). As no result thus far gained for oil extracts with the Ames test was 
inconclusive, the inhibition measured here had not influenced the Ames test results. 
These findings suggested however, that any oil extracted in the future, that produced a 
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weakly positive or intermediate result, should be tested for inhibition from other 
components in the mixture. 
3.9 CONCLUSIONS 
In this chapter mutagenicity has been found with and without S-9 with two different 
extraction methods (Grimmer and SPE). The Ames test indicated the presence of direct 
mutagens suggesting that mutagens other than PAHs are present in the oil. The 
Grimmer extracts in particular, indicated that mutagenicity increased when S-9 was 
added for oils that contained intermediate (Nytro-l OGBN) or high levels (oil 8) of 
PAH according to IP 346 % wlw data. This suggested that PAHs could be causing 
additional mutagenicity in the oil. However, due to the complexity of the GC-MS data, 
it was not possible to specifically identify PAHs, and therefore it cannot be concluded 
that the indirect mutagen observed was a PAH. Without identifying the specific 
contribution of PAHs to oil mutagenicity, the benefits or costs of having PAHs in the 
oil cannot be assessed. For this reason a new method of extraction is required. 
Preferably the method will generate an extract that can be used in the Ames test, but is 
clean enough to analyse with GC-MS so that mutagenic effect can be directly 
correlated to identified components. Development of such an extraction method is 
detailed in chapter 4. 
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CHAPTER 4.0 
RESULTS 
DEVELOPMENT OF A POLYCYCLIC 
AROMATIC HYDROCARBON EXTRACTION 
METHOD FOR TRANSFORMER OILS 
USING GC-MS ANALYSIS 
-97- 
4.1 INTRODUCTION 
As seen in Chapter 3, methods for oil extraction using liquid-liquid extraction (LLE) 
methods at 80% S-9 and silica solid phase extraction (SPE) using 10% S-9 were 
successful at isolating mutagenic components in the oil. Direct mutagenicity was 
observed from a non-polyaromatic source, while an increase in mutagenicity on the 
addition of activation enzymes was attributed to the presence of PAHs in oil Nytro- 
IOGBN and oil 8, as PAHs are indirect mutagens. However, it was not possible to 
identify PAHs or other mutagens in the oils by GC-MS as the extracts were still 
complex mixtures of unresolved peaks. 
Therefore, a new extraction method was required, that was more specific to PAHs, 
especially those considered carcinogenic. Such an extraction method would allow 
identification of potential carcinogenic PAHs without the requirement for mutagenicity 
testing, and would ensure that any mutagenicity observed with the Ames test could be 
directly linked to oil PAH content in the oil. Currently there is no extraction method 
that can be used with an analytical technique, such as GC-MS whilst providing a 
sufficient extract to test for mutagenicity. It was therefore the aim of this work to find a 
preparative extraction method that provided an extract of sufficient quantity for Ames 
testing, with sufficient purity for meaningful GC-MS analysis. 
4.1.2 Solid Phase Extraction Methods for PAH Analysis 
The LLE methods examined in Chapter 3 were crude methods that extracted the 
aromatic components from the oil. It proved difficult to improve these extractions 
without the addition of further clean-up or purification steps. SPE was considered a 
promising method of further sample clean-up due to operational simplicity. Although 
LLE followed by SPE clean-up proved to be unsuccessful (Section 3.7) it was believed 
that improvements could be made with further development and the use of alternative 
sorbents. SPE is commonly used for the extraction of PAHs from soil and water 
matrices, so was an obvious choice for purification of the sample. For these reasons 
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SPE methods were explored, primarily to identify improved sorbent-sorbent systems 
prior to use in combination with LLE or other SPE methods. 
4.1.2.1 Alternative Solvents 
The EPA had many standard extraction methods for extracting PAHs from a wide 
variety of matrices (EPA, 2002), but all involved hazardous solvents such a 
dichloromethane or hexane, which the National Grid Company Plc wished to avoid. 
For this reason, no pre-existing extraction method was utilised but several existing 
methods were used as the initial starting point for method development. 
4.1.2.2 Column Size and Oil Volume 
Sample loading and column dimensions are known to have an impact on the efficiency 
of the extraction method so both were considered carefully. The results from the large 
scale silica extraction method (Section 3.6) suggested that the extraction efficiency 
cannot be established without significant practical application. This was particularly 
true for complex mixtures such as oils. 
Column dimensions were determined by commercial availability. Two sizes of column 
were used, a 15 g sorbent column and a 1.2 g sorbent column. When silica (Si02) and 
alumina (A1203) were directly compared for extraction efficiency, the 15 g column was 
preferred (Section 4.2 and 4.3.1). This was because larger quantities of spiked oil could 
be extracted and analysed therefore reducing the error associated with quantifying 
PAHs with GC-MS. This was particularly important when two sorbents were directly 
compared or when the extraction efficiency of the system was very low. 
A series of experiments were performed using a number of sequential SPE extraction 
steps. These were performed on a small scale due to sorbent availability. Sorbents 
included cyanopropyl, Isolute PAH HC and C18, and were readily available in 1g 
cartridges. They were also useful for the initial screening of sorbents, as they required 
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less solvent and were less time consuming to perform. However, with less oil 
throughput, the error in quantifying poorly extracted PAHs is increased. This was 
remedied in a number of ways. The GC-MS sensitivity was repeatedly checked by 
running standards, the sample was concentrated to 1 mL before analysis and additional 
sample repeats were run (4-6 repeats rather than triplicate). Column loading could not 
be increased as this would saturate the column and affect extraction efficiency. 
White oil was used for initial investigation of extraction methods as it contained little 
or no PAHs. Residual native PAHs would therefore not significantly interfere with 
spiking experiments. A2 mL volume of an EPA 16 priority PAH standard mixture (10 
µg mL 1) was added to 10 mL of white oil and the solvent evaporated to dryness (2 µg 
mL-') at room temperature and used as required. White oil as a highly refined oil, is 
less complex than transformer oil, and was only used for selective ion chromatogram 
(SIC) quantification of the spike as its limitations were recognised (Section 2.1.1). 
Therefore extractions were performed with Nytro- l OGBN in total ion chromatogram 
(TIC) mode to determine the extent of extraction of additional oil components in the 
less refined transformer oil. 
4.2 DEVELOPMENT OF SILICA SOLID PHASE EXTRACTION 
Initial work was performed to determine the volume of sample and solvent most 
effective for each silica column format. In cases where a single analyte requires 
extraction, significant method development can be achieved by reviewing analyte 
properties, such as structural information, functional group properties, solubility, pH, 
ionic strength etc. However, in this case, the complexity of the matrix and the mixture 
of unknown PAHs meant that the suitability of a SPE method had to be elucidated 
empirically rather than theoretically. 
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4.2.1 Amount of Oil Used for Extraction 
Silica (Si02) was considered a good sorbent choice as it is commonly used for the 
separation of polar components from lipids, with alumina (A1203) often used as an 
alternative (Thurman and Mills, 1998). Various amounts of oil were passed down a 1.2 
g (3 mL volume) silica column, to determine the maximum amount of oil that could be 
extracted without compromising the effectiveness of the washing step. The oil (Nytro- 
lOGBN) was spiked with 1 gg mU1 of each EPA 16 priority PAH. An UV lamp was 
used to follow the fluorescence arising from the aromatic fraction. GC-MS SIC was 
used to analyse the cyclohexane eluent to determine the point at which PAHs began 
eluting from the column. It was found that an oil loading of 50-100 µL onto a 1.2g 
column was optimum (data not shown). A 1: 10-20 oil: sorbent ratio was used as a 
guideline for further development purposes. This wide ranging ratio was used as the 
oils had a range of PAH loadings, which may affect extraction efficiency. It was also 
found that 5-6 mL of cyclohexane per gram of sorbent was suitable for washing 
purposes. This was found to be dependent on column dimensions such as plate number 
(Section 1.5.3.2), so modifications were made when appropriate. 
4.2.2 Measuring Naturally Occurring PAHs in White "Blank" Oil 
with Silica Extraction 
Silica and alumina SPE were used to extract PAHs from white oil to test its 
effectiveness as a blank oil in spiking experiments. Although neither sorbent was likely 
to be completely efficient (efficiency was tested in Section 4.3.1) an indication of PAH 
interference was established. Unspiked white oil was extracted with Si02 and A1203 
sorbents through 15 g sorbent 10 mm x 46 cm columns (Section 2.2.4.1) and GC-MS 
SIC analysis with the Turbomass software was performed (Section 2.2.6.1) to 
determine the presence of the EPA 16 priority PAHs. Once the presence of native 
PAHs was established, this experiment was not repeated until a different sorbent 
showed enough potential to warrant further development. 
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TABLE 4.1. EPA 16 priority PAHs detected in white oil using GC-MS SIC 
quantification using Turbomass software. 
Name Silica Extraction of SD Alumina Extraction SD 
1 mL White oil (pg of I mL White Oil 
mL-') (fug mL ') 
Naphthalene 0 0 0 0 
Acenaphthylene 0 0 0 0 
Acenaphthene 0 0 0 0 
Fluorene 0.016 0.017 0.025 0.01 
Phenanthrene 0.023 0.0012 0.013 0.011 
Anthracene 0 0 0 0 
Fluoranthene 0 0 0 0 
Pyrene 0 0.011 0 0 
Benzo(a)anthracene 0 0 0 0 
Chrysene 0 0 0 0 
Benzo(b)fluoranthene 0 0 0 0 
Benzo(k)fluoranthene 0 0 0 0 
Benzo(a)pyrene 0 0 0 0 
Indeno(1,2,3-c, d)pyrene 0 0 0 0 
Dibenz(a, h)anthracene 0 0 0 0 
Benzo(g, h, i)perylene 0 0 0 0 
Results in Table 4.1 show that no native PAHs were detected in white oil using Si02 or 
A1203 SPE except fluorene, phenanthrene and pyrene. However, all 3 PAHs were 
present at very low levels (<0.025 µg mL-1) and as the oil was to be spiked at the 2µg 
mL-1 level the presence of these naturally occurring PAH was not considered 
significant. 
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4.2.2.1 Solvent Selection for Solid Phase Extraction 
A range of solvents was examined with respect to the SPE method. Solvents were 
categorised according to their eluotropic strength (Table 1.3). Cyclohexane was the 
preferred solvent for washing, as it was less hazardous than hexane but had one of the 
lowest eluotropic strengths. The efficacy of three solvents (ethyl acetate, acetone and 
methanol) in eluting 1 mL of spiked white oil (2 µg mL-) from a 15 g silica column 
was examined (n = 3). Acetone and methanol in particular were identified as good 
solvents for the extraction of PAHs (Noordkamp et al., 1997). Methanol was found to 
be unsuitable however, as the initial TIC showed significant column bleed (Figure 4.1). 
This was found to be from the silica extraction column rather than the GC column, as 
running pure methanol through the GC column did not have the same effect. 
1: Scan EI+ 
TIC 
3.59e6 
Time 
FIGURE 4.1. The TIC of Nytro- l OGBN silica solid phase extraction with methanol 
elution. The peaks were identified as bleed from the silica extraction column. 
Figure 4.2 shows a comparison of acetone and ethyl acetate extraction efficiency. 
Acetone proved the most efficient eluent for all EPA 16 priority PAHs except fluorene 
and fluoranthene where ethyl acetate was better by 0.06 and 0.03 µg mL-1 respectively. 
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However, as acetone was the most effective for carcinogenic PAHs, it was selected as 
the preferred solvent. 
2.5 
2 
.. ý 1J MW 
05 
U 
ýe , 
EPA 16 PAHS 
le 
FIGURE 4.2. Spiked white oil (2 pg mL-1) elution efficiency of acetone compared to 
ethyl acetate with silica solid phase extraction. SIC quantification of the EPA 16 
priority PAHs was performed using Turbomass software. 
4.2.2.2 Silica Sorbent Activation 
The first approach examined was the optimisation of the Si02 SPE procedure, as SiO2 
is widely referred to in the literature as the most suitable sorbent for PAHs in oil 
(Thurman and Mills, 1998). Activating the SiO2 by removing the water content 
improves PAH adsorption. However, a balance is required between adsorption and 
ease of elution. Si02 was dried overnight in a drying cabinet at 50°C to activate the 
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1 Silica SPE with Ethyl Actetate Eluent 
I1 Silica SPE with Acetone Eluent 
------- Spiked Level 
silica and improve the binding of polar substances. Filtration tubes with fits in the 
bottom were filled with silica (Section 2.2.4.3) and after conditioning with 8 mL 
cyclohexane, 50 µL of Nytro-1 OGBN was added. A6 mL volume of cyclohexane was 
washed through until the fluorescence band was displaced to approximately one 
quarter of the way down the tube. A6 mL volume of acetone was then used to elute 
the fluorescent band. The cyclohexane wash and acetone eluent fraction were collected 
separately and concentrated to 1 mL prior to GC-MS analysis. 
Activated Silica: Cyclohexane 
loo, 
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FIGURE 4.3. TIC comparison of the cyclohexane washes and ethyl acetate eluent of 
Nytro-1 OGBN from columns using activated and inactivated silica. Although no PAPIS 
were identified from this TIC, it suggested that activated silica led to ineffective PAH 
elution due to the few peaks. This was confirmed with SIC. 
Figure 4.3 shows the activated silica was better at removing unwanted components in 
the cyclohexane wash but PAH recovery was poor, presumably due to strong PAH 
adsorption to the sorbent. The cyclohexane wash with inactivated silica was not as 
- 105 - 
successful at removing unwanted components. However, the inactivated silica 
produced a TIC with better defined peaks, although specific PAHs could not be 
identified without selective ion monitoring (data not shown). The silica was therefore 
used without drying, under ambient laboratory conditions. 
4.2.2.3 Variation on Column Dimension 
An investigation was performed to determine the effect of column dimensions on 
extraction efficiency (Section 1.5.3.2). Washing required optimisation to purify oil 
extracts and hence produce accurate identification and quantification of PAHs. Figure 
4.4 shows the results of an experiment performed with unspiked Nytro-1 OGBN on 
Si02 columns of two different lengths and diameters. The first was a 10 mm x 460 mm 
glass column. The column was filled with 2.5 g silica and washed with 5 mL 
cyclohexane. This extraction was repeated in the same column with 5g sorbent and 10 
mL cyclohexane. The remainder of the extraction process was performed as described 
in Section 2.2.4.1. The column dimension used in this experiment are summarised in 
Table 4.2. 
The second column had twice the diameter of the first (20 mm x 200 mm). Once again 
2.5 g silica was added, but due to its larger diameter, the column length was shorter 
than the previous column. This column was washed with 5 mL cyclohexane. The 
second column was then repeated with 5g of silica and washed with 10 mL 
cyclohexane. 
The second column (20 mm x 200 mm) cleaned the oil effectively, but the fluorescent 
band reached the end of the column with a lower volume of cyclohexane than in the 10 
mm x 460 mm column so could not be cleaned with more than 5 mL of cyclohexane. 
The more sorbent that was used, the greater the volume of cyclohexane that could be 
added. Doubling the mass of sorbent therefore improved the sample clean up in both 
columns. However, the 10 mm x 460 mm glass column was more effective that the 20 
mm x 200 mm column, when both contained the same amount of sorbent. This is best 
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illustrated in Figure 4.4 when the 20 mm x 200 mm with 2.5 g of sorbent (A) is 
compared with the equivalent 10 mm x 460 mm column (B). It was concluded that 
simply increasing the am ount of sorbent was an improvement but maximising the 
sorbent bed length (and plate number), by reducing the column diameter, further 
improved cleaning. Having a small diameter to length ratio therefore allows 
optimisation of the washing step without losing large quantities of PAHs in the process 
and may improve PAH identification by removing interference. This correlates with 
plate theory that states that increased plate number improves efficiency (Thurman and 
Mills, 2000). 
TABLE 4.2. Column dimensions investigated to determine the impact on extraction 
efficiency. Columns refers to chromatograms in Figure 4.4. 
CoIun777 Length of Column DIU777E(CF of Column SU7'hent Mass Volume of C'lcloliexane 
(mm) (177117) (g) I Ush (mL) 
A 200 20 2.5 5 
B 460 10 2.5 5 
C 200 20 5 10 
D 460 10 5 10 
Time 
FIGURE 4.4. TIC of silica 10 mm x 460 mm column compared to a 20 mm x 200 mm 
column with Nytro-1 OGBN. 
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4.2.2.4 Flow Rate 
As flow rate can significantly alter extraction efficiency (Section 1.5.3.2) the optimum 
flow rate of washing and elution solvents was investigated. The 10 mm x 460 mm 
column with 15 g of Si02 sorbent was washed with cyclohexane and eluted with 
acetone as in Section 2.2.4.1 at various flow rates. An appropriate flow rate for the 
wash solvent was established by determining (with an 15V lamp) a flow that reduced 
fluorescent band broadening on the column. A washing flow rate of 2-3 mL min' was 
evaluated as a suitable compromise between band broadening and speed of extraction. 
The elution flow rate was established in the same way as the wash flow rate. It was 
observed that -10©/o more solvent was required to elute the fluorescent band at a flow 
rate of 1 mL min' compared to 5 mL min 1. This was possibly a consequence of 
reduced pressure through the column. Elution flow rates of 4-5 mL min-1 was 
therefore chosen to optimise the speed of extraction and reduce eluent volume. 
4.3 ALTERNATIVE SORBENTS 
Various sorbents were investigated to determine if they provided an alternative to 
Si02, or could be used with Si02 with further development. The sorbents were chosen 
because of their common use in the literature (Al, cyanopropyl, C 18) or because they 
have been specially developed for PAH extraction in water or soil (Isolute PAH HC) 
and may be manipulated for use in an oil matrix. 
4.3.1 Aluminium Oxide (Alumina) 
Alumina (A12©3) is an alternative normal phase sorbent commonly used for aromatic 
extraction from oils. However Figure 4.5 shows that A1203 has similar extraction 
efficiency to Si02 for the EPA 16 priority PAHs. 
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Si02 was more efficient at extracting the carcinogenic PAHs, and had better 
repeatability for fluorene, pyrene and benzo[g, h, i]perylene, so was the preferred 
sorbent. The improved repeatability of the Si02 method may be explained by Figure 
4.6 which shows that silica's TIC chromatogram was cleaner and had better defined 
peaks than that of A1,, O3. 
2 
18 
1.6 
1.4 
1.2 
r" C1 
ý- 0.8 
06 
0.4 
0.2 
0 
EPA 16 PAHSý 
ýý 
ýý 
FIGURE 4.5. Extraction efficiency of spiked white oil (1.5 pg mL-') through a solid 
phase extraction with silica or alumina as the sorbent. SIC quantification of the EPA 
16 priority PAHs was performed using Turbomass software. 
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Akimina Column L Silica Column - Spike Level 
Alumina Extraction 1: Scan EI+ 
TIC 
2 45e7 
Silica Extraction 1: Scan E1+ 
100 TIC 
2.81 e7 
% 
Time 
6 00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 
FIGURE 4.6. TIC spectra of Nytro-IOGBN extracted with Alumina and Silica SPE. 
The silica TIC produced more defined peaks, suggesting that it may the better sorbent 
for oil clean-up. 
4.3.2 Use of Cyanopropyl Sorbent as an Extra Sample Clean-Up Step 
Referring to the literature, cyanopropyl was used pre-silica for the clean up of oil 
matrices (Thurman and Mills, 1998). Small-scale extraction columns were used as 
cyanopropyl was available as 900 mg cartridges. The cyanopropyl cartridge was 
placed above the Si02 column. The small scale Si02 columns were made in-house 
using 1.2 g of sorbent in a smaller diameter column 10 mm x 30 mm (greater plate 
number) than the commercially available columns (20 mm x 60 mm) containing 1g of 
sorbent (Section 2.2.4.3). 
After pre-conditioning both sorbents with 10 mL cyclohexane, 100 µL of spiked 
Nytro-1 OGBN was added to the top of the cyanopropyl cartridge. The sorbents were 
washed with 10 mL cyclohexane added to the cyanopropyl cartridge so that the 
fluorescent band entered the Si02 column and was washed through until it was 
approximately three quarters of the way down the Si02 column. The cyanopropyl 
cartridge was then removed and the fluorescent band was eluted with 6 mL acetone. 
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6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 
A Si02 column was also run without cyanopropyl, for a direct comparison. The oil was 
added directly to the Si02 column, and only 5 mL cyclohexane was required to wash 
the fluorescence down to the base of the column. 
There was an improvement in extraction performance with the addition of the 
cyanopropyl step observed as more distinct peaks on the TIC (Figure 4.7). However, 
these peaks were not identified as PAHs from the MS spectrum and a substantial 
amount of interfering background material remained. 
Silica Extraction 
loo, 
5.00 7.50 10.00 12.50 15.00 17.50 20.00 22.50 25.00 27.50 30.00 32.50 
Cyanopropyl/Silica Extraction 
5.00 7.50 1 0.00 12.50 15.00 17.50 20.00 22.50 25.00 27.50 30.00 32.50 
1: Scan EI+ 
TIC 
5.37e6 
1: Scan El+ 
TIC 
3.81 e6 
FIGURE 4.7. TIC of cyanopropyl/silica extraction compared to a silica extraction 
performed at the same time with Nytro-1 OGBN. The TIC shows vary little variation 
when a cyanopropyl sorbent is used pre-silica suggesting that there is no benefit in the 
extra step. 
Figure 4.8 shows the extraction efficiency of the SIC cyanpropyl/Si02 method. It was 
clear that the addition of the cyanopropyl column did not dramatically improve PAH 
extraction. No significant differences were observed in extraction efficacy between the 
Si02 method and the cyanopropyl- Si02 method, therefore this approach was not 
examined further. 
Cyanop ropyl/S ilic a Column 
0.25 
02 
0 15 
01 
0 fj 
U 
Silica Column - Spike Level 
X-1 
EPA 16 PAHS 
FIGURE 4.8. Extraction efficiency of spiked NIOGBN oil (2 µg mL-1) through a 
cyanopropyl/silica column compared to a silica column. SIC quantification of the EPA 
16 priority PAHs was performed using Turbomass software. 
4.3.3 Isolute PAH HC Column 
A commercially available SPE cartridge, Isolute PAH HC was investigated for oil 
PAH extraction efficiency. The column was developed for extracting PAHs from water 
and soil. Jones Chromatography would not reveal the sorbents content of the column, 
but it was recommended for use with samples in organic solvents, so was compatible 
with oils. The extraction was performed with Nytro-IOGBN, once with hexane as in 
the protocol, and once with cyclohexane, the less hazardous solvent preferred by the 
National Grid Company Plc. The protocol supplied with the column was used and is 
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outlined in Section 2.2.7.1 The TIC of each was obtained to determine the efficacy of 
the column for the removal of unwanted components from the oil (Figure 4.9). 
A 
1: Scan Ei+ 
TIC 
1.88e8 
1 Scan EI+ 
TIC 
1.88e8 
Time 
5.00 7.50 10.00 12.50 15.00 17.50 20.00 22.50 25.00 27.50 30.00 32.50 35.00 
FIGURE 4.9. The TIC of oil Nytro-1 OGBN extracted with an Isolute PAH HC 
column using hexane (A) and cyclohexane (B). Both solvents produced a bare 
chromatogram, suggesting that PAHs were not extracted with this sorbent. 
The chromatogram produced seemed bare, as if all interference had been removed, but 
no PAHs could be detected. Neither solvent proved more efficient at extracting. 
Therefore the extraction was repeated with white oil spiked with EPA 16 priority 
PAHs (2 µg mL-' each PAH) using cyclohexane and the extraction efficiency was 
determined from a SIC (Figure 4.10). 
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PA 03 
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147 
EPA 16 PARS ti, 
FIGURE 4.10. Extraction efficiency of EPA 16 priority PAHs spiked into white oil (2 
µg mL-1) using an Isolute PAH HC column. SIC quantification of the EPA 16 priority 
PAHs was performed using Turbomass software. 
Extraction was very poor for all PAHs. However, the column is specifically 
manufactured for PAH extraction in soil and water so it was possible that the oil matrix 
was too complex for the column and an initial clean-up step would improve the 
efficiency of the column. The waste oil eluted from the column, although too complex 
to analyse by GC-MS, exhibited fluorescence suggesting that the oil was saturating the 
column therefore preventing full interaction between the sorbent and PAHs. This 
sorbent was therefore examined further as a final purification step following the 
development of a suitable preparative step (Section 4.5.1). 
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An important observation on the TIC of the Isolute PAH HC extract (Figure 4.9) was 
the large peak found at retention time 21 minutes. This peak could not be identified by 
the NIST MS library (part of the Perkin Elmer GC-MS software) but was present 
whenever an Isolute PAH HC column was used, so was likely to originate from the 
column itself. As the Isolute PAH HC column has been established as a useful final 
purification step, it was unlikely that this peak would be removed. However, although 
this peak would affect chromatogram scale due to its large size, it did not interfere with 
the data gained from the chromatogram so was not investigated further. 
4.4 MULTI-STEP SPE FOR PAPIS IDENTIFICATION IN OILS 
Having been unsuccessful at extractions using a single sorbent, the use of a 
combination of sorbents was examined. Most clean-up protocols reported in the 
literature for PAHs from soils and water used only one sorbent for reasons of high 
throughput and simplicity. 
Due the complex nature of the oil, it was unlikely that any one sorbent would remove 
sufficient interferents. The classic extraction method used in the literature involved a 
solvent clean-up followed by silica SPE (Wang, 2000). A similar method had already 
been performed (Section 3.7) and considering the large amount of solvent and time 
involved, as well as the inconclusive results gained with the Ames test, it was not 
considered an ideal method and would require considerable method development. 
The fingerprinting technique developed at the National Grid Company Plc was an 
extension of the LLE/SPE method, which used aC 18 column as an additional cleaning 
step (Wilson and Pahlavanpour, 2000). This method was useful as it provided a 
characteristic GC chromatogram that could be used to classify oil according to their 
aromatic content, and PAHs have been identified with this method by the National 
Grid Company Plc for Nytro-1 OGBN (Pahlavanpour and Wilson, 1999). 
However this method was qualitative and not quantitative and this extract still 
contained many components other than PAHs. More importantly to this work, the 
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chromatogram exhibited numerous interferent peaks at later retention times, the region 
in which the carcinogenic PAHs would be eluted. As the work here was concerned 
with the measurement of PAH mutagenicity, it required a method that would minimise 
the presence of unwanted components at this later time in the chromatogram. This 
method was still useful however, as it provided important information on sorbent 
selection and experimental protocol. 
4.4.1 Oil Fingerprinting 
In the fingerprinting technique (Wilson and Pahlavanpour, 2000) three sequential 
extraction methods were used, to provide a cleaner PAH preparation (Section 2.2.8). 
There were however, disadvantages to the fingerprinting technique. These included the 
requirement for a large amount of oil (5 g) and as there were three separate extraction 
methods, losses from transfer and evaporation of solvent could occur. The method was 
also time consuming; the LLE alone took 2 hours to perform, particularly when the oils 
were aged, to ensure proper separation. 
Figure 4.11 shows the fingerprinting technique TIC of oil 8, Nytro-1 OGBN and oil 4. 
The TIC for each oil showed a similar trend to IP 346, with the oil 8 extract having a 
greater mass of components when compared to Nytro-IOGBN and in turn oil 4. 
However, the TIC clearly shows that these extracts were still too complex, and would 
not be suitable for Ames testing. However, the use of a reverse phase C18 extraction 
(as opposed to normal phase) introduced an alternative approach to extracting oils. It 
was postulated that this sorbent could prove useful in conjunction with Si02, LLE, or 
an Isolute PAH HC columns. The use of cyclohexane with the C18 sorbent in the 
fingerprinting technique created a non-polar environment in both the solid and liquid 
phases, rather than the polar and non-polar environment present in the 
silica/cyclohexane step and could offer improvements in sample clean-up. 
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Oil 8 Fingerprint Scan E+ TIC 1001 
2.50e7 
N1 OGBN Fingerprint Scan EI+ TIC 
100- i 2.50e7 
Scan EI+ 
Oil 4 Fingerprint 2.50eTIC 7 
100, 
% 
5.00 10.00 15.00 20 00 25.00 30.00 40.00 
FIGURE 4.11. TIC of oil 8, Nytro- I OGBN and oil 4 using the mineral insulating oil 
fingerprinting technique. The initial large peaks (RT 5-7 minutes) are due to column 
bleed. The emergence of individual peaks is clearest for Nytro- l OGBN but none of 
these peaks were conclusively identified as PAHs due to interference from other 
components in the oil. 
The C18 sorbent was tested with whole oil using cyclohexane as the eluting solvent (as 
in the fingerprinting technique). Cyclohexane is a relatively non-polar solvent, but was 
suitable for PAHs elution as indicated by the progress of the fluorescent band. The 
resulting extract was still complex (Figure 4.12) but as the aromatic fraction was not 
retained on the column, the C 18 could be useful as an initial crude extraction step and 
an alternative to the preliminary liquid-liquid extraction step. 
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1: Scan EI+ 
TIC 1001 3.49e8 
6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 
Time 
FIGURE 4.12. TIC of Oil Nytro-1 OGBN removed from a C18 column with 
cyclohexane. No defined peaks are detectable due to many interferent components still 
present, suggesting that C 18 sorbent extraction alone is not effective at PAH 
extraction. 
4.5 DEVELOPMENT OF THE SPE C18/SILICA/ISOLUTE PAH HC 
METHOD FOR PAHS 
The fingerprinting technique, whilst having important diagnostic benefits was not 
suitable as a quantitative PAH analysis method. In addition, SPE methods were 
preferable to LLE, as they used less solvent and by their nature are less hazardous to 
health. They also allowed fractionation of a sample, which may be useful for 
separating oil components that have very similar bulk properties. SPE can also be 
automated. An additional benefit of using SPE over LLE is that PAHs fluoresce and 
therefore can be followed through SPE using an UV lamp. This prevented column 
overload and allowed simple optimisation of washing volume, to avoid analyte loss. 
For this reason, the main emphasis on method development was in the area of SPE. 
However, LLE were not ruled out at this stage as it may serve a valuable role in 
combination with other methods, as found in the fingerprinting protocol. 
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As a number of different combinations of sorbent were used, the TIC proved 
particularly useful as a rapid indicator of interferent removal and PAH identification. If 
an extraction proved promising with TIC the extraction efficiency was determined 
using SIC. 
Although primary development involved a trial and error approach to combining 
sorbents, the work to date gave clues to the best extraction combinations. The main 
requirement of the extraction was to recover PAHs with the least amount of interferent 
components. However, other considerations were considered important. The method 
should preferably minimise solvent volume and use less hazardous solvents. Ideally, it 
should be more rapid than existing methods, and be simple to perform. These extra 
concerns were addressed once the main requirement had been fulfilled. As with most 
procedures, some compromises had to be made in order to meet as many of the criteria 
as possible. 
The work to date indicated two promising sorbents. The first was the Isolute PAH HC 
column, said to be excellent for isolating PAHs by the manufacturer in less complex 
matrices (soil and water). This column was therefore used as a final purification step 
after sufficient quantities of the unwanted components were removed by an appropriate 
clean-up step. C18 sorbent was another possibility, but as a facilitator for sample 
clean-up. 
4.5.1 Liquid-Liquid Extraction Followed by Isolute PAH HC Column 
The first method performed was based on theLLE/SPE combination reported so 
frequently in the literature (Grimmer et al., 1981; Wang, 2000). The Isolute PAH HC 
column was used after LLE to determine if a reduction in matrix complexity improved 
the Isolute PAH HC purification. 
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fJ6 1 Scan EI+ 
Grimmer Solvent Extraction TIC 
3.16eß 
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ý VI uniýf 
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FIGURE 4.13. The TIC of oil 8 with Grimmer Liquid-liquid extraction compared to 
the liquid-liquid extraction in Wilson and Pahlavanpour (2000) prior to passage 
through an Isolute PAH HC column. 
Oil 8 
100 
0 
Methyl Dimethyl 
Phenanthrene Phenanthrene 
1 Scan EI+ 
1 66eTIC 8 
N1OGBN 1 Scan E4+ 
100 TIC 
1 HP-8 
0 
Oil 4 1 Scan EI+ 
100 TIC 1 
1 r; 6e8 
0 
6.00 8.00 10.00 12 00 14 00 16 00 18 00 20 00 
FIGURE 4.14. The TIC of the liquid-liquid extraction in Wilson and Pahlavanpour 
(2000) followed by Isolute PAH HC. Oil 8 native PAHs are labelled. 
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The LLE method used in the mineral oil fingerprinting technique developed by Wilson 
and Pahlavanpour, (2000) was chosen as an initial clean up step along with the 
Grimmer extraction. The fingerprinting LLE method worked on the same principles as 
the Grimmer method, but used five times the volume of solvent in each step for further 
cleaning, producing a less complex extract, as illustrated in Figure 4.13. The modified 
protocol used for the Isolute PAH HC extraction is described in Section 2.2.7.2. 
Oil 8 Methyl Dimethyl t Scan EI+ 
inn Phenanthrene Phenanthrene 
Phenanthrene 
TIC 
6.26e7 
Trimethyl 
Phenanthrene 
Methyl 
F ýý iý, 
0 
N1 OGBN 1: Scan EI+ 
TIC 100 
6.26e7 
ýýo 
U 
Oil 4 1: Scan EI+ 
100 TIC 
6.26e7 
6 00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 
FIGURE 4.15. The TIC of Grimmer liquid-liquid extraction followed by Isolute PAH 
HC of oil 8, Nytro-IOGBN and oil 4. Oil 8 native PAHs are labelled. 
- 121 - 
The fingerprinting LLE with Isolute PAH HC purification indicated a low level of 
PAHs in oil 8 only (Figure 4.14). Improved extraction was noted for the combined 
Grimmer/Isolute PAH HC procedure (Figure 4.15) and showed a clean profile for oil 8 
but with greater PAH recoveries. However, like the fingerprinting LLE, oil 4 and 
Nytro-1 OGBN gave featureless chromatograms. 
As oil 8 contained a greater aromatic content than the other two oils, the results 
suggested that larger quantities of oil 4 and Nytro- l OGBN were required for GC-MS 
analysis. However, as 5g of oil was already being used in the LLE, the use of more oil 
became impractical. For this reason, this extraction method was not developed further. 
Ideally, a method that does not involve LLE would be preferable, as it would not only 
use less oil and solvent, it would also be simpler to perform and more repeatable. 
Nevertheless, the Isolute PAH HC column may offer benefits as a final purification 
step, and with a better clean-up method may produce a clean extract ideal for PAH 
identification and Ames testing. 
4.5.2 C18 with Isolute PAH HC 
The C 18 column showed promise as an additional method for oil extract clean-up and 
so was performed in combination with the Isolute PAH HC column to determine if the 
C 18 sorbent could replace the LLE step. A loading of 100 µL of oil was used on a 900 
mg C18 cartridge. Conditioning with 10 mL cyclohexane occurred prior to Nytro- 
1 OGBN oil loading and 3 mL cyclohexane was added, displacing the fluorescence onto 
the Isolute PAH HC column. The Isolute PAH HC column was then treated as in the 
LLE/Isolute PAH HC purification method (2.2.7.2). 
Figure 4.16 shows the TIC of Nytro-IOGBN extracted by the C18/Isolute PAH HC 
method. The chromatogram was very similar to that of the single stage Isolute PAH 
HC extraction. During the procedure, the column appeared overloaded with extract. 
The fluorescence was spread throughout the column, rather than in a band as with the 
LLE/Isolute PAH HC method. However, reducing the oil load did not improve the 
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TIC. It was possible therefore, that the extract required further clean-up before it was 
added to the Isolute PAH HC column. 
1: Scan EI+ 
TIC 
2.43e7 
Time 
6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 
FIGURE 4.16. TIC of Nytro-1 OGBN from C 18 clean-up followed by Isolute PAH HC 
purification. No peaks were identified as PAHs. 
4.5.3 Combined C18-Silica SPE for Oil Clean-Up 
As the C18 sorbent appeared ineffective in cleaning the oil sample prior to loading 
onto the Isolute PAH HC, a Si02 column was used for further clean-up. The Si02 and 
C18 sorbents were used in combination to determine which order offered the best 
clean-up method. 
The silica column was used prior to C18 by extracting a 100 µL sample of oil as in 
Section 2.2.4.3 and adding the final extract (after acetone evaporation) to a conditioned 
900 mg C 18 cartridge in 1 mL cyclohexane. The extract was eluted from the C 18 
sorbent in 3 mL cyclohexane and evaporated to 1 mL for GC-MS analysis. 
The addition of a silica clean-up step (Figure 4.17) improved the extraction procedure 
compared to the TIC of C 18 only (Figure 4.12). However, using C 18 before Si02 (as 
described in Section 2.2.9) had a further cleaning effect as shown in Figure 4.18. Peaks 
were more visible with the C 18/SiO2 extract, although individual PAHs could not be 
identified. The C18/ Si02 clean-up was therefore used before the Isolute PAH HC 
column, to ascertain if this combination produced a cleaner extract. 
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FIGURE 4.17. TIC of Nytro-1 OGBN clean-up with silica followed by C 18 sorbent. 
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FIGURE 4.18. TIC of Nytro-1 OGBN clean-up with silica followed by C 18 sorbent. 
4.5.4 C 18/SilicalIsolute PAH HC 
The Cl8/Si02 method was combined with the Isolute PAH HC method and is detailed 
in Section 2.2.9. The oil used for extraction was Nytro-IOGBN spiked with 2 µgmL-' 
of each EPA 16 priority PAH. The spike allowed the extraction to be evaluated in 
regard to identifying PAHs from the TIC, as it would indicate if these PAHs were 
visible without resorting to SIC. Figure 4.19 shows the TIC of spiked Nytro-lOGBN 
and shows both PAHs spiked into the oil and native species. It was possible that the 
presence of so many native PAHs acted to obscure the spiked species at retention times 
10-16 minutes. However, a number of higher molecular weight PAHs spiked into the 
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oil were visible due to minimal interferences at later retention times. This method 
seems to be more specific to PAHs than the previous methods performed. 
4.6 TESTING THE C18/SILICAIISOLUTE PAH HC EXTRACTION 
FOR EFFICIENCY AND REPEATABILITY 
The C 18/Silica/Isolute PAH HC method was effective at removing unwanted 
components from the oil extracts. However, the repeatability of this method had to be 
tested, along with extraction efficiency. 
The extraction efficiency was measured with white oil and Nytro-GBN by quantifying 
the recoveries of PAHs from spiked and unspiked oil samples. Quantification was 
achieved by SIC detection, followed by manual integration, and comparison with a 
calibration curve over 6 concentrations at a range of 0.05-2 gg mL-1 (each repeated in 
duplicate). Each extraction was performed 6 times per oil for both the spiked and 
unspiked samples. Table 4.3 contains the calibration data. The %CV of these plots, 
shows that there was between 4.1-11.8% deviation in the calibration curve slope. No 
imprecision was recorded for the intercept as the trend line was forced through zero 
(Miller and Miller, 2000). 
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TABLE 4.3. Calibration data including slope deviation and limit of detection for 
quantification of the EPA 16 priority PAHs spiked into oil. 
PAH Spiked into Oil Retention 
Time 
R2 Graph Equation Error for 
Slope 
(%) 
Calculated Limit 
of Detection 
(ugmL ') 
Naphthalene 5.962 0.9946 y = 399414x 7 0.049 
Acenaphthylene 7.469 0.9959 y = 450051x 9 0.020 
Acenaphthene 7.682 0.9944 y = 275767x 8 0.19 
Fluorene 8.411 0.9922 y= 274641x 10 0.067 
Phenanthrene 10.311 0.9964 y =417115x 7 0.093 
Anthracene 10.431 0.9715 y = 325691x 11 0.29 
Fluoranthene 13.851 0.9983 y = 416997x 4 0.13 
Pyrene 14.628 0.9928 y = 40227l x 9 0.0093 
Benzo(a)anthracene 19.508 0.9881 y =183947x 10 0.10 
Chrysene 19.663 0.9888 y = 189378x 11 0.021 
Benzo(b)fluoranthene 23.98 0.9920 y =137052x 6 0.11 
Benzo(k)fluoranthene 24.085 0.9850 y = 119160x 12 0.13 
Benzo(a)pyrene 25.207 0.9947 y = 110893x 8 0.14 
Indeno(1,2,3-c, d)pyrene 29.246 0.9852 y = 93853x 8 0.21 
Dibenz(a, h)anthracene 29.408 0.9878 y = 79794x 12 0.017 
Benzo(g, h, i)perylene 30.072 0.9878 y = 11 1758x 9 0.0057 
Tables 4.4 and 4.5 show the concentrations of both native EPA 16 priority PAHs and 
those spiked into white oil and Nytro I OGBN. By subtracting the concentration values 
of the naturally occurring PAHs from the equivalent spiked PAHs, the extraction 
efficiency of the method for the spiked PAHs was determined. The repeatability of the 
extraction method is shown as %CV values. 
As previously measured by Si02 and Al SPE, unspiked white oil contained no 
detectable PAHs as the values in Table 4.4 were below the limits of detection 
calculated in Table 4.3. The most common EPA 16 priority PAHs in the Nytro-1 OGBN 
oil were fluorene, phenanthrene, anthracene and pyrene. 
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Tables 4.4 and 4.5 also shows that the extraction efficiencies for those EPA 16 priority 
PAHs identified as probable human carcinogens by the IARC (benzo[a]anthracene to 
dibenzo[a, h]anthracene) were 69.3-89.8% for the two types of oil tested. Of the 
remaining PAHs, the extraction efficiency varied from 21.2-71.4%, except for the most 
volatile PAHs (naphthalene, acenaphthylene and acenaphthene) where efficiency was 
<_ 3.3%. 
TABLE 4.4. Extraction efficiency of spiked white oil (2 µg mL-1) and unspiked oil 
through a small scale Cl 8/silica/Isolute PAH HC. 
PAH White Oil 
Extract in 
Acetone 
(ugmL-1) 
%CV White 
Oil 
White Oil Spiked 
with 20 pg mL-' 
EPA 16 Minus 
native PAHs 
(pgmL 1) 
%CV of 
spiked 
White Oil 
Percent 
Efficiency 
(%) 
Naphthalene 0 0 0.04 0 2 
Acenaphthylene 0 0 0.06 0 3 
Acenaphthene 0 0 0 0 0 
Fluorene 0.05 0 0.4 15 21 
Phenanthrene 0.06 0 1.1 5 58 
Anthracene 0.06 3 0.8 18 43 
Fluoranthene 0.05 0 1.3 11 67 
Pyrene 0.06 21 1.2 6 60 
Benzo(a)anthracene 0.04 0 1.6 8 84 
Chrysene 0.05 22 1.5 6 78 
Benzo(b)fluoranthene 0.04 0 1.5 10 79 
Benzo(k)fluoranthene 0.04 0 1.6 12 81 
Benzo(a)pyrene 0.04 0 1.6 4 83 
Indeno(1,2,3-c, d)pyrene 0.03 0 1.3 10 69 
Dibenz(a, h)anthracene 0.03 0 1.6 9 82 
Benzo(g, h, i)perylene 0.03 6 1.3 9 65 
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TABLE 4.5. Extraction efficiency of spiked Nytro-1OGBN oil (2 µg mL-1) and 
unspiked oil through a small scale C18/silica/Isolute PAH HC. 
PAH Spiked into Oil N1OGBN Oil 
Extract in 
Acetone 
(pg mL-f) 
%CVof 
N1OGBN 
Nytro-10GBN 
Spiked with 
20 pg mL-1 
EPA 16 Minus 
native PAHs 
(ygmL-1) 
%CVof 
Spiked 
N1OGBN 
Percent 
Efficiency (%) 
Naphthalene 0 0 0 0 0 
Acenaphthylene 0.06 0.7 0 36 0.04 
Acenaphthene 0 0 0 0 0 
Fluorene 0.10 14 0.4 28 23 
Phenanthrene 0.12 10 1.1 8 59 
Anthracene 0.09 17 0.9 20 49 
Fluoranthene 0.07 0 1.4 15 71 
Pyrene 0.37 41 1.0 12 50 
Benzo(a)anthracene 0.04 0 1.5 19 78 
Chrysene 0.07 0 1.5 8 78 
Benzo(b)fluoranthene 0.04 0 1.6 13 81 
Benzo(k)fluoranthene 0.04 0 1.7 10 86 
Benzo(a)pyrene 0.04 0 1.7 13 90 
Indeno(1,2,3-c, d)pyrene 0.03 0 1.4 6 75 
Dibenz(a, h)anthracene 0.03 0 1.6 15 83 
Benzo(g, h, i)perylene 0.03 0 1.3 11 68 
The 2 oils give similar extraction efficiencies, which suggested that the greater 
complexity and higher aromatic content of the Nytro-1OGBN transformer oil did not 
greatly affect the quantitative nature of the extraction method. However, overall 
repeatability was better for white oil, in which 11 of the 13 %CV values were lower 
than the corresponding Nytro- l OGBN values. The C18/Silica/Isolute PAH HC 
extraction method is further discussed in Section 7.3.3. 
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4.6.1 Loss of PAHs from Evaporation 
In order to determine the loss of PAHs during the evaporation steps, Nytro-1 OGBN 
prepared by the C 18/Silica/Isolute PAH HC method was reconstituted in 9.9 mL 
cyclohexane and spiked with 0.1 mL EPA 16 priority PAHs in cyclohexane (1 gg mL-1 
per PAH), mixed and left to evaporate for 16 hours. The spiked extract was then 
reconstituted in I mL acetone and analysed by GC-MS. The experiment was 
performed at the same time as the previous extraction efficiency tests, to allow the 
calibration data in Table 4.3 to be used to quantify PAH losses during the evaporation 
step. Results are shown in Figure 4.20. The evaporation step was found to be the main 
cause of the low recoveries of the more volatile PAHs such as naphthalene (20%), 
acenaphthylene (11 %), acenaphthene (0%), fluorene (27%), phenanthrene (61 %) and 
anthracene (62%). 
An extract of Nytro-1OGBN was also spiked after extraction and subjected to rotary 
evaporation to see if this improved recovery of the more volatile PAHs (Figure 4.20). 
Naphthalene was not retained by rotary evaporation but recovery of acenaphthene, 
fluorene and phenanthrene improved by 10-20%, acenaphthylene by nearly 40% and 
almost complete anthracene recovery was achieved, but at a loss of assay precision. 
This is possibly due to the restricted amount of solvent (1-2 mL) used to recover the 
sample from the round bottom flask. Washing the flask with more solvent increased 
efficiency, but the extra solvent belies the purpose of the evaporation step. With such 
small quantities of sample, it was therefore concluded that evaporation at room 
temperature was more appropriate. Although greater losses of the volatile PAHs were 
incurred, it was more efficient at recovering the carcinogenic PAHs, as sample transfer 
was not necessary. 
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FIGURE 4.20. PAH losses during the C 18/Silica/Isolute PAH HC extraction process. 
Shown are the results for Nytro-1 OGBN oil extract spiked with EPA 16 priority PAHs 
before evaporation and after both rotary evaporation and room temperature 
evaporation over 16 hours. 
4.6.2 Total Loss of PAHs from the C18/Silica/Isolute PAH HC 
Each stage of the extraction was analysed to determine exactly where losses of PAHs 
occurred. Results are shown in Table 4.6. Once again the quantification was performed 
at the same time as the calibration outlined in Table 4.3. Losses of PAHs during the 
C 18 extraction were determined by passing 10 mL of acetone through the column to 
remove residual PAHs. Up to 18% losses of individual PAHs was found, the greatest 
loss being the larger, carcinogenic PAHs. PAH levels in the cyclohexane and pentane 
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'aid 
® Oil Extract and Spiked PAH level before Evaporation 
O Oil Extract and Spiked PAH level after Rotary Evaporation 
D Oil Extract and Spiked PAH level after Evaporation (16h at Room Temp) 
Spiked Level 
washes were simply determined by evaporating the wash to 1 mL and analysing by 
GC-MC SIC. 
TABLE 4.6. Percentage loss of PAHs throughout the extraction method and 
calculation of unaccounted species. 
PAH Spiked into Oil Loss of Loss of Loss of 
PAHs from PAHs from PAHs ftom 
the C18 Cyclohexane Pentane 
Column Wash Wash 
(%) (%) (%) 
Total 
PAHs Not 
Accounted 
for in 
Method for 
White Oil 
(%) 
Total PAHs Not 
Accounted for in 
Method for 
N1OGBN Oil 
(%) 
Naphthalene 0 15.1 0 3 5 
Acenaphthylene 0 6.7 0 1 5 
Acenaphthene 0 0 0 0 0 
Fluorene 0 0 8.2 -2 -3 
Phenanthrene 0 0 0 4 2 
Anthracene 6.8 0 6.1 6 6 
Fluoranthene 7.7 0 0 23 18 
Pyrene 8.3 0 0 35 42 
Benzo(a)anthracene 0 0 0 14 19 
Chrysene 10.7 0 0 5 6 
Benzo(b)fluoranthene 0 0 0 16 14 
Benzo(k)fluoranthene 12.3 0 0 0 0 
Benzo(a)pyrene 14.2 0 0 -1 0 
Indeno(1,2,3-c, d)pyrene 0 0 0 31 26 
Dibenz(a, h)anthracene 15.5 0 0 5 3 
Benzo(g, h, i)perylene 17.2 0 0 18 15 
*Total PAH not accounted for include losses from room temperature evaporation illustrated in Figure 
4.22 
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The final two columns of Table 4.6 reports the percentage of PAH not accounted for 
by these investigations. These losses were possibly due to PAHs being irreversibly 
sorbed to the column or due to experimental error. The amount of pyrene not 
accounted for (31-41%) was of particular concern, but as pyrene was not a 
carcinogenic PAH, no further attempts to improve recovery were made. 
4.6.3 Extraction Efficiency over a flange of Spike Levels 
Further determination of the quantitative nature of the method was accomplished by 
measuring PAH extraction efficiency across the EPA 16 priority PAH loading range of 
0-4 gg mL-1 (total PAH of up to 64 µg mLj (Figure 4.21). This revealed the limits of 
the extraction process, indicating the point at which the extraction process becomes 
inefficient. Of the 16 EPA priority PAHs, 4 were measured for extraction efficiency; 
phenanthrene as a non-mutagenic PAH with intermediate extraction efficiency (58- 
60%), indeno[1,2,3-c, d]pyrene with a slightly better efficiency (70-75%) and 
benzo[b]fluoranthene, benzo[k]fluoranthene which had the best extraction efficiencies 
(79-86%) and represented the carcinogenic PAHs which were of greatest importance. 
Figure 4.21 shows a linear relationship between extraction efficiency and analyte 
concentration across the range 0-4 µg mL-1 per PAH and thus a promising quantitative 
method for carcinogenic PAHs. The result suggests that a single oil loading may be 
used (100 µL) during routine sample testing. However, confirmation of this 
supposition would be achieved by examining different oil loadings in cases where 
unrefined oil, aged oil or oil other than that used in transformers was under analysis. 
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FIGURE 4.21. Extraction efficiency of phenanthrene, indeno[1,2,3-c, d]pyrene, 
benzo[b]fluoranthene and benzo[k]fluoranthene when added in a mixture with the EPA 
16 priority PAHs at up to 4 µg mL-' per PAH. 
4.7 CONCLUSIONS 
The efficiency and improved cleanness of the developed C 18/Silica/Isolute PAH HC 
extraction method suggested that it would work better with the mutagenicity tests than 
previous methods and may overcome the problem of mixing the oil extract with the 
aqueous Ames test environment. However, this extraction method would require 
scaling up to produce enough extract to test at a variety of doses in the mutagenicity 
tests. This may prove to be difficult, for although the C 18 and silica stages could be 
scaled up due to the commercial availability of both sorbents, the Isolute PAH HC 
column was only available in 1g cartridges. This could be overcome by running the 
C 18/Si02 through several Isolute PAH HC columns, but would mean that the 
extraction became more time consuming. In addition, it was possible that by scaling up 
the procedure could become less efficient. It may therefore be of benefit to take a 
different approach to the problem and try to down scale the mutagenicity tests. 
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CHAPTER 5.0 
RESULTS 
THE BLACKBURN AND 
C18/SILICA/ISOLUTE EXTRACTION 
METHODS WITH MUTAGENICITY AND 
TOXICITY TESTS 
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5.1 INTRODUCTION 
In chapter 4, an extraction method was developed that produced a significantly cleaner 
extract than previous extractions and proved efficient for oil loadings of up to 4 µg 
mU-1 of each EPA 16 priority PAH. As the Ames test required large amounts of extract 
to test mutagenicity at a range of doses, either the extraction method requires scale up, 
or the Ames test requires scale down. Both approaches offer benefits and drawbacks. 
A larger scaled C 18/silica/Isolute PAH HC extraction would not necessarily yield the 
same extraction efficiency, even if the volume of solvent, sorbent weight and column 
dimension remained proportionate. GC-MS analysis of the large scale extracts would 
require comparison to the small scale extracts and more optimisation was envisaged. 
Scaling down of the Ames test would allow small scale extracts to be used with no 
more extraction development required. A small scale Ames test (Miniscreen) has been 
reported (Brooks, 1995), and thus was evaluate here with the oil extracts. This method 
still requires extensive preparation however and has a long incubation period. As the 
drawbacks of using the Miniscreen test were simpler to overcome than those 
associated with scaling up the extraction method, the Miniscreen test was investigated 
first (Section 5.3). 
However, to validate the use of C 18/Silica/Isolute PAH HC extracts with the Ames 
test, a further extraction method was simultaneously tested for mutagenicity. 
Previously, the Grimmer method had been performed using 80% v/v S-9, as described 
by Blackburn et al. (1984), a well accepted modification for testing oil mutagenicity in 
the literature (Brooks et al, 1995). The modified Ames test was now utilised in full, by 
combining the 80% v/v S-9 with the liquid-liquid extraction (LLE) that was later 
developed as part of the modified method (Blackburn et al., 1986). This method will 
be referred to as the Blackburn extraction (Section 2.2.3.3). The Blackburn extraction 
therefore provided another extraction method for comparison with IP346, Grimmer 
and the C 18/silica/Isolute PAH HC Ames test results. 
-136- 
5.2 AMES TESTING OF BLACKBURN EXTRACTS WITH 80% 
S-9 
As the less time consuming Grimmer method proved to be better at indicating 
mutagenicity than the industry standard IP 346 method, a similar method, found to be 
successful with the Ames test was used. The method is a LLE method developed by 
Blackburn et al., (1986) as part of the modified Ames test. Blackburn extracts of oils 8, 
4, Nytro- I OGBN and white oil were Ames tested at the same time as the 
C18/Silica/Isolute PAH HC purification to validate the new method. The revertant 
numbers found on individual Ames test plates are given in Appendix C. As described 
in Section 2.2.2, the dose of oil extract for Ames testing was given as milligrams of oil 
extracted (as opposed to milligrams of oil extract) per plate. 
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FIGURE 5.1. The Ames test revertants on the addition of Blackburn oil extracts of 
white oil and oil 4 over 4 doses in the absence and presence of S-9 (n = 3). %CV 
ranges from 3.6-24.7%. 
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, 999 
Direct mutagenicity was observed for white oil, oil 4 (Figure 5.1), Nytro-IOGBN and 
oil 8 (Figure 5.2) extracted by the Blackburn method at 500 mg plate-'. Direct 
mutagenicity was believed to originate from simple aromatics extracted with the 
polyaromatics in liquid-liquid extraction (Section 1.1.3.1). Revertant numbers were 
extremely high as with the Grimmer extracts, as all oil extracts produced over 800 
revertants with or without S-9. As with the Grimmer extracts, oil 4 and white oil 
indicated no indirect mutagenicity. 
The Blackburn extract results correlated with the Grimmer results seen in Section 3.4.2 
with a significant increase in mutagenicity observed on the addition of S-9 for both oil 
8 and Nytro- l OGBN. However, the Blackburn extracts for oil 8 and Nytro- l OGBN 
registered a similar level of mutagenicity after activation (40%) whereas the Grimmer 
extracts had exhibited a 35% increase in revertants for Nytro- I OGBN and 50% for oil 
8. As IP 346 % w/w data had shown oil 8 to contain 3 times the aromatic content of 
Nytro- I OGBN, the Grimmer extract mutagenicity showed a greater correlation with the 
industry standard. 
Indirect mutagenicity (as with Grimmer extracts) was only observed at the highest 
dose for Blackburn extracts, but was validated by the presence of indirect mutagenicity 
in the Grimmer extracts and C 18/Silica/Isolute PAH HC extracts. Results are further 
discussed in section 7.4.1 and 7.4.2.1. 
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FIGURE 5.2. The Ames test revertants on the addition of Blackburn oil extracts of oil 
Nytro-IOGBN and oil 8 over 4 doses in the absence and presence of S-9 (n = 3). %CV 
ranges from 2.4-21.0%. 
5.3 MINISCREEN TEST FOR C18/SILICA/ISOLUTE PAH HC 
EXTRACTS 
A number of LLE in the literature have been investigated for mutagenicity, but do not 
produce PAH specific extracts. The C 18/Silica/Isolute PAH HC extracts must be tested 
for mutagenicity as the GC-MS data indicated it was an improved method of PAH 
isolation. In order to test the small volumes of extract recovered from the 
C 18/Silica/Isolute PAH HC method however, a small scale mutagenicity test was 
required. The approach of the Miniscreen test is based on the Ames test, but uses 
smaller plates to allow a 5-fold reduction in the amount of sample required (Section 
2.2.12). 
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This approach seemed promising as it required no extra training or expertise for Ames 
test users. A potential problem was that with a smaller area available for growth, the 
difference in revertant number on a mutagenic and non-mutagenic plate was difficult 
to discern. However, the literature suggested that this was not significant, providing 
that the test remained a screening method and was not treated as the ultimate measure 
of mutagenicity. Nevertheless, on using this approach it was found that it was not 
possible to make conclusive measurements of mutagenicity. 
The Grimmer extracts used in Section 3.4 were used in the Miniscreen test as stated by 
Brooks (1995) initially. A 10% v/v of S-9 mix was used and the results are shown in 
Table 5.1. The positive and negative controls in particular showed that the results were 
not significantly different. Growth area was minimal thus less colonies could grow; it 
was not possible to determine toxicity due to the low spontaneous revertant count. 
TABLE 5.1. Miniscreen results for transformer oil Grimmer extracts, Brooks et al., 
(1995). 
Miniscreen Plate with Grimmer 
extract (20 pgmL-1) 
Number of revertants Mean 
Number of 
revertants 
SD 
(n = 3) 
%CV 
Negative Control 1 2 1 1 0.6 43 
Positive Control 4 2 3 3 1.0 33 
White Oil without S-9 1 3 1 2 1.2 69 
White Oil with S-9 2 1 5 3 2.0 78 
Oil 4 without S-9 2 4 5 4 1.5 42 
Oil 4 with S-9 2 2 4 3 1.2 43 
Oil N 10 without S-9 5 3 6 5 1.5 33 
Oil N10 with S-9 5 3 2 3 1.5 46 
Oil 8 without S-9 4 2 5 4 1.5 42 
Oil 8 with S-9 2 5 2 3 1.7 58 
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The same experiment was repeated with 10% S-9 using the modifications of Burke et 
al., (1996) (Section 2.2.12). The revertant count quoted by the researchers for the 
positive control of S. typhimurium TA98 with 2-amino anthracene and S-9 was 15-182 
and in the absence of S-9 was 0-16. The results in Table 5.2 proved no more 
conclusive than those obtained by the Brooks (1995) protocol. The modified method of 
Burke et al., (1996) was repeated with Grimmer extracts with 80% S-9 but proved 
inconclusive as all plates were too opaque to count due to the high concentration of S- 
9. Since previous work showed that 80% v/v S-9 was required for detection, the 
Miniscreen was considered unsuitable for oil extract testing. 
TABLE 5.2. Miniscreen results for the Grimmer extracts of transformer oils, Burke et 
al., (1996). 
Miniscreen Plate with Grimmer 
extract (20, ugmL-1) 
Number of revertants Mean Number 
of revertants 
SD 
(n = 3) 
%CV 
Negative Control 3 2 3 3 0.5 22 
Positive Control 6 8 9 8 1.5 20 
White Oil without S-9 5 3 4 4 1.0 25 
White Oil with S-9 7 3 5 5 2.0 40 
Oil 4 without S-9 2 4 4 3 1.2 35 
Oil 4 with S-9 5 4 5 5 0.6 12 
Oil N 10 without S-9 5 3 6 5 1.5 33 
Oil N 10 with S-9 5 4 5 5 0.6 12 
Oil 8 without S-9 4 3 5 4 1.0 25 
Oil 8 with S-9 8 8 6 7 1.2 16 
As miniaturisation of the Ames test proved unsuccessful, scaling up of the extraction 
method was considered. As all other extraction methods had been tested using the 
standard Ames test, this allowed direct comparison of new data with previous results. 
However, the extracts were analysed first with GC-MS to determine how the large 
scale extraction differs from the small scale method. 
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5.4 CHANGES IN PAH CHROMATOGRAMS FOR LARGE SCALE 
C18/SILICA/ISOLUTE EXTRACTION 
In order to perform a large scale C 18/SilicaiIsolute PAH HC extraction, C 18 and silica 
(Si02) were purchased as commercially prepared lOg columns. The 1g Isolute PAH 
HC columns were the only size available, thus all oil extracts were divided equally 
between 10 Isolute columns after extraction with C18 and Si02. Further details are 
given in Section 2.2.10. 
The chromatogram for the large scale extractions are shown for oil 8 (Figure 5.3), 
Nytro-1 OGBN (Figure 5.4) and oil 4 (Figure 5.5). Each chromatogram was less 
complex than its Grimmer or IP 346 counterpart, which can be seen by comparing 
Figure 5.3 with Figure 3.7. However, the large scale C 18/Silica/Isolute PAH HC 
chromatogram exhibited more interferent peaks than the small scale method. Oil 8 was 
still too complex and could not be used for identification of PAHs due to the presence 
of these interferents. Nytro-10GBN was less complex and could still be used to 
identify naturally occurring phenanthrenes eluted at retention times of >10 minutes, 
but the peaks were not as defined as those in the small scale extract (Figure 4.19). In 
addition there were many extra peaks at retention time 20-23 minutes which were not 
present in Figure 4.19. For this reason the small scale extracts were preferred for PAH 
identification in oil (Chapter 6). 
The large scale extract for oil 4 showed no identifiable PAH peaks, which was not 
unexpected given that oil 4 had a relatively low PAH content. However, the 
chromatogram also exhibited less interfering peaks. This was also the case for white 
oil (Figure 5.6). This suggested that oil 8 was not only more complex in its PAH 
composition, but also in its general composition. 
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FIGURE 5.3. TIC of oil 8 large scale Cl 8/silica/Isolute PAH HC extract. 
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FIGURE 5.4. TIC of oil Nytro-1 OGBN large scale Cl 8/silicallsolute PAH HC extract. 
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FIGURE 5.5. TIC of oil 4 large scale C 18/silica/Isolute PAH HC extract. 
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FIGURE 5.6. TIC of white oil large scale C 18/silica/Isolute PAH HC extract. 
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As the large scale extraction method was less effective than the small scale method, a 
small scale extract was also tested for mutagenicity (Section 5.5.3) to determine if the 
additional interferents in the large scale extract affected Ames testing. 
5.5 ANTES TESTING OF C18/SILICA/ISOLUTE PAH HC 
EXTRACTS 
5.5.1 Testing Column Residue for Interference 
As seen in Section 4.3.3, the Isolute PAH HC column produced column bleed that 
affected the GC-MS chromatogram of transformer oils (retention time 21 minutes). 
With possible additional column bleed from the C18 and silica columns, it was 
imperative that the mutagenic properties from such column components were 
identified before C 18/Silica/Isolute PAH HC extracts were tested for mutagenicity. 
Table 5.3 shows the results of two large scale C 18/Silica/Isolute PAH HC extractions 
performed without sample added. Two large scale extractions were run since two 
extract volumes were required to produce sufficient extract for testing (Section 2.2.10). 
It can be seen that the column residue did not produce a mutagenic response with or 
without 80% v/v S-9. The method therefore exhibited compatibility with the Ames 
test. 
TABLE 5.3. Number of revertants on the addition of column residue from C 18/silica 
clean up with Isolute PAH HC purification with and without 80% S-9. 
Sample on Plate Number of revertants Mean Number ± SD %CV 
of revertants (n = 3) 
Negative Control (DMSO) 27 32 33 31 3 10 
Positive Control (B[a]P) 251 265 281 266 15 6 
Column Residue without S-9 29 34 32 32 3 8 
Column Residue with 80%S-9 31 29 29 30 1 4 
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5.5.2 Mutagenicity of Oil with Large Scale C18/Silica/Isolute PAH HC 
Extraction with 80% S-9 
Figure 5.7 shows the Ames test results for white oil and oil 4 using the large scale 
C18/Silica/Isolute PAH HC extracts. The revertant numbers of individual Ames test 
plates is given in Appendix C. No direct mutagenicity was observed for white oil and 
oil 4 suggesting that the direct mutagens present in both Grimmer and Blackburn 
extracts were not extracted by the C 18/Silica/Isolute PAH HC method. This suggests 
that by measuring PAH content only, the full mutagenic nature of the oil is not 
observed. This further confirms that PAHs may not be the main source of unrefined oil 
mutagenicity as stated in the literature (Grimmer, 1983, McKee et al., 1989; Järvholm 
and Easton, 1990; Brooks et al., 1995) for these particular oils. 
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FIGURE 5.7. Mutagenicity of the C 18/silica/Isolute PAH HC extract of white oil and 
oil 4 over 4 doses in the absence and presence of S-9 (n = 3). %CV ranges from 4.6- 
9.9%. 
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When S-9 was added, white oil continued to show no mutagenicity, and therefore 
correlated with the fact that white oil contains a low aromatic content. Oil 4 however, 
produced a 62 revertant increase at 500 mg plate-, on the addition of S-9 representing 
a near-doubling of the background spontaneous rate (33 revertants) but an exact 
doubling when compared to the number of revertants at the same dose without S-9 (31 
revertants). This indirect mutagenicity was not observed with the Grimmer or 
Blackburn extracts. It was postulated that the presence of high levels of direct 
mutagens in the Grimmer and Blackburn extracts had obscured this indirect 
mutagenicity. 
However, although there was a dose response observed, a further increase in dose was 
required to ensure the results were repeatable. Previous comparison of extract 
mutagenicity (Blackburn with Grimmer extracts) was sufficient to validate a response 
observed at only one dose. However, as the C 18/Silica/Isolute PAH HC extraction 
method was substantially different to the LLE methods of both Grimmer and 
Blackburn extractions, it was postulated that further validation was required. As the 
highest dose (500 mg plate-) of extract was partially saturating the DMSO carrier 
solvent however, it was difficult to increase the dose substantially. 
No mutagenicity was observed with oil 8 and Nytro- I OGBN without S-9 (Figure 5.8) 
showing that the direct mutagens were absent as in the white oil and oil 4 extracts. The 
addition of 80% v/v S-9 however, did increase the number of revertants for both oil 8 
and Nytro- I OGBN extracts. Nytro- I OGBN, like oil 4 showed an intermediate response 
(71 revertants) representing a doubling of the spontaneous reversion number (33) but a 
near-doubling of the response observed at the same dose, without S-9 (38 revertants). 
Once again, a further increase in dose was required for testing mutagenicity. Oil 8 
showed a more pronounced increase in revertant number (-100) on the addition of 
80% v/v S-9; clearly a mutagenic response. Even this significant response however, 
required qualification with further measurement at a higher dose, to determine if the 
mutagenic response was still present. 
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FIGURE 5.8. Mutagenicity of the C18/silica/Isolute PAH HC extract of oil Nytro- 
IOGBN and oil 8 over 4 doses in the absence and presence of S-9 (n = 3). %CV ranges 
from 3.2-6.3%. 
Due to solvent saturation issues, a final dose of 580 mg plate-' (an increase of 16%) 
was achieved as the highest dose available for testing in a minimal solvent volume of 
0.6 mL DMSO. The results are shown in Table 5.4 and indicate the same findings as 
those obtained at 500 mg plate-', concluding that the mutagenic response observed for 
oil 4,8 and Nytro-IOGBN with 80% v/v S-9 was reproducible and therefore 
significant. Mutagenicity of the C 18/Silica/Isolute PAH HC extracts compared to the 
Grimmer and Blackburn extracts is further discussed in Section 7.4.2.1. 
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TABLE 5.4. Number of revertants on the addition of Nytro- l OGBN extracted by 
C 18/silica clean up with Isolute PAH HC purification at 580 mg plate-'. 
Sample on Plate (580 mg) Number of revertants Mean Number 
of revertants 
+ SD 
(n = 3) 
%CV 
White Oil without S-9 32 35 39 35 3.5 10 
White Oil with S-9 35 39 37 37 2.0 5 
Oil 4 without S-9 38 39 34 37 2.6 7 
Oil 4 with S-9 79 72 75 75 3.5 5 
Oil N10 without S-9 35 39 35 36 2.3 6 
Oil N 10 with S-9 79 84 80 81 2.6 3 
Oil 8 without S-9 38 37 34 36 2.0 6 
Oil 8 with S-9 115 124 116 118 4.9 4 
5.5.3 Mutagenicity of Nytro-10gbn with Small Scale C18/Silica/Isolute 
PAH HC Extraction with 80% S-9 
Results showed that the large scale extraction with C 18/Siiica/Isolute PAH HC PAH 
HC was not as effective at producing a clean PAH extract as the small scale version 
(Section 5.4). For this reason, small scale extracts were pooled and tested using the 
Ames test to determine if the large scale extract contained extra interference that 
altered mutagenicity. Nytro- l OGBN was extracted using the small scale columns 20 
times. 
A volume of 330 µL oil was run down each column (instead of 100 µL used for GC- 
MS analysis) to reduce the number of extractions required. A volume of 400 µL of oil 
spiked with I ig mL-1 had previously been extracted in triplicate to ensure that the 
greater volume of oil did not affect extraction efficiency, which it did not. A 330 µL 
Nytro- I OGBN oil sample produced an overall extract that was equivalent to the 
quantity of oil (5 g) extracted with the large scale version. This was not done for all the 
oils as it was both expensive and time consuming. Table 5.5 shows the results gained 
for small scale extraction at 500 mg plate-' . 
The test was performed with the same S. 
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typhimurium culture used to test the large scale Nytro-IOGBN extract, so results could 
be directly compared. Reversion number in Table 5.5 was approximately the same as 
that for large scale Nytro- I OGBN extraction (Figure 5.8) at 500 mg plate-', suggesting 
that the presence of the extra interference in the large scale extract did not significantly 
affect mutagenicity results. The next stage was to determine if this cleaner extraction 
method altered the mutagenicity previously observed with aged oils. 
TABLE 5.5. Numbers of revertants on the addition of Nytro-10GBN extracted by 20 x 
small scale columns with C 18/silica clean up with Isolute PAH HC purification. Total 
oil extracted was 5 g. 
Sample on Plate (500 mg) Number of revertants Mean Number ± SD %CV 
of revertants (n = 3) 
Negative Control 27 32 33 31 3.2 10 
Positive Control (B[a]p) 289 248 286 274 22.8 8 
Nytro-IOGBN without S-9 35 34 32 34 1.5 5 
Nytro-10GBN with S-9 69 78 76 74 4.7 6 
5.6 AMES TESTING OF BLACKBURN AND 
C18/SILICA/ISOLUTE PAH HC EXTRACTS OF AGED OILS 
5.6.1 Blackburn Extracts of Aged Oils with 80% S-9 
Aged oils were extracted and tested to give an indication of how mutagenicity changes 
with age. PAHs are believed to increase with ageing (Moret and Conte, 2000; Wang et 
al., 2000; Wong and Wang, 2001) and this could increase the risk of mutagenicity 
from oils. Such risks would increase the requirement for a full transformer oil service 
history and cause an increase in oil use, as the working life of an oil is reduced. The oil 
was extracted with the Blackburn method and tested before ageing (ALT 0) and after 
ageing for 1 week (ALT 1), 2 weeks (ALT 2) and 3 weeks (ALT 3). Results are 
reported in the absence (Figure 5.9) and presence of 80% v/v S-9 (Figure 5.10). 
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FIGURE 5.9. The Ames test revertants on the addition of Blackburn oil extracts of 
new oil ALT 0 and after ageing for I week (ALT 1), 2 weeks (ALT 2) and 3 weeks 
(ALT 3) without S-9 over 4 doses (n = 3). %CV ranges from 2.2-10.1%. 
The results showed that Blackburn extracts of all oils were mutagenic with or without 
S-9. The number of revertants for each age of oil was not significantly different. It was 
therefore concluded that mutagenicity did not change with artificial ageing of up to 3 
weeks. For the Blackburn extracts, revertant numbers increased from 550-850 
revertants for all oils without S-9, to 1000-1600 revertants with 80% v/v S-9 at 500 mg 
plate-'. This was approximately a doubling in revertant number, therefore suggesting 
that additional mutagenicity in the presence of 80% v/v S-9 was due to indirect 
mutagens such as PAHs. Indirect mutagenicity observed at only one dose was 
validated by comparison with the Grimmer extracts. The results correlate with the 
Grimmer extract results in Section 3.5 although the difference in revertant number with 
and without S-9 was greater for the Blackburn extracts and therefore more conclusive 
with regard to indirect mutagens. 
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FIGURE 5.10. The Ames test revertants on the addition of Blackburn oil extracts of 
new oil ALT 0 and after ageing for I week (ALT 1), 2 weeks (ALT 2) and 3 weeks 
(ALT 3) with 80% S-9 over 4 doses (n = 3). %CV ranges from 4.0-11.9%. 
5.6.2 C I8/Silica/Isolute PAH HC Extracts of Aged Oil with 80% S-9 
The results in Figure 5.11 showed that C 18/Silica/Isolute PAH HC extracts of all aged 
oils contained no direct mutagens. This again indicated that the C 18/Silica/Isolute 
PAH HC method did not extract significant quantities of direct mutagens as was the 
case with the Grimmer and Blackburn extracts (Section 3.4 and 5.2). 
The results observed with 80% v/v S-9 (Figure 5.12) indicated mutagenicity for all 
stages of oil ageing but were not significantly different. These results indicated that 
mutagenicity did not change with artificial ageing of up to 3 weeks. This correlated 
with the data collected for both Grimmer and Blackburn extracts, although the 
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mutagenicity with S-9 was easier to differentiate with C18/Silica/Isolute PAH HC 
extracts as there was no direct mutagenicity. Therefore using an improved extraction 
method did not change the final conclusion that oil mutagenicity does not change with 
artificially ageing. However, it was not possible to conclude from these results that 
PAH composition did not change in the oils during ageing. This issue affecting oil 
extract mutagenicity is discussed further in Section 6.6. 
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FIGURE 5.11. The Ames test revertants on the addition of Cl 8/silica/Isolute PAH HC 
extracts of new oil ALT 0 and after ageing for 1 week (ALT 1), 2 weeks (ALT 2) and 
3 weeks (ALT 3) without S-9 over 4 doses (n = 3). %CV ranges from 1.8-10.5%. 
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FIGURE 5.12. The Ames test revertants on the addition of Cl 8/silica/Isolute PAH HC 
extracts of new oil ALT 0 and after ageing for 1 week (ALT 1), 2 weeks (ALT 2) and 
3 weeks (ALT 3) with S-9 over 4 doses (n = 3). %CV ranges from 1.0-9.9%. 
5.7 INVESTIGATION OF OIL EXTRACT INTERFERENCE ON 
THE AMES TEST 
Although the C 18/Silica/Isolute PAH HC extraction was more successful in reducing 
oil interferents than the Grimmer or Blackburn extracts, it was possible that the extract 
may still cause inhibition. The use of a less efficient large scale version of the 
C 18/Silica/Isolute PAH HC extraction did not alter the mutagenicity measured with the 
small scale version (Section 5.5.3) but neither method produced a completely clean 
extract. For this reason, the inhibition effects of the C 18/Silica/Isolute PAH HC 
extracts on individual PAH was tested according to the methods described in Section 
3.8. The Blackburn extracts were also tested for comparison purposes. 
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Benzo[a]pyrene or 2-amino anthracene were added to the Ames test plates with oil 
extract. The amount of each extract (25 mg plate-' for C 18/Silica/Isolute PAH HC 
extracts and 50 mg plate-' for Blackburn extracts) was used as it was the highest dose 
of oil tested that did not produce a mutagenic response, so only the mutagenicity of the 
benzo[a]pyrene or 2-amino anthracene would be observed. 
In Table 5.6 it can be seen that none of the Blackburn extracts caused a greater 
inhibition of mutagen (32%) than non-extracted oil 8. As with the whole oil, inhibition 
increased as the PAH content of the oil increased, suggesting that the presence of other 
PAHs (possibly non-mutagenic PAHs) interfered with activation by inhibiting the S-9 
enzyme preparation. This finding was strengthened by the t-test values in Table 5.6 
which showed that the presence of white oil did not cause significant inhibition, whilst 
both oils 4 and 8 did. 
TABLE 5.6. Effects on revertant number of adding Blackburn extracts to mutagens 
benzo[a]pyrene and 2-amino anthracene (10% S-9). 
Sample on Plate Mean SD %CV Reduction in One-Sided t- 
Number of (n = 3) Revertants on Test (t) 
revertants Exposure to 
Oil (%) 
Benzo[a]pyrene (B[a]P) 196 34 17 N/A N/A 
Blackburn extract White oil and B[a]P 181 17 9 7 -1.4 
Blackburn extract Oil 4 and B[a]P 168 11 6 14 -4.5 
Blackburn extract Oil 8 and B[a]P 132 13 10 32 -8.1 
2-amino anthracene (2-aa) 729 37 5 N/A N/A 
Blackburn extract White oil and 2-aa 708 19 2 3 -1.9 
Blackburn extract Oil 4 and 2-aa 649 25 4 11 -5.5 
Blackburn extract Oil 8 and 2-aa 564 20 3 23 -15 
*Critical Value t3 = -2.35 (P = 0.05) 
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The same trend is seen in Figure 5.7 for the C18/Silica/Isolute extracts. However, in 
this case inhibition did affect the results measured in the Ames test, as both oil 4 and 
Nytro-IOGBN gave less significant results (Section 5.5.2). A 15% increase in revertant 
number for oil 4 would have strengthened the indicated mutagenicity. This showed that 
the C 18/Silica/Isolute PAH HC extract, even though cleaner and with lower levels of 
direct mutagens in the oil, still contained a matrix of sufficient complexity to alter 
PAH mutagenicity. For this reason, inhibition was looked at in more detail. 
TABLE 5.7. Effects on revertant number of adding C 18/silica/Isolute PAH HC 
extracts to mutagens benzo[a]pyrene and 2-amino anthracene (10% S-9). 
Sample on Plate Mean SD %CV Reduction in One-Sided t- 
Number (n= 3) Revertants Test (t) 
of from 
revertants Mutagen on 
Exposure to 
Oil (%) 
Benzo[a]pyrene (B[a]P) 196 13 7 N/A N/A 
C 18/Silica/Isolute PAH HC extract White 173 31 18 12 -1.2 
oil and B[a]P 
C18/Silica/Isolute PAH HC extract Oil 4 166 32 19 15 -1.5 
and B[a]P 
C18/Silica/lsolute PAH HC extract Oil 8 136 7 5 30 -15 
and B[a]P 
2-amino anthracene (2-aa) 729 37 5 N/A N/A 
C18/Silica/Isolute PAH HC extract White 653 33 5 10 -4.0 
oil and 2-aa 
C18/Silicallsolute PAH HC extract Oil 4 616 30 5 15 -6.4 
and 2-aa 
C18/Silica/Isolute PAH HC extract Oil 8 536 27 5 26 -12 
and 2-aa 
*Critical Value t3 = -2.35 (P = 0.05) 
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5.7.1 Inhibition at 80% S-9 
The previous inhibition tests (Section 3.8 and 5.7) were performed with 10% v/v S-9. 
Increasing the S-9 concentration would provide more enzymes for mutagen activation 
and would determine if the presence of PAHs was affecting the activation of the 
mutagen. If PAHs in the oil extracts were binding to the enzyme, this effect would 
decrease with increasing S-9 concentration. This was shown to be true (Table 5.8). The 
reduction in the number of revertants was much smaller with the addition of 80% v/v 
S-9, suggesting that the PAH content of oil was interfering with the activation of 
mutagenic PAHs. The inhibition of oil 4 and Nytro- l OGBN at 80% v/v S-9 was not 
sufficient to alter the Ames test results for C18/Silica/Isolute PAH HC extracts in 
section 5.5.2. However, even with 80% v/v S-9, (according to the t-test) oil 8 
significantly reduced the mutagenicity of 2-amino anthracene, as expected, given that 
oil 8 had a large aromatic content. Inhibition is further discussed in Section 7.5.1. 
TABLE 5.8. Effects on revertant number of adding C 18/silica/Isolute PAH HC 
extracts to mutagen 2-amino anthracene (80% S-9). 
Sample on Plate Mean SD %CV Reduction in One-Sided t- 
Number of (n = 3) Revertants Test (t) 
revertants from 
Mutagen on 
Exposure to 
Oil (0/, ) 
2-amino anthracene (2-aa) 909 16 2 N/A N/A 
C18/Silica/Isolute PAH HC extract White 903 38 4 0.6 -0.2 
oil and 2-aa 
C18/Silica/Isolute PAH HC extract Oil 4 896 31 3 1.4 -0.7 
and 2-aa 
C18/Silica/Isolute PAH HC extract Oil 8 885 15 2 3 -2.7 
and 2-aa 
*Critical Value t3 = -2.35 (P = 0.05) 
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Although inhibition effects were shown to be insignificant for the extractions 
performed in this work, there was another possible interference issue that required 
investigation to fully explore the mutagenic potential of PAHs in oil. It was possible 
that toxic effects, first observed in Section 3.2.1.2, could be affecting the mutagenicity 
test to the extent that mutagenicity is no longer observed. Toxicity testing also brought 
into question other potential hazards associated with oil, which should be addressed. 
5.8 TOXICITY OF OIL EXTRACTS 
Many methods for measuring the toxicity of a sample are available. However, for the 
purpose of this work, a simple toxicity test, using S. typhimurium was developed. S. 
typhimurium is not an ideal organism for determining the hazard to human health, as it 
is a prokaryote. However, the primary concern of this work was the investigation of 
toxicity on the Ames test (Section 1.3.2). Toxicity of a test sample would lead to a 
reduction in the number of viable S. typhimurium cells. With fewer cells to revert, the 
number of colonies counted on an Ames test plate would be reduced and may lead to 
false negative results. S. typhimurium was therefore the appropriate choice of test 
organism. 
The method used for toxicity testing is outlined in Section 2.2.11. Absorbance 
measurements were performed in a microtitre plate to allow high sample throughput. 
The wavelength that gave the greatest absorbance reading with S. typhimurium growth 
in nutrient broth was 600 nm. 
The top agar of the Ames test was -4% v/v S. typhimurium culture and -4% sample, so 
toxicity testing was performed by reproducing relative quantities (Table 5.9). As the 
microwell plates are x10 smaller than the Ames test plates, the toxicity observed at 50 
mg well-' is equivalent to the highest dose (500 mg plate") of the Ames test (both 
equate to the same final concentration). A measure at a dose of 75 mg well-' was 
performed to determine toxic effects at a level greater than that tested by the Ames 
test. As previously discussed (Section 1.4.1.6) many extract had solubility issues with 
respect to the carrier solvent at higher doses. The dose of 75 mg well-' therefore, was 
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difficult to achieve, without vortexing of the sample (highest speed available) before 
use. This test was not directly comparable with the Ames test as it used a different 
media and a different measurement parameter, but it gave an indication of possible 
toxicity issues in the Ames test. 
TABLE 5.9. The volumes of components in the S. typhimurium toxicity test compared 
to the Ames test. 
Component added I Ames Test (µL) Toxicity Test (pL) 
S. typhimurium 100 10 
Media 2500* 250 
Sample 1 100 10 
* Refers to the top agar with S-9 volume included 
An important factor in testing for toxicity was determining what reduction in 
absorbance would be considered significant. A reduction in growth (absorbance) of 
10% and particularly 50% (LD50) are often measured as and indication of toxicity 
(Toxicological Research Centre, 2003; ISO 10712,1995). As this toxicity test has not 
been performed before and therefore has not been standardised or optimised, there may 
be a level of imprecision. From repeating the test 10 times with a sample of Nytro- 
IOGBN Grimmer extract a %CV of up to 10% was observed. For this reason a >20% 
reduction in growth was used as an indicator of inhibition instead of 10%. Results were 
therefore expressed in terms of their relation to a 20% and 50% decrease in the 
absorbance observed at 0 mg well-1. 
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5.8.1 Toxicity of Oil 8,4, Nytro-1OGBN and White Oil Extracts 
Results for the Grimmer extracts of oil 8, Nytro-IOGBN, 4 and white oil are shown in 
Figure 5.13. At 50 mg well-' no absorbance drop of 20% or greater was observed. 
However, both oil 8 and Nytro-1 OGBN showed a decline in absorbance of >20% at 75 
mg well-'. This suggested that extending the mutagenicity measurement to a higher 
dose would have been subject to toxicity effects. 
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FIGURE 5.13. Toxicity effects of Grimmer extracts on S. tvphimurium grown in 
nutrient broth in a 96 well microtitre plate (n = 3). %CV ranges from 0.4-21.7%. 
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FIGURE 5.14. Toxicity effects of Blackburn extracts on S. typhirnuriwn grown in 
nutrient broth in a 96 well microtitre plate (n = 3). %CV ranges from 0.5-7.7%. 
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FIGURE 5.15. Toxicity effects of C 18/Silica/Isolute PAH HC extracts on S. 
ttiphimurium grown in nutrient broth in a 96 well microtitre plate (n = 3). %CV ranges 
from 1.5-24.1%. 
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Results for the Blackburn extracts of oil 8, Nytro-1OGBN, 4 and white oil in Figure 
5.14 showed no decrease in absorbance of >20% at 50 mg well-1. For 75 mg well-' 
however, the absorbance shows a decrease of -20% for oils 4 and Nytro- l OGBN 
suggesting toxicity may have altered the Ames test results if a higher dose had been 
tested. Figure 5.15 indicates no conclusive reduction in absorbance for the 
C18/Silica/Isolute PAH HC extracts of white oil, oil 4 and Nytro-1 OGBN. For oil 8, 
toxicity could not be concluded due to a greater standard deviation. As no toxicity was 
found at the doses tested with the Ames test, the reversion frequency was not measured 
(Section 1.3.2). Toxicity is further discussed in Section 7.5.2. 
5.8.2 Toxicity of Aged Oil Extracts 
The same toxicity tests were performed on aged oil extracts. At 50 mg well-' no 
decrease in absorbance at >20% was observed for the Grimmer extracts with the 
exception of ALT 3 (Figure 5.16). However, this reduction in absorbance was not 
consistent with increasing dose, suggesting that it was due to experimental 
imprecision. The final dose of 75 mg well-' gave an absorbance decrease of -20%, 
suggesting that ALT 3 was possibly toxic at higher dose. Repeats could not be 
performed due to a lack of sample. 
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FIGURE 5.16. Toxicity effects of Grimmer extracts of aged oils on S. tvphrmuriiun 
grown in nutrient broth in a 96 well microtitre plate (n = 3). %CV ranges from 0.1- 
25.0%. 
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FIGURE 5.17. Toxicity effects of Blackburn extracts of aged oils on S. thphimurium 
grown in nutrient broth in a 96 well microtitre plate (n = 3). %CV ranges from 0.7- 
9.7%. 
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FIGURE 5.18 Toxicity effects of C 18/Silica/Isolute PAH HC extracts of aged oils on 
S. tvphinnirium grown in nutrient broth in a 96 well microtitre plate (n = 3). %CV 
ranges from 0.6-21.7%. 
In the case of the Blackburn (Figure 5.17) and C18/Silica/Isolute PAH HC extracts 
(figure 5.18) no oil produced a consistent reduction in absorbance of >20% at 50 mg 
well-' so no significant toxicity effects could be established. However, at 75 mg well"', 
Blackburn extracts of all oils and C 18/S 1 lica/l solute PAH HC extracts of oils ALT I 
and 2 indicated a possible toxic effect. Nevertheless, no clear, consistent toxic effect 
was observed for any oil at the 50 mg well-' level, so potential toxicity effects on the 
Ames test were not conclusively observed for aged oils. 
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5.9 CONCLUSIONS 
The C 18/Silica/Isolute PAH HC extracts have been successfully used to determine the 
impact of PAHs on the total mutagenicity observed for transformer oils and with 
comparisons to the liquid-liquid extracts that measured total aromatic mutagenicity, it 
was concluded that PAHs are not the only mutagenic threat in oil. This justifies the 
measure of total aromatic content with the IP 346 % w/w method as an estimate of the 
oil's hazard to health. As PAHs still contribute to oil mutagenicity, and as they are an 
environmental pollutant, the development of the C 18/Silica/Isolute PAH HC extraction 
is of great value. The C 18/Silica/Isolute PAH HC extracts may be used to identify and 
quantify the PAHs present, as suggested by the results in Chapter 4. For this reason, 
the Chapter 6 will explore the use of the C 18/Silica/Isolute PAH HC extracts as an 
alternative to immunoassay and IP 346 % w/w data. 
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CHAPTER 6.0 
RESULTS 
MEASURING VARIATION IN POLYCYCLIC 
AROMATIC HYDROCARBON CONTENT 
WITH THE C18 SILICA ISOLUTE 
EXTRACTION IN OILS 
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6.1 INTRODUCTION 
6.1.1 Comparison of Qualitative Measurement 
The primary function of developing a more PAH specific extraction method was to 
determine the mutagenicity risk of PAHs compared to total oil mutagenicity. In 
Chapters 3 and 5 it was found that PAH mutagenicity was not the only source of threat 
in the oils tested and that direct mutagen(s) were present in the aromatic fraction that 
were of equal, if not greater concern. This finding has established that measuring total 
aromatic content by the IP 346 % w/w method rather than PAH content is justified as 
all sources of mutagenicity seem to originate from the aromatic fraction of the oil. 
As PAHs are environmental pollutants and do contribute to oil mutagenicity, the 
development of the C 18/Silica/Isolute PAH HC extraction is still of great importance. 
The method was both repeatable and sufficiently efficient to allow quantification of the 
PAHs. Moreover, this method could be performed to identify unknown PAHs in the 
sample for an indication of possible mutagenicity. The National Grid Company Plc. 
(Pahlavanpour and Wilson, 1999) had previously identified the PAHs in transformer 
oils using the fingerprinting method developed by Wilson and Pahlavanpour (2000). 
Nytro- I OGBN was one of the oils analysed with the fingerprinting technique so could 
be compared with the C 18/Silica/Isolute PAH HC method to indicate the extraction 
capability of the new method. Unfortunately, the Wilson and Pahlavanpour (2000) 
method proved difficult to repeat due to the crude initial liquid-liquid extraction step, 
so quantitative data proved difficult to compile. For this reason, as well as being an 
easier, safer and more quantitative extraction method, the C 18/Silica/Isolute PAH HC 
method offers significant analytical benefits. 
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6.1.2 Comparison of Total Aromatic Measurement 
As the IP 346 % w/w extraction is a laborious method that measures aromatic content 
instead of polyaromatics (Stang, 1993; 1999) the C18/Silica/Isolute PAH HC 
extraction will be compared to the IP 346 % w/w method to determine if it could be 
used as an alternative or replacement method. Although the C18/Silica/Isolute PAH 
HC method should be more specific to PAHs, it was possible that the two measures 
were related. In order to compare the IP 346 % w/w data with C 18/Silica/Isolute PAH 
HC data, the total peak area of the GC-MS chromatograms of the C 18/Silica/Isolute 
PAH HC extracts were measured. 
Two approaches were examined with regard to determining the total PAH content by 
the C 18/Silica/Isolute PAH HC method. The first uses a measure of the total peak area 
of a total ion chromatogram (TIC) of a series of oils to indicate a trend in PAH content. 
For example, oil 8 which was estimated by IP346 to have a very high aromatic content 
(8.9% w/w), should have an area 8 times greater than oil 4 which was low in aromatics 
(<I% w/w). Oil Nytro-1 OGBN according to IP346 should have an area that falls in 
between these two extremes. The peak area at 21 minutes was not included as it was 
believed to be a contaminant from the extraction process. The second approach uses a 
selective ion chromatogram (SIC) instead of the TIC. Only the major molecular ions of 
the EPA 16 priority PAHs would be monitored with SIC but the methylated and 
unmethylated EPA 16 priority PAHs would also be included, as they all contain the 
molecular ions of the EPA 16 priority PAHs. 
The C 18/S iiica/Isolute PAH HC extraction method and IP 346 % w/w values were also 
compared to a commercially available total PAH immunoassay kit. The immunoassay 
kit is specific to PAHs rather than total aromatic content, and has been used to measure 
PAH content in oils (Kim et al., 2001). The kit is of interest to the National Grid 
Company Plc but is currently too expensive to be used in routine PAH detection. It 
was postulated that the C 18/Silica/Isolute PAH HC extraction would correlate with the 
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PAH specific immunoassay data rather than the IP 346 % w/w data, and therefore be 
used as an alternative to immunoassay detection. 
Additionally, a second immunoassay kit was also used to measure carcinogenic PAHs. 
This would relate carcinogenic PAH content to total PAH content. This would 
determine if total PAH detection could indicate carcinogenic risk without the use of 
mutagenicity testing (for screening purposes). 
6.2 IMMUNOASSAYS AS A QUANITATIVE DETECTION 
METHOD 
As IP 346 % w/w data was already available, no further extractions were required to 
correlate total aromatic content with the C 18/Silica/Isolute PAH HC extraction 
method. However, to correlate total PAH content, immunoassay data had to be 
generated. Two commercial kits for the analysis of PAHs in water and soil were 
examined. The first measured total PAH content, that may be directly compared to 
IP346 measurements. The second had greater affinity for carcinogenic PAHs present in 
the sample. This carcinogenic kit was also evaluated as it was able to detect 
carcinogenic PAH levels below that of the Ames test. By measuring the carcinogenic 
PAH content, links may be established to the total PAH content. This would determine 
if a measure of total PAH content, such as the IP 346 % w/w method was an effective 
indication of carcinogenicity. 
These kits have been used for the detection of PAHs in oil (Kim et al., 2001) with 
results indicating that immunoassays may be more sensitive and selective for PAH 
detection, than the IP346 % w/w method. 
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6.2.1 Effect of Environment on Immunoassay 
Both total and carcinogenic immunoassay kits were used to determine PAH content. 
The recommendation of the manufacturers (SDI) was that samples were made up in 
water, with a maximum of 25% v/v methanol. Organic solvent was used for dilution, 
with the final dilution in diluent. 
Diluent (a buffered saline) from the kit was limited, so alternative buffer solutions 
were investigated as a blank. It can be seen in Table 6.1 that the recommended 
environment of water with 25% v/v methanol gave a reading of 5.8 µg L'. This error 
was small, but the sample dilution would have multiplied this imprecision. In addition, 
all other buffer solutions introduced further error. Table 6.1 shows that only using 
100% diluent (from the kit) gave an error free reading. For this reason the percentage 
of diluent in the final dilution must be maximised. The level and type of organic 
solvent most compatible with the assay was also tested since the dilution of standard 
PAH samples with diluent gave imprecise results. This was believed to be due to PAH 
preference for an organic (as opposed to an aqueous) environment. After dilution of 
samples in various solvents, a washing of the dilution vessel yielded the following 
data: 100% diluent -18% phenanthrene remaining in the vessel; 1% v/v methanol 
-7%; 10% v/v methanol -4%. All samples were therefore measured in a final dilution 
solution of 10% v/v methanol. 
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TABLE 6.1. The affect of solvent conditions on the blank response of the PAH 
immunoassay. 
Sample PAH Reading from graph 
(fig L-1) 
Water with 25% v/v methanol 5.8 
100% phosphate buffer ph7.4 4.8 
Phosphate buffer with 10% v/v acetone 34 
Phosphate buffer with 1% v/v acetone 8.0 
Phosphate buffer with 10% v/v methanol 12.0 
Phosphate buffer with 1% v/v methanol 5.0 
100% buffered saline ph7.4 2.4 
Buffered saline pH 7.4 with I% v/v acetone 5.2 
Buffered saline pH 7.4 with 10% v/v acetone 8.6 
Buffered saline pH 7.4 with 1% v/v methanol 2.4 
Buffered saline pH 7.4 with 10% v/v methanol 8.0 
50% buffered saline pH 7.4 with 50% v/v diluent 2.2 
10% buffered saline pH 7.4 with 90% v/v diluent 1.1 
100% diluent from kit 0 
Diluent with 1% v/v acetone 2.4 
Diluent with 10% v/v acetone 4.0 
Diluent with 1% v/v methanol 1.2 
Diluent with 10% v/v methanol 2.6 
6.2.2 Testing the Immunoassay Kits for Accuracy 
Both the total PAH kit and the carcinogenic PAH kit were tested for accuracy by using 
a solution of phenanthrene (total PAH kit) and benzo[a]pyrene (carcinogenic PAH kit). 
The solutions were made in-house to determine the imprecision likely when diluting 
real samples rather than the control solutions provided in the kit. A calibration curve 
was constructed for each kit. Measured values were compared to the expected result to 
determine if the kit was accurate at the range of detection stated by the manufacturer. 
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6.2.2.1 Total Immunoassay Kit 
Figure 6.1 shows the calibration curve for the total PAH kit. Predictably, the largest 
deviation occurred at the detection limits of the system. This could not be due to 
systematic error from the dilution as no systematic increase in error was observed with 
dilution. The kit was most reliable at the 25 pg L-' level, the mid-point of the assay 
range. This indicated that the most accurate results would be obtained by diluting the 
samples to an approximate concentration at the mid-point of the assay range. 
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FIGURE 6.1. Phenanthrene solution prepared in-house to determine the accuracy of 
the total PAH kit within the range stated by the manufacturer (n = 3). 
This made measurement difficult for samples with unknown PAH concentration. Many 
repeats over a range of dilutions is expensive to undertake, at a cost of -£ lO per 
sample and with the additional cost of £ 100 whenever the standards and controls were 
performed. This made the immunoassay kits impractical for the end-user. For this 
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reason, the test range was extended to between 10-40 µg L-' and a 1W ,O level of 
imprecision was deemed acceptable. 
6.2.2.2 Carcinogenic Immunoassay Kit 
Figure 6.2 shows the calibration curve for the carcinogenic PAH kit. The largest 
deviation occurs at the lower limits of the assay. This was concluded to be due to 
systematic factors as the error increased with dilution. Systematic error may be 
improved with better dilution technique but error could be further minimised if 
measuring within the range of between 3-5 pg L-'. Again, the accepted test range was 
extended with a 10% level of imprecision, yielding a carcinogenic kit detection range 
to between 0.5-5 µg L-1 that was more practical for use with unknown samples. 
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FIGURE 6.2. Benzo[a]pyrene solution prepared in-house to determine the accuracy of 
the carcinogenic PAH kit within the range stated by the manufacturer (n = 3). 
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6.2.3 Total and Carcinogenic PAH Content of Oils with Immunoassay 
The total and carcinogenic PAH content of oils 1 to 12 were measured with the 
immunoassay kits as described in Section 2.2.13. The oils were diluted to a range that 
would allow measurement within the most accurate range of the kits (determined in 
Section 6.2.2). The data produced by the kit standards is recorded in Table 6.2 for the 
total immunoassay kit and Table 6.3 for the carcinogenic kit. 
The %B/Bo of the standards were plotted against the amount of PAH (µg L-) on 
logarithmic graph paper supplied in the kit. The resulting linear calibration plot was 
used to determine the amount of PAH (µg L) of the samples from their %B/Bo values. 
Data, including dilution factor, mean absorbance and B/Bo values, are given in Table 
6.4 for total PAH and Table 6.5 for carcinogenic PAH. Both oil 3 and oil 8 for the total 
PAH measurement, required further dilution (Table 6.4) as the PAH content of both 
was too high to be measured within the same range of the other oils. 
TABLE 6.2. Calibration data for the total PAH immunoassay kit. The %B/Bo values 
were plotted against the amount of PAH (µg L-) on logarithmic graph paper (included 
in the kit) to produce a calibration curve on which the %B/Bo values of the samples 
could be used to determine the amount of PAH (µg L-) in each sample. 
Sample Absorbance 450nm Mean ± SD %CV %B/Bo 
Absorbance (n = 4) 
(B) 
Negative control (Bo) 1.186 1.189 1.158 1.154 1.1* 0.018 1.5 N/A 
Standard 1 (2 µg L-) 0.956 0.959 1.052 1.038 1.0 0.050 5.0 85 
Standard 2 (10 gg L-) 0.758 0.774 0.781 0.780 0.7 0.010 1.3 66 
Standard 3 (50 µg L-) 0.523 0.513 0.499 0.486 0.5 0.016 3.2 43 
Control (25 gg L-) 0.607 0.599 -- -- 0.6 0.005 0.9 51 
* Bo value 
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TABLE 6.3. Calibration data for the carcinogenic PAH immunoassay kit. The %B/Bo 
values were plotted against the amount of PAH (µg L-) on logarithmic graph paper 
(included in the kit) to produce a calibration curve on which the %B/B0 values of the 
samples could be used to determine the amount of PAH (µg L-) in each sample. 
Sample Absorbance 450nm Mean f SD %CV %B/Bo 
Absorbance (n = 4) 
(B) 
negative control (Bo) 0.715 0.714 0.714 0.719 0.71* 0.002 0.3 N/A 
standard 1 (0.1 µg L-') 0.650 0.652 0.645 0.654 0.65 0.003 0.5 91 
standard 2 (1 µg L"') 0.433 0.444 0.447 0.439 0.44 0.006 1.3 62 
standard 3 (5 µg L-') 0.278 0.281 0.268 0.286 0.27 0.007 2.7 39 
Control (2 µg L-) 0.388 0.382 -- -- 0.38 0.003 0.8 54 
* Bo value 
TABLE 6.4. Data for the total PAH immunoassay kit for transformer oils 1 to 12. 
Transformer Dilution Mean f SD %CV %B/BO 
Oil Factor Absorbance (n = 4) 
(B) 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
* Due to hig) 
obtained that 
look similar tc 
10 -' 0.63 0.007 1.1 54 
10 -5 0.49 0.007 1.4 42 
10 -6 0.91 0.004 0.4 78* 
10 -5 0.90 0.004 0.4 77 
10 -5 0.49 0.005 1.1 42 
10 -5 0.62 0.014 2.2 53 
10 -5 0.68 0.009 1.3 58 
10 -6 0.67 0.016 2.3 58* 
10-5 0.57 0.015 2.7 49 
10 -5 0.48 0.010 2.2 41 
10 -5 0.67 0.016 2.3 57 
10 -5 0.51 0.005 0. 66 
PAH content, these oils were diluted further so that an absorbance reading could be 
{ell within the range of the immunoassay kit. For this reason, although the %B/Bo values 
the other oils, their content is 10 times that of oil with a similar %B/B0 value. 
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TABLE 6.5. Data for the carcinogenic PAH immunoassay kit for transformer oils 1 to 
12. 
Transformer 
Oil 
Dilution 
Factor 
Mean 
Absorbance 
(B) 
± SD 
(n = 4) 
%CV %B/BO 
1 10 -6 0.63 0.010 1.5 89 
2 10-6 0.54 0.012 2.3 77 
3 10 -6 0.63 0.005 0.9 88 
4 10 -6 0.68 0.008 1.2 96 
5 10 -6 0.58 0.009 1.6 81 
6 10 -6 0.59 0.006 1.0 83 
7 10 -6 0.64 0.005 0.8 90 
8 10 -6 0.50 0.006 1.2 71 
9 10 -6 0.63 0.005 0.8 88 
10 10 -6 0.57 0.007 1.2 81 
11 10 -6 0.67 0.009 1.3 94 
12 10 -6 0.61 0.005 0.9 86 
Figure 6.3 shows a comparison of the total and carcinogenic PAH content of the 
twelve transformer oils. The carcinogenic data was multiplied by a factor of 33, (mean 
difference between the two sets of data) to allow comparison of the two test kits. This 
allowed a better determination of the trends observed for the twelve oils. 
The general trend observed was that carcinogenic content of an oil increased with 
overall PAH content. The exception was oil 4 which contained a much lower 
carcinogenic PAH content than would be estimated by the trend, possibly due to lying 
outside the dynamic range of the assay. As 11 of the 12 oils followed the trend, it was 
considered a significant finding in that the measure of total oil PAH content by the IP 
346 % w/w method, immunoassay or total GCMS spectral integration were potentially 
valid methods of assessing carcinogenic threat. 
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FIGURE 6.3. Comparison of the percentage total and carcinogenic PAHs detected in 
transformer oils 1 to 12. Carcinogenic PAH data has been multiplied by a factor of 33 
to allow comparison of the data on the same scale. Error bars are not shown as the 
repeated samples shown in Table 6.2 and 6.4 were combined to give mean readings of 
PAH content. 
6.3 GENERAL TRENDS IN PAH CONTENT OF TRANSFORMER 
OILS 
Oils 1 to 12 (100 µL) were extracted with the small scale C18/Silica/Isolute PAH HC 
method (Section 2.2.9). The TIC chromatograms obtained varied according to their 
PAH composition and were used to identify and quantify PAHs. From a simple 
examination of the chromatograms, it was observed that the oils yielding a higher 
aromatic content by IP 346 % w/w, yielded more complex chromatograms, as can be 
seen for oils 10,4 and 8 in Figure 6.4. As shown in Table 2.1, oil 8 contained the 
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greatest aromatic content according to IP 346 % w/w data and proved the most 
complex oil on GC-MS analysis (Figure 6.4 and 6.5). In turn, oil 10 contained a higher 
quantity of PAH species than oil 4 indicating a correlation in trend for Cl 8/Si/Isolute 
GC-MS extracts and IP 346 % w/w data. However, a more detailed comparison of 
PAH composition and quantity with IP 346 % w/w data, immunoassay and 
C18/Silica/Isolute PAH HC extraction was established before a definite conclusion 
was made. Further work is detailed in Section 6.3.1. 
1 1: Scan EI+ 
TIC 100 
5.79e7 
% 
0 YIVV42 
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% 
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3 1: Scan EI+ 
TIC 100 1 5.79e7 
Time 
10.00 12.50 15.00 17.50 20.00 22.50 25.00 27.50 30.00 32.50 
FIGURE 6.4. The TIC of oils extracted by the C 18 Silica Isolute PAH HC method. 
1 =oil 10 (IP 346 %=4.5), 2= oil 4 (IP 346 %= <1), 3= oil 8 (IP346%=8.9). 
Spectra run on the Perkin Elmer Turbomass (Section 2.2.6). 
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FIGURE 6.5. A close up of the first 17 minutes of the spectra shown in Figure 6.4 
extracted by the C 18 Silica Isolute PAH HC method. 1= oil 10,2 = oil 4,3 = oil 8. A 
= Phenanthrene, B= Phenanthrene methyl isomers, C= Phenanthrene dimethyl 
isomers. 
6.3.1 Validation of the C18 Silica Isolute PAH HC Extraction Method 
for Total PAH Determination 
Due to the laborious and crude nature of the IP 346 % w/w method it was 
advantageous to find an alternative method of measuring polyaromatic content. The 
immunoassay method offered an obvious alternative, as it measured total PAH in a 
sample. This method had its disadvantages however, as the immunoassay kits were 
considered too expensive in the long term for the end-user. 
As the C 18/Silica/Isolute PAH HC method extracts a range of representative PAHs 
present in the oil, it may be possible to use this method as an alternative to IP 
346 or 
immunoassays. As seen in Section 6.3, the chromatograms of oils with a high PAH 
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content tend to be more complex, and the summing of the peak areas of a whole 
chromatogram should be much greater than those oils of low PAH content. A 
comparison of total peak area was therefore used to compare the oils according to PAH 
content. This is shown in Figure 6.6 along with the total PAH immunoassay data and 
the IP 346 % w/w data. Total integration of the selective ion chromatogram was also 
compared. The raw data from both TIC and SIC integration is compiled in Appendix 
D. The immunoassay and IP 346 % w/w data is given as milligram of PAH per mL of 
oil (mg mL-l). The immunoassay data was multiplied by a factor of 7.1 (the mean 
difference between immunoassay data and IP 346 % w/w data) purely to allow direct 
method comparison on the same scale. 
The TIC data was compared to the immunoassay, SIC and IP 346 % w/w data in turn 
to determine if the C 18/Silica/Isolute PAH HC TIC peak integration could be used as 
an alternative to each method: 
1. TIC vs. Immunoassay. The data for TIC integration and immunoassay in Figure 
6.6 followed a similar trend for most oils, although the extent to which each oil 
varied was more exaggerated using the immunoassay method. In addition, the PAH 
content for oil 4 (3.14 x 106 peak area) was less than oil 3 (3.86 x 106 peak area) 
with TIC integration, but the immunoassay methods yielded a higher PAH content 
for oil 4 (4.2 mg mL-1) than oil 3 (3.8 mg mL-1). 
2. TIC vs. SIC. SIC correlated with TIC data with the exception of oil 2 and 3. SIC 
data showed oil 2 and 3 to have a lower PAH content than oil 1. However, both the 
TIC and immunoassay data showed oil 1 to have the lowest. This suggested that 
the integration of a TIC was more accurate than the integration of a SIC for 
determining the trend in oil PAH content. 
3. TIC and IP 346. IP 346 data followed a similar trend to TIC data, although the 
TIC trend was not as exaggerated as the IP 346 trend. For example, the TIC data 
for oil 8 was not as different from all other oils as IP 346 or immunoassay data. 
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The IP 346 % w/w method, although used to determine the polyaromatic content of an 
oil, is known to extract total aromatic content (Stang, 1993; 1999). As the 
C 18/Silica/Isolute PAH HC TIC integration correlated with both IP 346 and 
immunoassay, it was clear that total PAH content (measured by immunoassay) and 
total aromatic content (extracted by IP 346) were linked. This suggests that the 
overestimation of polyaromatic content with the IP 346 method is of no consequence 
in comparing the oils and therefore justifies the choice of the IP 346 method as the 
industry standard. 
However, the trend in the TIC data correlates sufficiently to suggest that it could be 
used as an alternative to IP 346 % w/w data for the estimation of polyaromatic content 
or immunoassay data for the estimation of total PAH content. This was beneficial as IP 
346 proved difficult to repeat (Table 3.7) and immunoassay was expensive for the end- 
user. In addition it was easier to perform, therefore IP 346 % w/w data and 
immunoassay data was not used again in this investigation. 
6.4 IDENTIFICATION OF PAHS IN TRANSFORMER OIL 
In addition to determining the general PAH content of an oil, the Cl 8/Silica/Isolute 
PAH HC extraction method with GC-MS, can be used to identify and quantify PAHs. 
In particular, the presence of the EPA 16 priority PAHs and additional carcinogenic 
PAHs could be used as a screening technique to indicate potential health threats, 
without mutagenicity testing. 
6.4.1 Insulating Mineral Oil Fingerprinting Compared to 
C 18/Silica/Isolute Extracts 
To determine the qualitative nature of the C 18/Silica/Isolute PAH HC extracts, the 
PAHs identified with the fingerprinting technique were compared to those in the 
C 18/Silica/Isolute PAH HC extract of oil Nytro- l OGBN. Although the NIST library 
allowed the identification of PAHs in the samples, GC-MS could not determine which 
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isomers were present without the use of standards. As standards for each isomer 
proved to expensive to purchase for the identification of all the PAHs in the oil, 
identification did not go as far as the determination of isomers. For this reason Table 
6.6 groups the isomers of each PAH found by the National Grid Company Plc and 
indicates which of these groups are present in the C 18/Silica/Isolute PAH HC extract. 
TABLE 6.6. Identification of PAHs in Nytro-IOGBN C18/Silica/Isolute PAH HC 
extracts compared to those found by the National Grid Company Plc using the 
fingerprinting technique (Wilson and Pahlavanpour, 2000). 
PAHs Identified by the National Grid Company Plc in PAH Found in C18/Silica/Isolute 
Nytro-IOGBN PAH HC spectrum 
1,1'-Biphenyl Yes 
1, F-Biphenyl, 2-methyl Yes 
1, F-Biphenyl, 3-methyl 
2,2'-Dimethyl-1,1'-biphenyl No 
3,3'-Dimethyl-1,1'-biphenyl 
1,1'-Biphenyl, 4,4-dimethyl No 
Naphthalene, 1,4,6-trimethyl- No 
Naphthalene, 1,4,5-trimethyl- 
9-H-fluorene Yes 
3-methylfluorene Yes 
9-H-Fluorene, 2,3-dimethyl Yes 
Phenanthrene Yes 
Phenanthrene, 9-methyl- Yes 
Phenanthrene, 4,5-dimethyl- Yes 
Phenanthrene, 2,5-dimethyl- 
Phenanthrene, 2,7-dimethyl- 
Phenanthrene, 2,3,5-trimethyl- Yes 
Pyrene Yes 
Pyrene, 1-methyl Yes 
Pyrene, 2-methyl 
Pyrene, 1,3-dimethyl No 
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It can be seen that the C18/Silica/Isolute PAH HC extract did not contain the 
naphthalenes identified by the National Grid Company Plc. This absence was possibly 
due to loss during the evaporation steps of the C18/Silica/Isolute PAH HC extraction 
discussed in Section 4.6.1. Nevertheless, the most abundant PAHs, such as 
phenanthrenes and fluorene were present and suggested that the C 18/Silica/Isolute 
PAH HC extraction method may be used for the identification of PAHs in oil. 
6.4.2 Identification of PAHs in Oil 1 to 12 
Oils 1 to 12 provided by the National Grid Company Plc were extracted using the 
C 18/Silica/Isolute PAH HC method and the GC-MS TIC of each were analysed to 
determine PAH composition, which is recorded in Table 6.7. 
It can be seen that a mixture of PAHs were present, although the majority were 
phenanthrene or fluorene based. However, no suggestion that these methylated PAHs 
were mutagenic was found in the literature as they are not well studied. It is assumed 
that they have the same mutagenicity as the parent PAH (Irwin, 1997). 
Dibenzothiophene (including its methylated forms), benzo[g, h, i]fluoranthene, dimethyl 
benzo[c]phenanthrene, and methyl chrysene were of concern as they might impact on 
the observed mutagenicity in the oil. Dibenzothiophene, although strictly a 
heterocyclic compound and therefore not a PAH, was included due to its abundance in 
the extract and possible carcinogenic and toxic implications, although carcinogenic 
properties were not conclusive (Irwin, 1997). 
No information on benzo[g, h, i]fluoranthene mutagenicity or carcinogenicity was 
found, but caution was applied due to inconclusive evidence in carcinogenic test 
(IARC, 2002). Benzo[c]phenanthrene was considered to be mutagenic with the Ames 
test (IARC, 2002) and therefore may be one of the sources of mutagenicity in oil 5,6 
and 8, although the carcinogenicity of dimethyl benzo[c]phenanthrene was not found 
in the literature. 
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Methyl-chrysene was of concern as 5-methyl chrysene has been identified by the 
IARC as of carcinogenic risk (IARC, 2002) which is explained by the fact that this 
isomer is methylated in the bay region of the structure (Harvey, 1991) (Section 1.2.3). 
No other well known mutagen was found. This showed that either the mutagenic 
component of the oil had not been identified, and/or the mutagenicity was a product of 
the identified PAHs in combination, as the mutagenicity of such mixtures are not well 
understood in the literature. 
6.5 QUANTITATION OF EPA 16 PRIORITY PAHS IN EACH OIL 
Although a number of PAHs were identified, quantification of the EPA 16 priority 
PAHs was performed to identify levels of carcinogenic PAHs that may account for the 
indirect mutagenicity observed in the Ames test. SIC was analysed for the presence of 
the EPA 16 priority PAHs and quantified using the HP GC-MS with manual 
integration. Manual integration allowed very small peaks (that would usually be 
omitted by the software) to be identified. Samples were concentrated to 0.1 mL (as 
opposed to 1 mL) to improve the precision of the GC-MS analysis. 
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TABLE 6.8. Calibration data for the EPA 16 priority PAHs. 
PAHs R` y= bx +a Error Of 
Calibration 
Curve (%) 
Limit of 
Detection 
(, ug mL"') 
Naphthalene 0.994 73394x + 4371.7 11 0.21 
Acenaphthylene 0.993 55658x + 3614.1 12 0.24 
Acenaphthene 0.990 30666x + 4818.5 14 0.44 
Fluorene 0.990 10341x + 4267.3 14 0.34 
Phenanthrene 0.986 8512.5x + 3187.6 17 0.23 
Anthracene 0.993 48911x + 5593.2 12 0.33 
Fluoranthene 0.993 60267x + 3249.4 12 0.11 
Pyrene 0.992 64196x + 3288.9 13 0.21 
Benzo(a)anthracene 0.991 41021x + 856.35 13 0.16 
Chrysene 0.987 26121x + 2928.2 16 0.35 
Benzo(b)fluoranthene 0.993 28567x + 705.59 12 0.15 
Benzo(k)fluoranthene 0.991 26876x + 1781.3 13 0.25 
Benzo(a)pyrene 0.992 20161x + 1306.2 12 0.24 
Indeno(1,2,3-c, d)pyrene 0.990 9767.8x + 490.55 14 0.22 
Dibenz(a, h)anthracene 0.990 6740.6x + 1086.2 13 0.44 
Benzo(g, h, i)perylene 0.991 10406x + 918.39 13 0.29 
Table 6.8 shows the calibration data for each EPA 16 prority PAH. To improve 
precision the samples were tested in triplicate. Six extractions were performed 
simultaneously to increased the throughput of samples. As the HP GC-MS had to be 
manually injected, 1 µg mL-l deuterated chrysene was added to each sample after 
extraction but prior to GC-MS injection. The deuterated chrysene was quantified in the 
same way as the EPA 16 priority PAHs. The efficiency of the sample injection was 
therefore measured by quantifying the deuterated chrysene and a multiplication factor 
(Table 6.9) was used to correct for injection errors. 
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TABLE 6.9. Amount of internal standard recovered after injection with oil extracts of 
oils 1 to 12. Each extract was spiked with 1 µg ml-1 deuterated chrysene after 
extraction to determine the efficiency of injection into the GCMS. The multiplication 
factors were used to compensate for inefficient sample injection. 
Oil Chrysene-D 
(pg mL-1) 
Multiplication 
factor 
1 0.56 1.7 
2 0.83 1.2 
3 0.71 1.3 
4 0.86 1.1 
5 0.43 2.3 
6 0.26 3.8 
7 0.34 2.9 
8 0.78 1.2 
9 0.10 9.8 
10 0.56 1.8 
11 0.56 1.8 
12 0.56 1.8 
The quantities of the EPA 16 priority PAHs identified in oils 1 to 12 are given in Table 
6.10. Benzo[k]fluoranthene was identified in the SIC but was not present in quantities 
that could be quantified. This PAH is a known mutagen (IARC, 2002) and so could 
contribute to the indirect mutagenicity observed with the C 18/Silica/Isolute PAH HC 
extracts in the Ames test. 
Considering that the extraction efficiency of all PAHs was below 100%, the 
efficiencies previously calculated in Section 4.6 (Table 4.4) were used to determine the 
content of oil at 100% efficiency. 
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The use of a multiplication factor however, meant that there were further errors 
incurred. This would be greatly improved by (1) automating the extraction method (to 
reduce variation in the method), (2) using an autosampler for injecting the sample into 
the GC-MS, (3) further sample repetition and (4) extracting larger quantities of oil. 
Unfortunately all such measures were not possible at the time of the investigation. 
Nevertheless, due to the absence of quantifiable PAHs, it was clear that the majority 
of PAHs present in the oil were likely to be the methylated species identified in Table 
6.7. Alternatively PAHs may have been in such low quantities that they could not be 
quantified without a further increase in sample volume or sample concentration. More 
importantly, no single carcinogenic EPA 16 priority PAH was found in large 
quantities in the oils. Benzo[a]anthracene was found only in oil 8, so contamination of 
the oil 8 sample could not be ruled out. However, the higher level of mutagenicity 
observed in the Ames test for oil 8 (Section 5.5.2) may be explained by the presence 
of benzo[a]anthracene. 
From comparison of Table 6.10 with Table 6.7 it can be seen that not all of the EPA 
16 priority PAHs identified in the TIC spectra were quantified in the SIC and vice 
versa. An example of this is benzo[a]anthracene which was identified with SIC and 
not TIC, or chrysene which was identified in some of the oils with TIC but was not 
quantified in SIC. Benzo[a]anthracene could not be identified without SIC due to the 
overlapping of peaks with a similar retention time. Chrysene concentration was not 
sufficient for quantification, but the peak was visible in the TIC for identification. 
A further example of this is benzo[k]fluoranthene which was identified by SIC but 
which was not quantified due to lack of sensitivity in the GCMS. The possible 
presence of these carcinogenic PAHs such as benzo[a]anthracene and 
benzo[k]fluoranthene, in addition to dimethyl benzo[c]phenanthrene, methyl chrysene 
and dibenzothiophene mutagenicity (Section 6.4.2) may cause the mutagenicity 
observed in oil extracts with S-9 (Section 5.5.2). In addition, there may be other PAHs 
in the oil that were not identified in the TIC due to the number of overlapping peaks. 
Such PAHs may only be identified using SIC if standards of the compound were run 
190 
to determine retention time and molecular mass. As the compounds were unknown, 
this would have been an expensive trial and error process and was therefore not 
performed. 
6.6 EFFECTS OF AGEING ON PARS IN OIL 
6.6.1 Qualitative Variations of PAH in Aged Oils 
To determine changes in transformer oils with ageing the TIC spectra of ALT 0, ALT 
1, ALT 2 and ALT 3 were compared. This was performed in the same way as for oils 
1 to 12, as it had been found that the area of a TIC could be used to evaluate PAH 
content (Section 6.3). The TIC chromatogram (Figure 6.7) showed that ALT 0 oil had 
the largest TIC area, which suggested that it had the greatest PAH content. It was also 
clear from the TIC that ALT 3 had the smallest total area suggesting that area (and 
therefore PAH content) decreases with ageing. This was investigated further by 
repeating the extraction of each oil in triplicate and measuring the total area of the 
TIC of each repeat. This ensured that the results seen in Figure 6.7 were not affected 
by inefficiencies within the extraction process. 
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FIGURE 6.7. The TIC of oils ALT 0, ALT 1, ALT 2 and ALT 3. 
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Figure 6.8 shows that the area of the TIC (and therefore possibly PAH content) did 
decrease by almost half after 1 week of artificial ageing. This increased on average by 
20% after two weeks, although the %CV of 30% suggested that this was not 
conclusive. The total area of the ALT 3 TIC decreased again to a similar level as ALT 
1. The increase in %CV after ageing from 5.5% for ALT 0 to 24-30% (ALT I, ALT I 
and ALT 3) may be explained by the fact that the aged oils contained a high level of 
particulates produced during oxidation. Although efforts were made to decant the oil 
from the particulates, it was possible that particulates were still interfering with the 
extraction, and made the extraction less repeatable. 
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FIGURE 6.8. Area of the total ion chromatogram for aged oils (n = 3). %CV ranges 
from 5.5-30%. 
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ALT 0 ALT 1 ALT 2 ALT 3 
6.6.2 Quantitative Variations of PAH in Aged Oils 
The EPA 16 priority PAHs naturally occurring in the oil were quantified before and 
after ageing to determine changes in PAH composition. The quantification was 
performed at the same time as quantification of oils 1 to 12, so the calibration data in 
Table 6.8 applies here. Multiplication factors of internal standards of deuterated 
chrysene were used in the same way as in Section 6.5 and the multiplication factors 
are given in Table 6.11. The figures in Table 6.12 have been multiplied to determine 
the amount of each PAH if the extraction had been 100% efficient. 
TABLE 6.11. Amount of internal standard recovered after injection with oil extracts 
of oils 1 to 12. Each extract was spiked with 1.8 µg ml-' deuterated chrysene after 
extraction to determine the efficiency of injection into the GCMS. The multiplication 
factors were used to compensate for inefficient sample injection. 
Aged I Chrysene-D Multiplication 
Oil I factor 
ALT 0 1.8 1.0 
ALT 1 1.8 1.0 
ALT 2 1.8 1.0 
ALT 3 1.5 1.2 
Of the EPA 16 priority PAHs determined with SIC only phenanthrene, fluoranthene 
and pyrene were found to be present in the oil. The results in Table 6.12 suggested 
that there was an overall increase in oil PAH content with ageing. Phenanthrene 
showed a decrease with 1 week of ageing (by 0.1 . tg mL-') which then increased after 
2 weeks (by 0.25 µg mL-) and slightly decreased again after 3 weeks (by 0.02 µg mL- 
1). Fluoranthene increased after 2 weeks (by 0.2 µg mL-) and remained at a similar 
level after 3 weeks. 
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Finally, pyrene decreased after 1 week of ageing by 0.145 µg mL-l followed by an 
increase to a greater level than was originally present by three weeks (increase of 0.43 
µg mL-' ). The overall results for ageing therefore showed a general increase in these 
three PAHs with ageing. This did not correlate with the finding in Figure 6.8, which 
suggested that PAH content decreased with age. However, it was postulated that the 
TIC estimation of total error may have been less accurate with aged oils due to the 
accumulation of debris and particulates that occur with use. Results are further 
discussed in Section 7.6.4. 
TABLE 6.12. The amount of the EPA 16 priority PAHs found in 100 µL of aged oils. 
The results have been subject to the multiplication factors in Table 6.11 and 
multiplied to determine the amount of each PAH if the extraction had been 100% 
efficient (using extraction efficiencies in Table 4.4). 
PAHs ALTO 
(Fug) 
ALTI 
(Pg) 
ALT2 
(fug) 
ALT3 
(Fug) 
Naphthalene 0 0 0 0 
Acenaphthylene 0 0 0 0 
Acenaphthene 0 0 0 0 
Fluorene 0 0 0 0 
Phenanthrene 0.27 0.16 0.41 0.39 
Anthracene 0 0 0 0 
Fluoranthene 0.13 0.13 0.35 0.30 
Pyrene 0.38 0.24 0.44 0.81 
Benzo(a)anthracene 0 0 0 0 
Chrysene 0 0 0 0 
Benzo(b)fluoranthene 0 0 0 0 
Benzo(k)fluoranthene 0 0 0 0 
Benzo(a)pyrene 0 0 0 0 
Indeno(1,2,3-c, d)pyrene 0 0 0 0 
Dibenz(a, h)anthracene 0 0 0 0 
Benzo(ghi)pe lene ý' 0 0 0 0 
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A large range of PAHs at a higher concentration in the aged oil would have allowed a 
more accurate monitoring of PAH content with GC-MS. A more appropriate method 
of determining PAH change with ageing would be to spike the oil with a large 
quantity of each EPA 16 priority PAH before ageing and determine changes after 
extraction with the C 18/Silica/Isolute PAH HC extraction method. This was not 
possible at the time of the investigation. Nevertheless, the results suggested that PAH 
content does change with age and that individual PAHs may be affected in different 
ways. 
6.7 USE OF C18 SILICA ISOLUTE PAH HC EXTRACTION WITH 
NON-TRANSFORMER OILS 
As the C 18/Si/Isolute extraction was successfully used with transformer oil, it was 
possible that other oils could be extracted for PAH identification. A number of oils 
were extracted, including petrol and red diesel, both thought to contain higher levels 
of PAH, and edible oils such as Olive oil and Sunflower oil, which it was hoped, 
contain little or no PAH. 
Figure 6.9 shows the TIC of Diesel. The PAHs found are labelled. It was clear that 
diesel had a high PAH content, and the extraction method produced a clean extract. 
The Spectrum in Figure 6.9 is only shown at up to 14 minutes as there were no PAHs 
of later retention time found. The red diesel, like transformer oils contained many 
fluorene and phenanthrene derivatives with the addition of anthracene and pyrenes, 
which were not as prevalent in transformer oil. 
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FIGURE 6.9. Close up of diesel extracted by C 18 Silica Isolute PAH HC method. 
Naphthalenes were also identifiable in red diesel, but were not observed in 
transformer oils, although the mineral insulating oil fingerprinting technique indicated 
their presence. This showed that the C 18/Silica/Isolute PAH HC method was capable 
of extracting naphthalenes, although it was not understood why it did not extract them 
from the transformer oil. It was possible that the extraction of naphthalene was 
inefficient and that there was not enough of each naphthalene to ensure detectable 
amounts were extracted in transformer oil. Most importantly, no large carcinogenic 
PAHs of the EPA 16 priority PAHs were identified. 
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FIGURE 6.10. Close up of petrol extracted by C 18/Silica/Isolute PAH HC method. 
Figure 6.10 shows the TIC of petrol. It was clear that the petrol did not contain as 
much PAH as the diesel, but once again an abundance of fluorene and phenanthrenes 
are found. No carcinogenic EPA 16 priority PAHs were identified. Figure 6.11 and 
6.12 respectively, show the TIC of C 18/Silica/Isolute extracts of olive oil and 
sunflower oil. No PAHs of any type were found in any of these oils. 
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method. 
6.8 CONCLUSIONS 
The C 18/Silica/Isolute PAH HC extractions with GC-MS analysis clearly had benefits 
not present for the IP 346 % w/w method or immunoassay detection. GC-MS analysis 
of IP346 samples was inconclusive for PAH identification or quantification, due to the 
complexity of the sample and immunoassay buffer environments were not compatible 
with GC-MS. Using the C18/Silica/Isolute PAH HC extracts to determine total PAH 
content would provide a simply, fast, less hazardous and less expensive method that 
fulfils the criteria of IP 346 estimation but that can also be used to analyse all aspects 
of PAH content. 
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CHAPTER 7.0 
DISCUSSION AND FURTHER WORK 
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7.1 INTRODUCTION 
PAHs are natural components of the transformer oils that reduce the rate of oil 
breakdown and therefore prolong the life of electrical power transformers. Some of 
the larger PAHs have been found to be carcinogenic however, and for this reason the 
National Grid Company Plc are concerned that PAHs may be of risk to the health of 
employees exposed to oil. Legislation produced by CONCAWE, for the labelling of 
oils states that oil with an polyaromatic content of over 3% w/w according to IP 346 
gravimetric quantification, must be labelled as hazardous. Oils with an IP 346 % w/w 
values over 3% are of risk according to skin painting data (Stang, 1993; 1999; 2000). 
Although PAHs are thought to be the main source of oil mutagenicity (McKee et al, 
1989) the IP 346 overestimate of polyaromatic content (Section 1.1.3.1) so cannot be 
related to PAH risk alone. Therefore the PAH content, rather than the aromatic 
content must be identified and analysed for mutagenicity to determine if PAHs are the 
main risk from oils, or if the aromatic IP 346 fraction contains other mutagens. 
Much analysis has been performed to determine PAHs in mineral oils but is 
complicated by the fact that each oil is composed differently. Mineral oils are refined 
to different extents according to their uses. Refining processes may be categorised as 
unrefined, slightly refined and heavily refined. Although it may be safe to assume that 
unrefined oils are more dangerous than slightly refined oils and that heavy refining 
reduces mutagenicity (IARC, 2002) it cannot be assumed that all oils within the same 
class of refinement have broadly the same PAH composition or mutagenic threat. 
Even within a specific application, such as use in transformers, PAH content will vary 
greatly according to the origins of the oil (illustrated by IP 346 % w/w values in Table 
2.1). Each oil therefore, must be analysed and assessed individually. For this reason, 
although a number of extraction methods were taken from the literature, the results of 
other work could not be directly compared to those in this study as the oils were so 
different in composition and usage. No data was found in the literature for the 
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particular transformer oils used in this work, so no indication of possible outcome 
could be assessed before the work was completed. 
7.1.1 Aims and Approaches of the Work 
The main aim of this work was to identify PAH composition in the oil and 
demonstrate possible mutagenic risks from PAHs to National Grid Company Plc 
employees. An outline of the work progression is given in Figure 7.1. This would 
involve providing evidence of total oil mutagenicity to establish if PAHs are the main 
source of mutagenic risk. This would indicate if efforts should be made to remove 
PAHs from oil and replace them with an artificial inhibitor that may itself pose a 
threat to health (Section 1.1.3). It would also determine whether the current labelling 
legislation was sufficient to protect the health of employees. In addition, it would help 
identify environmental concerns about PAH contamination from oil leakage, which is 
becoming an important issue particularly in the UK and USA (EPA, 2002). 
As PAH content of all mineral oils vary greatly, 14 transformer oils commonly used 
by the National Grid Company Plc were tested. When resources were limited, 4 of 
these oils were selected for in-depth testing based on their widely differing aromatic 
content (IP 346 % w/w values) so that general trends could still be observed. Oil 8 
contained the greatest amount of PAH, oil 4 the least and Nytro-1 OGBN contained an 
intermediate amount and was widely used by the National Grid Company Plc. White 
oil was also used to give a background "blank" reading as it was highly refined and 
thought to contain little or no PAHs. 
The Ames test is an effective method of testing for mutagenicity and is a screening 
method for detecting possible carcinogens without animal testing. The test remains 
one of the cheapest and effective ways of testing mutagenicity. It has been modified to 
suit its application to oils and involves the extraction of the aromatic portion of the oil 
as well as the increased use of S-9 activation enzymes (Blackburn et al., 1986). This 
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modification made the Ames test the obvious choice for testing the mutagenicity of 
transformer oils. 
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FIGURE 7.1. Outline of work progression throughout this thesis to determine the 
mutagenicity of PAHs in transformer oil. 
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One difficulty in PAH mutagenicity testing is that different methods of extraction 
yield different results (Stang, 1993; 1999). This discrepancy is compounded by the 
fact that the extracts used to measure mutagenicity are never analysed to identify 
PAHs, as they are too complex. This means that the presence of a mutagen is never 
directly attributed to the presence of a PAH. For this reason, whilst current methods 
will be analysed, an extraction method that can be used for both PAH analysis as well 
as PAH mutagenicity tests was developed. 
Two approaches to assessing PAH content were used based around the development 
of a novel Cl 8/Silica/Isolute PAH HC extraction method for PAHs in oil (Chapter 4), 
which is further discussed in Section 7.3. 
The first approach was to measure mutagenicity directly using the Ames test and 
demonstrate the impact of PAH mutagenicity on total oil mutagenicity. The current 
methods available in the literature were investigated prior to the development of the 
new C 18/Silica/Isolute PAH HC extraction method to determine if an improved 
extraction was required (Chapter 3). When it was found that the current extraction 
methods contained mutagens other than PAHs, the new extraction method was 
developed and used to establish PAH mutagenicity only (Chapter 5). This is further 
discussed in Section 7.4.2. 
The second approach was to use the new C 18/Silica/Isolute PAH HC extraction 
method to analyse PAH composition of oil. This determined if analysis allowed the 
identification of mutagenic threat without the need for complex mutagenicity testing 
(Chapter 6). This is further discussed in Section 7.6. Different aspects of GC-MS 
analysis of the oil extracts were investigated including direct quantification of the 
EPA 16 priority PAHs, identification of other PAHs (particularly mutagenic ones) and 
an estimation of total PAH content by integrating the whole GC chromatogram of 
each oil. This method was compared to other methods already available, namely IP 
346 and immunoassay methods. 
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Initial concerns with the work originated from the complexity of the oil matrix. Oil is 
composed of many different compounds, and it was possible that transformer oil 
contained a variety of both mutagenic and toxic compounds. Toxic effects would 
reduce the amount of Salmonella typhimurium present and could cause a reduction in 
revertant number that would lead to false results. Additionally, there were concerns 
that some oil components may be antagonistic to mutagenic PAHs, once again 
producing false Ames test results. For these reasons, inhibition and toxicity affects on 
the Ames test were also investigated and are discussed further in Section 7.5.1 and 
7.5.2 respectively. 
Finally, artificially aged oils were briefly analysed to see if PAH composition and 
therefore mutagenicity changed with in-service usage. This would have great 
implications on the electricity industry, as it would determine if monitoring PAH 
levels during the lifetime of the oil was required or if testing before use was sufficient. 
This is further discussed in Section 7.2.5,7.4.3 and 7.6.4. 
7.2 MUTAGENICITY OF PAHS IN OIL 
The oil was tested as a whole, and then extracted using methods reported in the 
literature (Chapter 3) to determine the PAH contribution to oil mutagenicity. 
7.2.1 Ames Testing of EPA 16 PAH Standard 
Testing some of the EPA 16 priority PAHs separately established the S. typhimurium 
strain's (TA98) sensitivity to PAHs (Section 3.2.1.1). The findings agreed with the 
literature showing that the S. typhimurium strain was behaving as expected and was 
appropriate for use with PAHs (Hermann, 1980). Chrysene, was the only PAH of 
those tested that did not show a clear positive or negative response. There is 
contention in the literature as to whether S. typhimurium shows mutagenicity in the 
presence of chrysene. For example, Basler et al. (1977) found no mutagenicity, while 
McCann et al. (1975) identified mutagenicity. The intermediate responses obserti ed 
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here supported these inconsistencies in the literature, and illustrated the limitations of 
the Ames test for the analyte. If such an inconclusive result was obtained from the oil 
samples, a further mutagenic test such as MutatoxTM would be required. 
Testing was then performed on a mixture of the EPA 16 priority PAHs to determine 
the mutagenicity of a mixture of these compounds (Section 3.2.1.2). It was found that 
antagonistic effects were present and toxicity effects may be acting to mask 
mutagenicity. This would lead to positive results being mistaken for negative results 
and illustrated the requirement for toxicity testing in conjunction with mutagenicity 
testing. 
7.2.2 Ames Testing of Whole Oil 
Although modifications have been made to improve the Ames test for oil analysis by 
extracting the aromatic fraction, the initial concern was to test the oil in its unmodified 
form. Extracting the aromatic fraction of the oil as described by Blackburn et al. 
(1986) meant that any mutagens present in the remainder of the oil were not 
accounted for. In addition, it was interesting to see if the whole oil mutagenicity 
differed from the mutagenicity of the aromatic extract. It was found that the whole oil, 
whether added directly, or made more compatible to the aqueous environment with 
Tween 80, showed no mutagenic effects (Section 3.3.1 and 3.3.2). 
There were three possible causes for this: 
1. The oil was not mutagenic. This could be resolved by testing the aromatic fraction 
of the oil (discussed in Section. 7.2.3). 
2. The oil environment was not compatible with the Ames test, and inhibited either 
the growth of S. typhimurium, or affected the enzymatic properties of the S-9 
fraction (Watson et al., 1985). The oil matrix was shown to affect S. typhimurium 
in particular (Table 3.6). It was considered that this effect may be overcome by 
extracting the oil before testing. 
206 
3. Due to the many synergistic and antagonistic effects occurring within the oil, the 
oil matrix may trap or deactivate mutagens (Watson et al., 1985). This was tested 
by spiking the oil with a known mutagen (benzo[a]pyrene or 2-amino anthracene) 
and observing any reductions in reversion number. This inhibition test was 
performed for all the oil extracts used in this work and is therefore discussed 
collectively (Section 7.5.1). 
7.2.3 Ames Testing of IP 346 and Grimmer Extracts at 10% S-9 
The mutagenicity of an oil is best determined by extracting the aromatic fraction of 
the oil (Blackburn et al., 1986). The amount of oil extracted and tested was limited by 
the end user's health issues arising from using large volumes of solvent and by the 
amount of extract that was soluble in the minimum solvent volume required for the 
Ames test. For this reason no more than 5g of oil was extracted (Section 1.4.1.6). The 
method used by Blackburn et al. (1986) includes the use of an 80% v/v S-9 mix and a 
liquid-liquid extraction (LLE) step, using DMSO and cyclohexane. 
The extraction worked on the same principle as the IP 346 % w/w method used to 
estimate polyaromatic content (Section 1.5.2). As IP 346 is an industry standard LLE 
method, the use of LLE was deemed appropriate for measuring PAH mutagenicity in 
oil. As with the IP 346 % w/w method however, the Blackburn extracts uses DMSO 
to extract polyaromatics (Section 1.1.3.1) and therefore may extract simple aromatic 
and other polar components in addition (Stang, 1993,1999). This suggested that 
mutagens other that PAHs may be extracted by these methods. 
As well as the IP 346 % w/w method and the Blackburn method, the LLE method 
used by Grimmer et al. (1981) was also employed to determine if the type of 
extraction method altered the mutagenicity measured. The extractions, although using 
the same solvents, contained different numbers of washing steps, which may affect 
the efficiency of extraction. The IP 346 % w/w method, when used as a gravimetric 
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estimation of polyaromatic content was believed to correlate well with skin painting 
data, (Stang, 1993; 1999; 2000) so was used with the Ames test initially. The 
Grimmer method was also investigated, as it was much simpler to perform (Section 
3.4.1). 
As the Blackburn method was the most popular method for use with the Ames test for 
oils (Brooks et al., 1995; Granella et al., 1995), it was not tested until the 
C 18/Silica/Isolute PAH HC extraction had been developed. This allowed a direct 
comparison and validation of the new method with an established method of 
measuring PAH mutagenicity (Section 5.2) from oils and is discussed in Section 
7.4.1. 
The dose is reported as milligrams of oil extracted rather than milligrams of oil extract 
and is plotted against the mean number of revertants per plate. This allowed a simpler 
comparison of whole oil mutagenicity results with oil extract results. 
Oil 8, oil 4 and Nytro- I OGBN were extracted using the IP 346 % w/w method and the 
Grimmer method to provide data on a range of oils, having differing aromatic 
contents. The extracts were Ames tested over 5 consecutive doses (0.5-500 mg of oil 
per plate) to determine the best dose with which to test further extracts. Only 10% v/v 
S-9 was used for the initial testing since an 80% v/v loading (Blackburn et al., 1984) 
would be prohibitively expensive to the end user for routine sample analysis over 5 
doses. 
The trends in Ames test data from all aromatic extracts of oil 8, Nytro- I OGBN, 4 and 
white oil are compiled in Table 7.2 in Section 7.4.2.1 for comparison to the new 
C 18/Silica/Isolute PAH HC extraction, but Grimmer and IP 346 extracts are discussed 
here initially. 
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7.2.3.1 Grimmer Method 
The Grimmer extracts produced a mutagenic response for white oil, oil 8,4 and 
Nytro- I OGBN without S-9, which suggested that a direct mutagen (mutagenic without 
S-9 activation) was present (Section 3.4.1 and Table 7.2). Direct mutagens present in 
mineral oil were also acknowledged by Granella et al., (1995). The reversion number 
was high at -1000 revertants plate 1 at an oil extract dose of 500 mg plate-'. As these 
mutagens were direct, the mutagenesis could not be due to PAHs, as PAHs must be 
activated into their mutagenic form by S-9 enzymes. This suggested that there were 
other unknown mutagens in the oil that could threaten the health of oil users. 
Removing PAHs from the oil would only reduce the mutagenic threat therefore, 
unless this direct mutagenic threat was also identified and removed. The direct 
mutagen was believed to be an aromatic compound, known to be extracted with 
polyaromatic compounds in liquid-liquid extractions (Stang, 1993; 1999). 
For the Grimmer extracts with S-9, mutagenicity was slightly greater than that 
observed without S-9 for Nytro-1 OGBN suggesting an accumulation of mutagenicity 
from direct and indirect mutagens. However, no increase in mutagenicity was 
observed for white oil, oil 8 or oil 4 with S-9. For oil 4 and white oil, the absence of 
mutagenicity was thought to be due to insufficient PAHs in the oil. However, as oil 8 
was found to have the greatest PAH content (Section 6.2.3,6.3.1) the majority of 
which were later identified as non-mutagenic PAHs (Section 6.4.2), it was postulated 
that competitive or non-competitive inhibition of the S-9 enzymes from non- 
mutagenic oil PAHs was the cause of reduced mutagenicity. This was later validated 
and is discussed further in Section 7.5.1. 
Nevertheless the results from using 10% v/v S-9 were used to draw a number of 
conclusions that would be useful in further testing. The results indicated that the 
largest dose used (500 mg plate-) was required to determine mutagenicity. It also 
demonstrated that the Grimmer method was better than the IP 346 method at revealing 
mutagenic content. Most significantly, the results revealed direct mutagen(s) were 
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present indicating that indirect mutagens such as PAHs were not the only source of 
mutagenicity. 
7.2.3.2 IP 346 Method 
It was found that the IP 346 extracts for all the oils were not mutagenic with or 
without S-9 (Section 3.4.1 and Table 7.2). This suggested that mutagens were not 
present in the aromatic fraction in sufficient quantities to elicit a positive Ames test 
response. Alternatively lack of mutagenicity could be caused by an insufficient 
amount of activation enzymes. It was possible that there were non-mutagenic PAHs 
competing for the active sites of the enzymes and therefore reducing mutagenicity. 
Although no mutagenicity was observed with IP 346 extracts, the use of IP 346 % 
w/w values as a measure of total aromatic content of the oil (as opposed to PAH 
content only), has been justified by the presence of direct mutagens in the aromatic 
fraction. If only the PAH content had been extracted, the full mutagenic nature of the 
oil would not have been established. These findings indicated that extracting the total 
aromatic fraction of the oils is potentially the most viable way to measure oil 
mutagenicity. However, concluding that the mutagenicity in the aromatic content is 
due to the polyaromatic content (Grimmer, 1983; Järvholm and Easton, 1990; Brooks 
et al., 1995; Granella et al., 1995) is not justified for the oils tested in this work due to 
the presence of additional direct mutagens. 
As the Grimmer extracts revealed mutagenicity at 10% S-9, Grimmer extracts of 
white oil, oil 4, oil 8 and Nytro-1 OGBN were repeated with 80% v/v S-9 to determine 
if an increase in activation enzymes affected the results (Section 3.4.2). 
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7.2.4 Ames Testing of Grimmer Extracts at 80% S-9 
As the Grimmer method appeared superior to the IP 346 method with regard to 
mutagenicity analysis, extracts were tested with elevated levels of S-9 (80% v/v) over 
3 doses for oil 8,4, Nytro-IOGBN and white oil (Section 3.4.2 and Table 7.2). The 
increase to 80% v/v in S-9 enzymes produced -200-500 more revertants with oil 8 
than for oil 4 and Nytro-l OGBN. The number of revertants for oil 8, on the addition of 
80% v/v S-9 had doubled compared to the number of revertants without S-9. This 
doubling in reversion number clearly showed that indirect mutagens (possibly PAHs) 
were present. 
As the number of revertants had increased for oil 8 at elevated levels of S-9, it was 
believed that the same outcome may occur for oil 4 and Nytro-10GBN. Revertant 
number did not significantly change for oil 4 on the addition of 80% v/v S-9. The 
same number of revertants was observed with or without S-9, suggesting that oil 4 did 
not contain a sufficient amount of PAH to induce a positive response. The same 
response was observed for white oil showing that the `blank' oil contained direct 
mutagens only. These results showed a similar trend to those in Granella et al., (1991, 
1995) where liquid-liquid extracted oils with a low PAH content (in this case recycled 
oils) showed only direct mutagenesis while those with a high PAH content showed 
both direct and indirect mutagenicity. 
An increase of 200 revertants (24%) previously observed for Nytro- I OGBN with 10% 
v/v S-9, increased to 300 (35%) with 80% v/v S-9. This increase was not considered 
significant and suggested that there was a sufficient enzyme loading in 10% v/v S-9 to 
activate the majority of mutagenic PAHs in Nytro-1OGBN. 
The IP 346 % w/w quantification of polyaromatic content (Table 2.1) showed oil 8 to 
have a value of 8.9% w/w, while oil 4 contained 0-1% w/w and Nytro- l OGBN 
contained around 1.75-2.64% w/w. If IP 346 correlated with Ames test data as stated 
by the oil manufacturer, Nynas (Stang, 1993; 2000), oil 8 should have a much greater 
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mutagenic response with S-9 than the other oils. In turn Nytro-lOGBN should have 
given a greater response than oil 4 and white oil. Therefore, the Ames test results of 
the Grimmer extracts correlated with IP 346 % w/w data as white oil and oil 4 gave no 
indirect mutagenicity, while Nytro-IOGBN gave a 35% increase in revertant number 
and oil 8a 50% increase in the presence of activation enzymes. 
Identification of the individual indirect mutagens was not attempted using these 
extraction methods however, due to the complexity of the oil extracts as shown by the 
GC-MS total ion chromatograms (TIC) in Section 3.4.1.1. 
7.2.5 Ames Testing of Aged Oil Grimmer Extracts at 80% S-9 
It has been reported in the literature that PAH levels can increase over time in oils 
subjected to high temperatures during there working life (Moret and Conte, 2000; 
Wang et al., 2000; Wong and Wang, 2001). As transformer oil will be subject to 
oxidation and heat during its lifetime, PAH composition must be monitored to 
determine the build up of PAHs (Section 7.6.4) and changes in mutagenicity must be 
assessed. 
Aged oils were also investigated using the Grimmer method (Section 3.5). It was 
found that once again mutagenicity was present without S-9 for all oils, but no change 
in revertant number was observed with ageing. In addition, the increase in reversion 
number (-14-20%) on the addition of S-9 was not as great as that observed for Nytro- 
IOGBN or oil 8. Nevertheless it was possible that such a consistent increase was due 
to indirect mutagens. 
7.2.6 Ames Testing of Solid Phase Extracts 
Solid phase extraction (SPE) was performed as an alternative method to LLE (Section 
3.6). It was postulated that the SPE would produce a cleaner extract that could be 
analysed by GC-MS to identify the mutagens responsible. It was also believed that by 
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fractionating the extract during elution, the complexity of the extract would be 
reduced and less S-9 (10% v/v) would be required during Ames testing. 
Fraction 1 of oil 4 proved mutagenic without S-9 (as with the Grimmer and Blackburn 
extracts). However, the number of revertants increased by over 200 (4.5 fold) on the 
addition of 10% v/v S-9 suggesting the additional presence of an indirect mutagen, 
which was not observed with the Grimmer or Blackburn extracts. Nytro-IOGBN also 
showed mutagenicity in fraction 1 without S-9 and revertants increased by over 100 
(1.6 fold) on the addition of S-9 (refer to Table 7.1 for summary of results). These 
results suggested that oil 4 contained more indirect mutagens than Nytro-1 OGBN, but 
this result was not conclusive as SPE was unable to remove some of the aliphatic 
components of the oil, contributing to a lack of precision (%CV up to 42%) in the 
Ames test results. 
TABLE 7.1. Summary of Ames test results for SPE extracts. The mean number of 
revertants is shown. 
Oil SPE Fraction 1 (10% S-9) SPE Fraction 2 (10% S-9) 
(-)S-9 (+)S-9 
4 83 370 
(-)S-9 (+)S-9 
35 29 
Nytro-1OGBN 114 221 135 32 
8 24 252 177 217 
Although a lack of precision affected results, the fractionation of the aromatic extract 
showed that the mutagens were probably resident within the less polar fraction 
(fraction 1). No mutagenicity was found in fraction 2 of oil 4 and Nytro- I OGBN with 
or without S-9. This suggested that approximately half of the fraction extracted by 
liquid-liquid methods was not mutagenic and should ideally be removed for 
mutagenicity measurements, as they may cause interference. 
Different results were obtained for oil 8. Mutagenicity was only observed for fraction 
1 when S-9 was added (increase of 5 fold). The direct mutagens were found 
in 
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fraction 2. This indicated that the properties of the indirect mutagens were different 
enough to allow separation from the direct mutagens, although this extraction method 
was not effective enough to allow this for all the oils. 
The TIC of the two fractions of Nytro-1OGBN (figure 3.14) indicated the limitations 
of this extraction method as SPE failed to produce cleaner extracts than LLE (IP 346 
and Grimmer). PAHs and other possible mutagens were therefore not identified 
As LLE benefited from better repeatability due to the removal of aliphatic 
components, but SPE benefited from fractionation, a combined process was employed 
(Section 3.7). The results however, indicated no mutagenicity or toxicity, possibly due 
to PAHs being fractionated between the cyclohexane wash and the two collected 
fractions, so that no single fraction contained sufficient PAHs to cause a mutagenic 
effect. The GC-MS TIC scan once again indicated inefficient separation of PAHs 
from the other aromatic compounds (figure 3.16). A novel approach was therefore 
required to conclusively determine the mutagenicity solely due to PAHs. 
7.3 DEVELOPMENT OF A NEW EXTRACTION METHOD FOR 
TESTING OIL PAH MUTAGENICITY 
Current methods of measuring the mutagenicity of oil, such as that described by 
Blackburn et al. (1984,1986) produced extracts that were found to contain many 
interfering components. These extracts although useful in determining overall 
mutagenicity, could not be used to determine PAH induced mutagenicity. For this 
reason, a study was initiated based on the development of a new extraction method, 
with greater specificity to PAHs. 
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7.3.1 Solid Phase Extraction (SPE) 
From primary studies of extraction methods used for oil PAH mutagenicity tests, 
LLEs were the most popular methods. However, GC-MS analysis of such extracts 
confirmed the suggestion in the literature (Stang, 1993; 1999) that LLEs extract all 
aromatics rather than PAHs. SPE was often employed after the LLE process when 
cleaner extracts were required (Wang et al., 1999; Grimmer et al., 1981). The main 
benefit of SPE is the ease by which samples can be fractionated, allowing more subtle 
separation of components with similar properties. SPE was found to be more effective 
that LLE for the recovery of PAHs by Sargenti et al. (1998). Although SPE had not 
proven successful in previous studies (Section 3.6 and 3.7) it was considered a more 
appropriate choice for further development as it typically consumes less hazardous 
solvent and has potential for automation. 
Of the many sorbents used in SPE, only silica (Si02) was found to be an appropriate 
sorbent for PAH extraction from the literature. Alumina (A1203) was suggested as an 
alternative to Si02 (Thurman and Mills, 1998) but proved to be no better at extracting 
PAHs from oil (Section 4.3.1). Cyanopropyl sorbents was used as a pre-cleaning step 
before Si02 but added no benefits to extraction efficiency (Section 4.3.2). SiO2 
therefore remained the main extraction sorbent on which the rest of the extraction was 
based. Parameters such as column size, shape, sample volume and solvent type and 
volume were all varied to optimise this extraction method (Section 4.2.2.1 to 4.2.2.4). 
It was clear from the complexity of the oil sample that only a multi step extraction 
with a combination of sorbents would be effective. It was postulated that the most 
demanding phase of the extraction would be to remove the PAHs from other 
aromatics due to their similar properties. 
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7.3.2 New Sorbents 
Of the extraction sorbents investigated, two were identified as having the most 
potential for PAH extraction. The first was a sorbent specifically designed for the 
extraction of PAHs in soil and water. The Isolute PAH HC sorbent proved to be 
ineffective with whole oil (Section 4.3.3). However, the sorbent showed promise 
when used after a clean up stage such as LLE (Section 4.5.1) and gave a clean extract 
for oil 8 that could be analysed for PAH content with GC-MS. However, the 
extraction produced no PAH peaks for oil 4 or oil Nytro-IOGBN after GC-MS 
analysis. It was postulated that the aromatic content of the oil affected the extraction 
efficiency as only the high aromatic content of oil 8 was extracted. A possible 
improvement was to increase the amount of oil used in the initial LLE, but as the LLE 
was already time consuming (1-2 hours) and used appreciable volumes of hazardous 
solvent (a minimum of 100-200 mL), an alternative clean up stage was investigated 
for use with the Isolute PAH HC sorbent. 
The second sorbent identified as having potential for PAH extraction was used in the 
fingerprinting technique (Wilson and Pahlavanpour, 2000) (Section 4.4.1). The C18 
column was utilised to bind the less polar components in the oil while the PAHs were 
transferred through the column using cyclohexane. This was particularly useful at 
separating non-polar components that varied only slightly in polarity and that would 
not have been separated in a normal phase extraction (Section 1.5.3.1). 
7.3.3 The C18/Silia/Isolute PAH HC Method 
The C18 column was used as a clean-up step before Isolute PAH HC purification 
(Section 4.5.2) but proved inefficient until a Si02 column was added as an extra clean 
up step, as used in the mineral insulating fingerprint technique (Section 
4.5.3). Unlike 
the fingerprinting technique, adding the Si02 column after the C 18 column produced 
the most efficient cleaning. This C 18/silica clean up step followed 
by the Isolute PAH 
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HC purification proved to be highly effective at PAH extraction, producing a clean 
GC-MS chromatogram with clearly defined peaks (Section 4.5.4) 
One drawback to the use of the Isolute PAH HC extract was the large peak found by 
the GC-MS at a retention time of 21 minutes (Figure 4.9). This peak was 
unidentifiable (NIST MS library) but was present whenever the Isolute PAH HC 
sorbent was used. As the Isolute PAH HC column was the final step in this new 
extraction, the eluting species could not be extracted without further preparative steps. 
However, this peak did not interfere with the data gained from the chromatogram and 
did not affect mutagenicity data (Section 5.5.1) so was not investigated further. 
To summarise the extraction procedure (detailed in Section 2.2.9), 100 gL of oil was 
washed through a 900 mg C18 column with 3 mL cyclohexane onto a 1.2 g silica 
column which was further washed with 5 mL cyclohexane. PAHs were then eluted in 
6 mL acetone and after evaporation reconstituted in 1 mL cyclohexane and added to a 
Ig Isolute PAH HC column which was washed with 3 mL pentane. The final 6 mL 
acetone eluent was then quantified using GC-MS according to Section 2.2.6.1. 
To test the efficiency of the procedure, a 100µL sample of pure oil was spiked with 2 
gg mL-1 of each EPA 16 priority PAH and extracted. In determining carcinogenic risk 
to humans, the larger PAHs were of most interest. They were extracted with 
efficiencies ranging from 68-84% (Table 4.4 and 4.5) and the chromatogram at later 
retention times (20 minutes onwards) was clean enough to allow peaks to be 
visualised in the TIC mode (Figure 4.19). The process was found to operate at this 
efficiency with a PAH loading of up to 4 gg mL-1 of each EPA 16 priority PAH 
(Section 4.6.3). 
Extraction efficiencies of the non- mutagenic PAHs such as fluorene, phenanthrene, 
anthracene, fluoranthene and pyrene ranged from 21-67%. The volatile PAHs, 
naphthalene, acenaphthylene and acenaphthene were lost in the process due to 
concentrating the extract by evaporation. Wang et al. (2000) identified a 40% 
loss of 
acenaphthene due to such a procedure. These volatile PAHs were not of concern 
in 
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this work as they had not been found to have a mutagenic impact (IARC, 2002). 
Rotary evaporation used instead of evaporation at room temperature increased the 
amount of volatiles recovered, but was not used as it reduced the recovery of the 
larger carcinogenic PAHs. The loss was incurred when removing the evaporated 
extract from the round bottomed flask of the rotary evaporator in a minimal solvent 
volume (Section 4.6.1). 
There were two modes of analysis for the new extract. The first was the investigation 
of mutagenicity with the Ames test (Chapter 5) which was compared to work 
performed with extraction methods previously developed (discussed in Section 7.4). 
The second was the GC-MS analysis of the extracts for PAH identification and 
quantification which was compared to the fingerprinting technique described by 
Wilson and Pahlavanpour, (2000), IP 346 data and immunoassay detection (Chapter 
6). This is further discussed in Section 7.6. 
7.4 AMES TESTING OF NEW EXTRACTION METHOD 
The new C 18/Silica/Isolute PAH HC extraction method was used to test oil 
mutagenicity as GC-MS analysis showed the oil extracts to be rich in PAHs. In 
parallel, the Blackburn extracts were also tested with the Ames test to validate the 
new method alongside an existing process (Section 5.2). Mutagenicity data for the 
Blackburn extracts is discussed here followed by the C 18/Silica/Isolute PAH HC 
extract data which includes a summary of all mutagenicity data for comparison 
purposes (Table 7.2). 
7.4.1 Ames Testing of Blackburn Extracts with 80% S-9 
The Blackburn extracts were tested for mutagenicity with 80% v/v S-9 (Section 5.2). 
The Blackburn and Grimmer methods were extracted using similar volumes of 
solvents. Mutagenicity was observed for all oils extracted by the Blackburn method 
at above 50 mg plate-' without S-9 (as with the Grimmer extracts). There was an 
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increase however, of approximately 40% in the number of revertants observed on the 
addition of 80% v/v S-9 for oil 8 and Nytro- I OGBN at 500 mg plate-l. The Grimmer 
extracts had shown a greater increase in revertant number for oil 8 than Nytro- 
10GBN, which correlated with IP 346 % w/w data. Nevertheless the trend correlated 
sufficiently to indicate that both Grimmer and Blackburn extracts contained direct and 
indirect mutagens, as although indirect mutagens were only observed for one dose, 
they were present with both extracts. As many compounds are indirect mutagens it 
was not possible to conclude that the indirect mutagen was a PAH without analytical 
data, which was not available for the Grimmer and Blackburn extracts due to the 
complexity of the GC-MS chromatograms. 
7.4.2 Ames testing of C1.8/Silica/Isolute PAH TIC Extracts with 80% 
S-9 
As the C 18/Silica/isolute PAH HC extraction method had been developed on a small 
scale, mutagenicity testing initially involved the use of a smaller version of the Ames 
test. The Miniscreen assay described by Brooks (1995) was such a version, but proved 
to be too small to allow conclusive growth of revertants on the plate (Section 5.3). 
When used with 80% v/v S-9 the plates became too opaque to read and were therefore 
inconclusive. 
This lead to the scaling up of the C 18/Silica/Isolute PAH HC for use with the Ames 
test. GC-MS analysis however, indicated that up scaling did not produce as clean an 
extract (Section 5.4). To determine if the discrepancies in extract efficiency would 
affect the mutagenicity of the oil extracts, the small scale extract and large scale 
extract were compared for mutagenicity. The small scale extract of Nytro- I OGBN was 
extracted 20 times and the extracts combined to create the equivalent volume 
produced by the large scale method. The small scale extract of Nytro- I OGBN showed 
the same level of indirect mutagenicity (-74-77 revertants) as the large scale extract 
(Section 5.5.3). This indicated that although the large scale extract contained more 
interferents, it was not affecting the mutagenicity measured with the Ames test and 
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the further improvement of the large scale extract was unnecessary for mutagenicity 
testing. 
7.4.2.1 C18/Silica/lsolute PAH HC Comparison to Grimmer, IP 346 and 
Blackburn Extracts 
The mutagenicity results from the large scale extracts of the C 18/Silica/Isolute PAH 
HC method showed a correlation with IP 346 % w/w data, and therefore the Grimmer 
and Blackburn extracts. All C18/Silica/Isolute PAH HC extracts were tested at 80% 
S-9 with the same S. typhimurium culture to ensure that reversion number could be 
directly compared. A particularly important observation was the absence of direct 
mutagenicity from the C 18/Silica/Isolute PAH HC extracts. This indicated that the 
extraction had been successful at removing direct mutagens from the extract (Section 
5.5.2). This reduced the background number of reversion observed on the plates and 
therefore improved the clarity with which an indirect mutagenic response was 
observed, ensuring that the indirect mutagenicity was not obscured by direct 
mutagenicity. 
The C 18/Silica/Isolute PAH HC extract of white oil showed no indirect mutagenicity 
whilst only a doubling in reversion number was observed for oil 4 and Nytro-IOGBN 
at the highest dose tested. This doubling was found to be consistent at two doses (500 
and 580 mg plate-) so both oils were considered mutagenic. Oil 4 had shown no 
indirect mutagenicity with Grimmer and Blackburn extracts so it was postulated that 
the presence of direct mutagenicity had previously obscured mild indirect 
mutagenicity. The oil 8 extract showed greater mutagenicity than the Nytro-1 OGBN 
extract. Unlike the Grimmer and Blackburn extracts, these extracts were analysed 
with GC-MS to determine the possible cause of the observed mutagenicity. As 
discussed in Section 7.6, PAHs were clearly the main component of the extract, and 
increases in PAH content (oil 8> Nytro- l OGBN > oil 4> white oil) correlated with 
increases in reversion number, indicating that PAHs were the major cause of 
indirect 
mutagenicity. 
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On comparison of the Grimmer and Blackburn extracts with the C 18/Silica/Isolute 
PAH HC extracts, the latter extracts produced a much smaller number of revertants 
(Table 7.2). Even if the Blackburn extracts for example, had not contained direct 
mutagens, oil 8 and Nytro- l OGBN would still produce a reversion number of -600 
revertants plate-1, whereas C18/Silica/Isolute PAH HC extracts only produced -100 
revertants. This was also true for the aged oils. The indirect mutagenicity observed 
with the C18/Silica/Isolute PAH HC aged extracts (100 revertants) was not as great 
as that observed for Blackburn aged extracts (-400-600 revertants). This suggested 
that either the C18/Silica/Isolute PAH HC extraction was not extracting all mutagenic 
PAHs and therefore the complete mutagenicity was not observed, or the Blackburn 
extraction (and the Grimmer extracts) contained additional indirect mutagens which 
were not PAHs. As the C18/Silica/Isolute PAH HC extraction was shown to be 
efficient at extracting the large carcinogenic PAHs (Section 4.6) it was more probable 
that the Blackburn extract contained indirect mutagens other than PAHs. This cannot 
be proved due to the complex nature of the Blackburn extract, although the fact that 
the extract was so much more complex than the C 18/Silica/Isolute PAH HC extract, 
added weight to the suggestion that it did contain additional indirect mutagens. 
Alternatively, the direct mutagenicity could have enhanced the indirect mutagenicity 
of the Blackburn of Grimmer extract, therefore showing PAHs to be of greater threat. 
This indicates the importance of measuring PAH mutagenicity with the 
C 18/Silica/Isolute PAH HC extraction with the absence of direct mutagenicity. 
The findings of this investigation therefore indicate that the contribution of 
PAHs to 
oil mutagenicity was not as significant as suggested by the literature (Grimmer, 
1983; 
McKee et al, 1989) for the particular oils tested in this work. A 
better indication of 
total oil mutagenicity was gained by measuring the total aromatic 
fraction. Therefore 
the aromatic content of these oils, extracted by LLE, which are 
known to contain 
components other than polyaromatics (Stang, 1993; 1999) may not 
be mainly subject 
to PAH mutagenicity, as sometime alluded in the literature (Grimmer, 
1983; McKee 
et al, 1989; Järvholm and Easton, 1990; Brooks et al., 1995). However, the 
PAHs that 
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contributed to oil mutagenicity, and that were potential environmental pollutants, had 
to be determined with GC-MS analysis as will be discussed in Section 7.6. 
TABLE 7.2. Compiled results of the Ames data for all aromatic extracts. Mean 
revertant number for each oil extract is shown with (+) S-9 and without (-) S-9. 
oil Oil Extraction Methods 
IP 346 Grimmer 
(10% S-9) (10% S-9) 
(-)S-9 1 (+)S-9 1 (-)S-9 
White 35 33 831 
4 33 28 886 
Nytro-1OGBN 33 31 837 
8 34 32 1228 
Grimmer Blackburn 
(80%S-9) (80%S-9) 
Cl8/Silica/ 
Isolute PAH 
HC (80% S-9) 
(+)S-9 I (-)S-9 f(+)S-9 I (-)S-9 f(+)S-9 I (-)S-9 I(+)S-9 
786 831 845 1274 1321 37 42 
857 886 968 1221 1159 32 61 
1037 837 1170 1017 1697 37 71 
1091 1228 2444 964 1569 36 99 
7.4.3 Ames Testing of Aged Oil Blackburn and C18/Silica/Isolute 
PAH HC Extracts 
The oil end-users expressed concerns about changes in oil mutagenicity with ageing, 
as PAH levels are believed to increase over the working life of an oil (Moret and 
Conte, 2000; Wang et al., 2000; Wong and Wang, 2001). Oils were artificially aged 
(Section 2.1.1) for 1 week (ALT 1) 2 weeks (ALT 2) and 3 weeks (ALT 3). The aged 
oils were extracted with both the Blackburn and C18/Silica/Isolute PAH HC 
extraction along with the original oil (ALT 0). 
The Blackburn aged oil extracts (Section 5.6.1) produced results that correlated with 
the Grimmer extracts (Section 3.5). All Blackburn extracts of ALT 0, ALT 1, ALT 
2, 
and ALT 3 produced a similar direct mutagenic response indicating that oil 
composition did not alter enough with artificial ageing to affect mutagenicity 
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measured with the Ames test. In addition, revertant numbers increased from 550-850 
revertants for oils on the addition of S-9, to 1000-1600 revertants, suggesting the 
presence of an indirect mutagen. Such direct and indirect mutagenicity was observed 
for used mineral oils by Granella et al., (1995), although different oil were used, 
making a direct comparison of results inappropriate. 
The C18/Silica/Isolute PAH HC extracts of ALT 0, ALT 1, ALT 2, and ALT 3 were 
also tested for mutagenicity and produced no direct mutagenesis. The 
C 18/Silica/Isolute PAH HC method therefore, did not extract the additional direct 
mutagens found in Grimmer and Blackburn extracts. Due to the lack of background 
mutagenicity, the PAH results observed with S-9 was clearly mutagenic (-100 
revertants). The mutagenicity however, did not alter sufficiently with artificial ageing 
to elicit change in mutagenic response from Ames test. 
7.5 INHIBITION AND TOXIC EFFECTS FROM THE OIL AND 
OIL EXTRACTS 
7.5.1 Inhibition 
The oil and oil extracts were tested throughout the work to determine if the 
components of the oil affect PAH mutagenicity. The main concern, with respect to 
inhibition effects was that such compounds would disguise weakly mutagenic results. 
The highest dose of each extract that did not produce a mutagenic response, with or 
without S-9 was added to the plate with benzo[a]pyrene and 2-amino anthracene so 
that only the mutagenicity of the benzo[a]pyrene or 2-amino anthracene would 
be 
observed. This was done to avoid the difficulty of subtracting benzo[a]pyrene/2- 
amino anthracene mutagenicity from oil extract mutagenicity. 
The whole oil was tested (Section 3.3.3) and then the extracts from all the extraction 
methods examined were tested to determine if the extraction process 
increased or 
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decreased inhibition (Section 3.8 and 5.7). The inhibitions for oil and oil extracts were 
very similar; the greatest inhibition observed was -32-40% for oil 8. As inhibition 
remained in the oil extract, it was concluded that the inhibitor must have been 
extracted with the PAHs. This inhibition effect was noted by Granella et al. (1995) 
with naphthenic mineral oils. 
It was found that inhibition increased with aromatic content, suggesting that PAH 
content was the inhibiting factor. This explained why inhibition remained unaltered 
by extraction. Oil 8 reduced the revertant numbers of a mutagen by -30%. White oil, 
which had no identifiable PAH content, resulted in a much lower reduction in 
revertant number. From analysing the composition of oil 8 by GC-MS (Section 6.3 
and 6.4), it was observed that it did contain larger quantities of non-mutagenic PAHs 
than the other oils (Section 6.3.1 and 6.4.2). Non-mutagenic PAH inhibition of the 
enzymes was therefore postulated. Inhibition from mutagenic PAHs was unlikely as 
they may have their own mutagenic effect, thus increasing mutagenicity. However, 
Demarini (1998) noted that the mutagenicity of a PAH mixture will be dominated by 
the most mutagenic chemical, so no change in mutagenicity was more probable if 
other mutagens were competitively inhibiting benzo[a]pyrene. 
Nordqvist et al., (1981) showed that small, non-mutagenic PAHs such as 
phenanthrene were excellent substrates for S-9 enzymes. It was therefore possible that 
the non-mutagenic PAHs were being preferentially catalysed by the enzymes and 
hence interfering with mutagenicity. This did not correlate however, with work done 
with mineral oils by Hermann (1981) where mutagens were found to decrease the 
mutagenicity of benzo[a]pyrene and non-mutagens were found to enhance the 
mutagenicity even in an oily matrix solubilised by Tween 80, although the mechanism 
of enhancement is not clear. If Hermann (1981) is correct, the inhibition observed 
here must have been due to other factors that were not prevalent in the Tween 80/oil. 
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7.5.1.1 Inhibition at 80% S-9 
To further determine if non-mutagenic PAHs were the source of inhibition, the S-9 
concentration was increased to 80% v/v (Section 5.7.1). If non-mutagenic PAHs were 
interfering with enzyme active sites, increased activation enzyme concentration would 
increase the probability of activating a mutagen and therefore reduce inhibition. A 
reduction in inhibition was observed at elevated levels of S-9 indicating enzyme 
inhibition. Results in Table 5.8 also indicated that inhibition effects did not interfere 
with the data gained from the Ames test with 80% v/v S-9 since the inhibition 
(although still significant according to the t-test) was reduced for oil 8 to 2.6% from 
26%. This reduction at elevated levels of S-9 was not observed by Granella et al., 
(1995) who used naphthenic mineral oils common to the rubber industry. However, 
work done by Taylor et al. (1995) showed that S-9 concentration does have an affect 
on mutagenicity in a mixture. Furthermore, Hermann (1981) showed that the presence 
of PAHs decreases the indirect mutagenicity of benzo[a]pyrene but not the direct 
mutagen benzo[a]pyrene-4,5-oxide. This further implies that the cause of the observed 
reduction in revertants in the presence of 2-amino anthracene was inhibition of S-9 
enzyme activation. 
7.5.2 Toxicity 
As inhibition affected the mutagenicity of the oil, it was possible that toxicity effects 
would also alter the mutagenicity observed. Toxicity would reduce the number of 
viable S. typhimurium cells that could be mutated and therefore lead to a reduction in 
revertant colonies and a false negative result in the Ames test. When testing a mixture 
of the EPA 16 priority PAHs for mutagenicity (Section 3.2.1.2) it was found that 
antagonistic effects were present and toxicity issues possibly disguised or cancelled 
out mutagenicity by reducing revertant numbers. This would lead to misinterpretation 
of positive results for negative results and illustrated the requirement for toxicity 
testing in conjunction with mutagenicity testing. As toxicity often causes extensive 
DNA damage, it was possible that mutagenicity would be most likely at 
doses lower 
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than the toxic dose. However, if the toxicity was due to factors unrelated to a 
mutagenic effect (Haroun and Ames, 1981), it was possible that the toxic effects 
would affect the mutagenic response observed 
For this reason the toxicity of all extracts was considered in relation to the 
corresponding Ames test data (Section 5.8). Rather than using a standardised toxicity 
test, S typhimurium was used to develop a toxicity test that would reflect toxicity 
effects with direct relevance to the Ames test. 
The S, typhimurium culture was grown in nutrient broth and decreases in absorbance 
on oil extract addition were measured at 600 nm to determine toxic effects. No 
conclusive toxic effects were observed at the equivalent concentration of sample used 
in the Ames test for any of the oil extracts, so it was improbable that toxicity would 
have had an affect on the mutagenicity data gained However, possible toxicity effects 
were observed at the highest two doses of all oils except white oil, suggesting there 
were toxic issues when using large quantities of oil. Further work is required to assess 
this potential hazard. In addition, as these toxic effects were observed at higher doses 
than those producing the mutagenic effect, the mechanism of toxicity is more likely to 
be due to acute DNA damage. There was a suggestion that PAH toxicity increases 
with alkylation (Irwin, 1997) and as the majority of PAHs in oil were later found to be 
methylated (Section 6.4), further investigations into the toxic threat to human health 
should be conducted. 
With inhibition and toxicity issues with the Ames test resolved, the C 18/Silica/Isolute 
PAH HC extracts were considered suitably characterised for PAH composition 
analysis by GC-MS. 
226 
7.6 TRENDS IN PAH CONTENT OF OILS 1-12 
In order to assess the C18/Silica/Isolute PAH HC extraction's use in analysing the 
PAH content of oils, the data was compared to the IP 346 % w/w data provided by the 
National Grid Company Plc (Table 2.1) and immunoassay data. Immunoassay had 
previously been used as a PAH detection method at Cranfield University by Kim et al. 
(2001) and was shown to be a useful characterisation tool. Separate immunoassay kits 
were available for determining carcinogenic PAH content in addition to total PAH 
content, so immunoassay data also allowed the relationship between the total and 
carcinogenic PAH content of oils to be established. 
7.6.1 Immunoassay 
Immunoassay data for oils 1 to 12 was measured to compare with IP 346 % w/w data 
and the C 18/Silica/Isolute PAH HC data. The results from kits specific to 
carcinogenic PAH were compared to kits measuring total PAH (Section 6.2.3). It was 
found that carcinogenic PAH increase correlated with total PAH increase, although it 
was evident that two oils with the same total PAH content would not necessarily have 
a similar carcinogenic PAH content. This showed that measuring total PAH with the 
IP 346 % w/w method may correlate with carcinogenicity, and indicated that 
measuring total PAH alone may eventually remove the requirement for mutagenicity 
testing for rapid screening purposes. 
7.6.2 Comparing IP 346, Immunoassay and C18/Silica/Isolute PAH 
HC Extract Data 
As the C 18/Silica/Isolute PAH HC extracts were compatible with GC-MS analysis, 
this method was used to identify and quantify PAHs in transformer oil. The total peak 
area of the TIC and SICs were integrated and analysed as to whether the 
C 18/Silica/Isolute PAH HC extraction method could be used as a replacement 
for 
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both the IP 346 measure of total aromatics, or the immunoassay measure of total PAH 
content (Section 6.3.1). The replacement of either method is desirable, as IP 346 is 
laborious to perform, and the immunoassay approach is expensive for the end-user if 
routinely used. 
A correlation between TIC integration and IP 346 data was observed. A correlation 
was also evident for immunoassay and IP 346, although there was a slight variation in 
the trend for oils 3 and 4. The SIC data did not correlate as well as the TIC data for 
the immunoassay and IP 346 methods. Oil 2 and 3 had a lower PAH content than oil 1 
by SIC whilst the TIC, IP 346 and immunoassay data all indicated that oil 1 had the 
lowest PAH content. The total integration of TIC area was therefore a significant 
indicator of total PAH content and correlated more closely with the IP 346 % w/w 
industrial standard method and the immunoassay approach. In addition, as the 
C 18/Silica/Isolute PAH HC TIC integration method yielded a correlation with both IP 
346 % w/w and immunoassay methods, it was clear that total PAH content (measured 
by immunoassay) and total aromatic content (measured by IP 346) were linked. This 
confirmed that the IP 346 % w/w method, although a crude extraction method, did 
give a valid indication of both total aromatics and total PAH content and along with 
its correlation with skin painting tests (Stang, 1993; 1999), explains why it is an 
industry standard. However, IP 346 could not identify or quantify specific PAHs (or 
other mutagens) in the oil and in this respect the C 18/Silica/Isolute PAH HC 
extraction may be considered an improvement over the IP 346 % w/w method. 
7.6.3 Identification of PAHs in Oil 
The TICs of the C 18/Silica/Isolute PAH HC extracts were also used to identify the 
PAHs naturally present in the oil (Section 6.4). The mass spectrometric data was used 
to determine the most compatible structure for those compounds found. In this case 
the NIST MS library (part of the GC-MS Turbomass software) was used 
for 
comparison. The majority of PAHs present were methylated 
fluorenes and 
phenanthrenes, eluted at retention times between naphthalene and chrysene and 
228 
agreed with the work of Wang et al., (2000). The exact isomers present could not be 
determined by GC-MS without comparison with standards. However, such an 
approach is not feasible given that there may be hundreds of naturally occurring PAH 
isomers found in transformer oil. 
Interestingly, the heterocyclic dibenzothiophene was also found in the extracts and 
was considered as a PAH in this study due to its abundance and concerns over its 
potential toxicity and mutagenicity. Other PAHs identified that may also contribute to 
mutagenicity were methyl chrysene, benzo[g, h, i]fluoranthene and dimethyl- 
benzo[c]phenanthrene, although the mutagenicity of the latter two compounds has 
not been conclusively established (IARC, 2002). 
The EPA 16 priority PAHs were also identified (Section 6.4) with TIC and quantified 
(Section 6.5) using SIC to reveal PAHs obscured in the TIC by overlapping peaks. 
Fluorene, phenanthrene, anthracene, pyrene and benzo[a]anthracene were the main 
EPA 16 priority PAHs identified, although absolute values varied greatly between 
oils. Benzo[k]fluoranthene was also identified although the amounts found were 
below the detection limits of the calibration profile. 
From this analysis it was concluded that the probable causes of indirect mutagenicity 
were benzo[a]anthracene, dibenzothiophene (and its methylated forms), 
benzo[g, h, i]fluoranthene, methyl chrysene, dimethyl-benzo[c]phenanthrene and 
possibly benzo[k]fluoranthene. Many of the methylated PAHs found in the oil have 
previously been assumed to present the same hazards as unmethylated PAHs (Irwin, 
1997). However, this assumption is questionable since 5-methyl chrysene, for 
example shows an enhancement of mutagenicity due the methyl group being present 
in the bay region (Harvey, 1991). Thus, should the methyl chrysene found in the oil 
be 5-methyl chrysene, it would certainly contribute towards mutagenicity. This 
highlights the requirement for thorough determination of individual isomers and the 
consequences of incorrect identification. It cannot be concluded therefore that the 
methylated PAHs do not contribute towards mutagenicity, especially in such complex 
mixtures. 
229 
7.6.4 Identification and Quantification of PAHs in Aged Oil 
By analysing the C18/Silica/Isolute PAH HC extracts by GC-MS, identification and 
quantification of PAHs was monitored for changes with age. This gave an indication 
of whether the PAH composition of the oil changed while in service and whether 
ageing led to a further build up of mutagenic PAHs, which would increase the risk to 
the end-user. As the oils had been artificially aged prior to acquisition, they could not 
be spiked before ageing and those EPA 16 priority PAHs naturally occurring in the 
oils were the only PAHs selected for quantification. 
Initial assessment of total PAH content was performed by integrating the total area of 
the TIC. ALT 0 oil contained the most PAHs according to this measurement and PAH 
contents showed a general decreased with artificial ageing of up to 3 weeks (Section 
6.6). If this trend in total PAH was correct, ALT 0 oil would also contain the greatest 
amount of carcinogenic PAHs according to the trend seen for immunoassay data 
(Section 6.2.3). 
According to the quantitative data, phenanthrene, fluoranthene and pyrene, were all 
present in the oil and showed a general increase in quantity with ageing. Pyrene and 
phenanthrene increased after 3 weeks of ageing to twice their original amount while 
fluoranthene increased by three times (Section 6.6.2). The literature suggests that 
organic compounds partially break down at high temperatures into smaller unstable 
fragments that can recombine into PAHs and that two and three ringed PAHs 
accumulate particularly quickly in used lubricating oils (Wang et al., 2000; Wong and 
Wang, 2001). Aromatisation at lower temperature can also occur, given sufficient 
time to create alkylated PAHs (Moret and Conte, 2000). The PAHs themselves are 
very stable and so are less prone to breakdown, making it more likely that PAH 
content should increase with age than decrease. This explained the increase observed 
for phenanthrene, pyrene and fluoranthene. However, as the opposite trend had been 
observed when total PAH content was monitored by TIC integration (Section 6.6.1), 
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the TIC was not a good indicator of PAH contents for aged oils. Nevertheless, the 
TIC integration method was shown to be effective for new oils 1 to 12 (Section 6.3.1) 
and it was postulated that the reduction in TIC area of aged oils was due to the more 
complex oil matrices overloading the extraction sorbents (Wang et al., 2000). Thus, 
less oil sample should be used in the extraction of aged oils in future. 
7.6.5 Measuring the PAH Content of Non-transformer Oils using the 
C18/Silica/Isolute PAH HC Extraction 
The C 18/Silica/Isolute PAH HC method was used to extract PAHs from a range of 
mineral and edible oils (Section 6.7) to ascertain if this method could be used to 
determine the PAHs in a wide range of oil matrices. Red diesel and petrol were tested 
as they were known to have a high PAH content. Edible oils such as Olive oil were 
tested for their low PAH content, observed by Marquez-Ruiz et al. (1996). However, 
due to their lipophilic nature, edible oils are often contaminated with PAHs from plant 
exposure to vehicle exhaust emissions, originating from fuels such as diesel and 
petrol, industrial emissions or the packing process (Moret and Conte, 2000). 
The red diesel and petrol extracts were found to contain a mixture of PAHs, 
suggesting that the method can be extended to relatively assess the PAH content of 
general oils. The edible oils, as expected, contained no quantifiable PAHs, suggesting 
that the refining processes used to produce the oil were sufficient to remove 
contaminating PAHs (Moret and Conte, 2000). 
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7.7 OVERALL CONCLUSIONS OF THE THESIS 
The main findings of this work are briefly outlined and suggestion are made as to how 
these results affect transformer oil end-users and how resultant concerns may be 
addressed. 
"A variety of PAHs including methylated fluorenes and phenanthrenes were 
identified in transformer oil (Table 6.7). The mutagenicity and toxicity of these 
PAHs is not well understood due to the large number of alkylated forms. 
Therefore it cannot be assumed that theses alkylated forms are only as hazardous 
as the non-alkylated parent PAH (Irwin, 1997). The testing of all the PAHs 
identified in this study would be a very significant undertaking, thus all sources of 
mutagenicity could not be individually assessed. Nevertheless, all PAHs are 
prevalent in the environment, so all the PAHs in oil are of concern if they should 
leak from transformers. Accumulation of the carcinogenic PAHs in particular 
would cause the greatest impact to the general environment and human health. For 
this reason, the transformer oils with lower PAH content (oils 1,4,7,11 and 
Nytro- l OGBN) should be preferentially employed for their lower overall PAH 
content and lowest carcinogenic PAH content. 
" PAHs were found to contribute to the total mutagenicity observed in the oil but 
were not found to be the main source. The mutagenicity observed with the 
Grimmer (Section 3.4.2) and Blackburn (Section 5.2) extracts was mostly caused 
by direct mutagens and therefore were not attributable to PAHs. Of those indirect 
mutagens measured, the reversion number was significantly reduced in the 
presence of the PAH specific C18/Silica/Isolute PAH HC extracts (Section 5.5.2) 
when compared to the Grimmer or Blackburn extracts. This suggested that the 
additional indirect mutagenicity observed for the Grimmer and Blackburn extracts 
was due to compounds other than PAHs. As PAHs were not the main cause of 
mutagenicity in the oil in this case, removing them from the oil would not reduce 
the hazard associated with oil handling but would reduce the in-service lifetime of 
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the oil as the PAHs reduce oil deterioration. For this reason, removal of PAHs 
from the oil is immaterial. Nevertheless, using transformer oils with the lowest 
mutagenic PAH content (oil 1,4,7,11 and Nytro-IOGBN) would be a preferred 
option. 
" Dibenzothiophene, methylated dibenzothiophene, benzo[g, h, i]fluoranthene, 
dimethyl-benzo[c]phenanthrene, benzo[a]anthracene and possibly 
benzo[k]fluoranthene (found at low concentrations) were identified in the oil and 
were considered to contribute to the mutagenicity of transformer oil. Oils 1,4,7, 
11 and Nytro- 1 OGBN, as well as having the lowest overall PAH content, were not 
found to contain any of these compounds (Table 6.7) and thus may prove the most 
suitable oils to use in order to reduce PAH-specific carcinogenic risk factors. 
Using these oils will not remove the threat imposed from the direct mutagens 
however, as these were present in all oils tested (including white oil) with the 
Ames test. 
" The presence of non-mutagenic PAHs was found to be the probable cause of 
PAH-induced mutagenic inhibition (discussed in Section 7.5). The revertant 
number produced in the presence of a strong mutagen decreased when an oil 
extract with high non-mutagenic PAH content was added. The higher the level of 
PAH in the oil extract, the more inhibition was observed. It was postulated that 
non-mutagenic PAHs were preferentially interacting with the active site of the 
enzyme, thereby inducing some form of inhibition. Increasing the levels of S-9 
from 10% to 80% v/v confirmed this suggestion (Section 5.7.1). The presence of 
inhibiting non-mutagens would therefore suggest a reduction in the impact of the 
mutagenic threat to humans when handling the oil. However, the process is 
complicated in that mammalian skin and liver cells contain an excess of these 
activating enzymes, so inhibition would be minimised and offer no protection 
from mutagenesis. 
" Total PAH content measured by immunoassay was found to relate to carcinogenic 
PAH content (Section 6.2.3). This indicated that the IP 346 % w/w method of 
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determining total PAH may well correlate with carcinogenicity, so that total PAH 
may be used to predict the risk of carcinogenicity from the oil. However, it was 
found that although an oil with higher total PAH content would in all probability 
contain a higher carcinogenic content, two oils that contained the same total PAH 
content would not necessarily exhibit the same carcinogenic PAH content. 
" The new C 18/Silica/Isolute PAH HC extraction offered benefits over those PAH 
extraction methods reported in the literature. The method was found to be 
effective at determining the mutagenicity of PAHs in oil when used with the Ames 
test (Section 5.5.2). The extracts were sufficiently clean for individual PAH 
determination by GC-MS, unlike the Blackburn, Grimmer and IP 346 methods 
and also by definition, the total and carcinogenic immunoassay methods. Only the 
C 18/Silica/Isolute PAH HC extracts were conclusive for PAH identification 
(Section 6.4) or quantification (Section 6.5) due to a reduction in interference in 
the sample. A further application exclusive to the GC-MS analysis of the 
C 18/Silica/Isolute PAH HC extracts was the determination of total PAH content 
(Section 6.3.1) and provided a simple, rapid, less hazardous and less expensive 
method that directly fulfils the criteria of IP 346 % w/w estimation. 
" Possible toxic effects were observed in oils 8,4 and Nytro-1OGBN, although they 
did not affect the Ames test at the doses of extract tested (Section 5.8). This 
suggested that had the oil extracts been tested to a higher dose, toxicity effects 
would have been observed. Toxic effects are of as much concern as mutagenicity 
for users, especially as the oil is used in large quantities and so must 
be 
investigated further. 
" Ageing of the oil was found to affect the PAH composition (Section 
6.6). The 
amount of individual PAHs increased by between 2 and 3-fold 
following 3 weeks 
of ageing. Mutagenicity was not affected by ageing however, according to 
the 
Ames test (Section 3.5 and 5.6). This was possibly because the observed 
increase 
in PAHs levels were due to the smaller non-mutagenic PAHs as noted 
by Wang et 
al. (2000) and Wong and Wang (2001). 
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7.8 FURTHER WORK 
A number of interesting points emerge from the discussion above which merit further 
investigation. Such further work is outlined here. 
9 The C18/Silica/Isolute PAH HC extracts should be concentrated further (by 
extracting more oil into a small volume of solvent) and analysed with GC-MS. 
PAHs that were present in very small quantities, and therefore not identified by 
previous studies, could be identified and quantified. 
" As many of the PAHs in the oil extracts have been identified using the NIST 
library with GC-MS, HPLC may be used to separate and identify the different 
isomers present, as some may present a greater mutagenic threat than others. 
" Standards of those PAHs identified in the oil could be tested for mutagenicity to 
determine which cause the mutagenicity in oil. It was been suggested that 
dibenzothiophene methylated benzothiophene, benzo[g, h, i]fluoranthene, 
dimethyl-benzo[c]phenanthrene, benzo[a]anthracene and possibly 
benzo[k]fluoranthene may contribute to mutagenicity, but testing standards would 
conclusively confirm if this was the case. Methylated fluorene and phenanthrene 
would also require mutagenicity testing once the isomers were resolved, to 
determine their individual contributions. 
" The effects of complex mixtures of PAHs on mutagenicity should be explored. 
Although the oil extract from the C 18/Silica/Isolute PAH HC method were mainly 
composed of PAHs, there was still a possibility that indirect mutagens were also 
present. Ideally, as PAH quantification of the oil may now be possible, it would be 
useful to recreate the PAH mixture in the oil, using standards in the correct 
quantities, and test the mixtures for mutagenicity. It would be interesting to 
observe if the resultant mutagenicity correlated with that seen in the oil extract and 
would also support the use of the use of the C 18/Silica/Isolute PAH HC extracts 
for PAH mutagenicity testing. 
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Improvement in the application of the C 18/Silica/Isolute PAH HC extraction 
method would benefit the oil users through the identification and quantification of 
PAHs in oil. The method would benefit from system automation, which would 
increase the speed of the extraction method and would improve the repeatability 
of the solid phase extraction method through the application of a constant 
displacement pressure. The extraction system could be directly attached to the 
GC-MS for high samples throughput and reduce the need for highly trained staff. 
The system may also be miniaturised using solid phase sorbent disks (Thurman 
and Mills, 1998). Ultimately, a field-based system incorporating a portable GC- 
MS system may be envisaged. 
" Use of an alternative, preferably small scale, mutagenicity assay with the small 
scale C 18/Silica/Isolute PAH HC extraction, would provide further useful data on 
transformer oil mutagenicity. An example is the yeast mutagenicity test 
(Gentronix, 2001) which is automated and conducted in microtitre plates. The 
yeast assay has the benefit of employing an eukaryotic system, which related more 
closely to the mutagenicity observed in humans. 
" Developing the large scale C 18/Silica/Isolute PAH HC further, for use with the 
Ames test or other mutagenicity or toxicity tests may be useful in situations where 
a small scale mutagenicity tests is not appropriate. Although the inefficiencies 
observed when using the large scale extraction did not effect the mutagenicity 
results, this extraction may be developed further to improve extraction efficiency. 
This would preferably involve the use of larger Isolute PAH HC columns, and 
would require co-operation from the sorbent supplier. 
" Further toxicity testing, with a standardised toxicity test kit, would determine 
if 
there was any acute hazards involved in using transformer oil, which was 
suggested to be present from the toxicity observed at high doses of oil with 
S. 
typhimurium. 
236 
. Finally, the affects of ageing on PAH composition should be investigated further. 
PAHs could be aged individually to see the effects of mutagenicity, in addition to 
the ageing of a mixture. Ideally, a further study is required with oil that was spiked 
with all 16 EPA PAHs at representative concentrations before ageing, to obtain 
more conclusive results. It is possible that individual PAHs will be affected by the 
ageing process to differing extents. 
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APPENDIX A: ADDITIONAL MATERIALS 
AMES TEST RECIPES Maron and Ames (1983) 
Routine Checks to Ensure the Desired Mutations are Intact 
Carried out on nutrient agar plates, once every 3 months or if the bacteria demonstrate 
unexpected characteristics. 
Nutrient Agar Plates for Testing Genotypes: 
Per litre: 
9 Nutrient broth 25g 
" Agar 15g 
" Distilled water 1000 ml 
1. Test For Crystal Violet Sensitivity (rfa) 
Per litre: (make up a few mL at a time) 
" Crystal violet 0.1 g 
" Distilled water 100ml 
Create well in the centre of a nutrient agar petri dish containing 0.1 ml (approx. 108 
bacteria) of nutrient broth culture to be tested in a thin overlay of agar (top agar). 
Add 4µl of the crystal violet solution to the well. After 12hrs incubation at 37°C a 
clear zone of inhibition around the well (approx. 14mm diameter) indicates the 
presence of rfa mutation. Alternatively 2mg of deoxycholate could be used instead 
of crystal violet. 
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2. Test for Presence ofAmpicillin Resistant R-Factor. 
Per litre: (Make up a few mL at a time) 
" Ampicillin trihydrate 0.8g 
" Sodium hydroxide (0.02 N) 100ml 
Create a well in the centre of the nutrient plate and add 4µl ampicillin. Incubate for 12- 
24 hrs at 37°C R-factor strains will show no growth inhibition around the streak. 
3. Testing for Histidine Requirement. 
" Sterile O. 1M L-histidine O. lml 
" 5mM biotin O. lml 
Create a well in the centre of the minimal glucose plate and add 2µl of histidine and 
2µl biotin. 
Vogel-Bonner Solution: 
Per Litre: 
" 670mL Warm distilled water (45°C) 
" lOg Magnesium sulphate (MgSO4.7H20) 
" 100g Citric acid monohydrate 
" 500g Potassium phosphate dibasic anhydrous (K2HPO4) 
" 175g Sodium ammonium phosphate NaHNH4(PO4.4H20) 
Add salts in order to warm water in 2L beaker or flask placed on magnetic stirrer hot 
plate. Allow each salt to dissolve completely before adding the next. Store at 4°C. 
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Sodium Phosphate Buffer for S-9 (PH 7.4) 
Per 500mL: 
" 60mL 0.2M sodium dihydrogen phosphate (NaH2PO4. H20) (27.6 g mL-' ) 
" 440mL 0.2m1 disodium hydrogen phosphate (Na2HPO4) (28.4 g mL-' ) 
Sterilize by autoclaving for 20 mins at 121 °C. 
0.5mM Histidine and Biotin Solution for Top Agar 
Per 100 mL: 
12.4 mg D-Biotin 
9.6 mg L-Histidine. HC1 
100 mL Distilled Water 
IMMUNOASSAY KITS 
The reagents supplied with the kit are as follows: 
0 PAH standards containing three concentrations of either phenanthrene (total kit; 2, 
10 and 50 µg L-') or benzo[a]pyrene (carcinogenic kit; 0.1,1 and 5 µg L-'). These 
were used to obtain a calibration curve on which all unknown samples were 
quantified. 
9 PAH control containing 25 µg L-' phenanthrene (total kit) or 2 µg U' 
benzo[a]pyrene (carcinogenic kit) 
"A buffered saline diluent for the blank control and for diluting samples 
" PAH analogue labelled with horeradish peroxidase (HRP) which was made up in 
buffered saline 
" Magnetic particles covalently bonded to anti-PAH antibody in buffered saline 
" Deionised water/detergent mixture to wash away excess reaction material 
"A solution of hydrogen peroxide and 3,3', 5,5'-tetramethylbenzi dine which acted as 
the enzyme substrate and produced an indicative colour change 
0 Sulphuric acid (0.5% v/v) to stop the reaction 
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APPENDIX B: ADDITIONAL METHODS 
IP 346 METHOD 
(Method BS2000 Part 346,1996). All procedures were carried out in a fume cupboard 
with protective clothing and eyewear. 
1. The DMSO was pre-equilibrate with cyclohexane by shaking 900 mL DMSO 
with 70 mL cyclohexane in a 250 mL separating funnel (with stopper) at room 
temperature for 30 seconds. The layers were left to separate for 10 minutes and 
the DMSO collected. The cyclohexane was discarded. The procedure was 
repeated until a sufficient amount of DMSO was obtained for the extraction. 
All references to DMSO in this protocol refer to pre-equilibrated DMSO. 
2. A3 mL volume of oil was added to a 250 mL separating funnel (with stopper) 
with 45 mL cyclohexane and 100 mL DMSO. The components were shaken 
vigorously (100 shakes) and left for 20 minutes to ensure complete layer 
separation. The DMSO layer was removed through a funnel (containing a plug 
of cotton wool) into a1L separating funnel. 
3. To the 250 mL separating funnel, a fresh 100 mL portion of DMSO was added 
and step 2 was repeated. 
4. To the 1L separating funnel (containing the 2x 100 mL DMSO fractions) 40 
mL cyclohexane and 400 mL aqueous sodium chloride solution (4% w/v) was 
added. The stopper was replaced and the mixture was shaken vigorously (200 
shakes) and left for 30 minutes to allow complete layer separation. The stopper 
was removed briefly after shaking 20 times to vent the pressure 
build up in the 
funnel, and replaced before shaking continued. The 
bottom layer 
(DMSO/NaCI) was removed to a second 1L separating 
funnel. The 
cyclohexane was removed to a clean 250 mL separating funnel. 
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5. The DMSO/NaCI layer in the 1L funnel was rinsed with 2x 25 mL of 
cyclohexane, which was then added to the cyclohexane in the 250 mL funnel. 
A further 40 ml of cyclohexane was then added to the second 1L funnel. The 
stopper was replaced and the mixture was shaken vigorously (200 shakes) and 
left for 30 minutes to allow complete layer separation. The lower layer was 
then discarded. 
6. The remaining 40 mL cyclohexane was added to the cyclohexane fractions in 
the 250 mL funnel and washed with 2x 25 mL sodium chloride solution 
(warmed to 70°C). The sodium chloride solution was discarded and the 
cyclohexane layer dried by passing it through a funnel containing filter paper 
and 5g anhydrous sodium sulphate (Sigma-Aldrich). The cyclohexane was 
evaporated by rotary evaporator. 
THE MINERAL INSULATING OIL FINGERPRINTING 
TECHNIQUE 
The following was added to a 100 mL separating funnel: 
5g Oil sample 
20 mL Cyclohexane 
45 mL DMF 
5 mL De-ionised water 
The components were shaken vigorously (100 shakes) and left until the two 
layers 
were completely separate (-1 hour). The lower aqueous layer was retained. 
To a clean 250 mL separating funnel the following was added: 
Aqueous layer from previous separation 
40 mL de-ionised water, 
90 mL Cyclohexane 
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All of the above were shaken vigorously (100 shakes) and left to separate for -30 
minutes. The layers on some occasions were still cloudy and incomplete phase 
separation was evident, thus the lower aqueous layer was removed with great care (5- 
10 mL removed, then left to separate again for 5 minutes, before removing another 5- 
10 mL and repeated as required) until all of the lower layer was removed. The lower 
aqueous layer was then discarded. 
A 15 mL volume of de-ionised water was then added to the residual material in the 
funnel to wash the organic layer. The aqueous phase was removed from the bottom of 
the funnel. This wash step was then repeated. 
Filter paper was added to a glass funnel and a few grams of magnesium s ulphatewere 
placed onto the filter paper. The organic layer from the separating funnel was filtered 
through the filter paper/magnesium sulphate into a clean beaker to ensure all water had 
been removed. The solvent was finally evaporated with a rotary evaporator leaving a 
residual of aromatic material. 
The next stage of the extraction was to pass the aromatic residue through a silica and 
C 18 column for further clean up using cyclohexane. 
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BLACKBURN WITH 80% S-9: REVERTANTS NUMBERS 
Sample on Plate Blackburn 5g Extract Blackurn 0.5g Extract Blackburn 0.05g 
Extract 
White Oil without S-9 1104 1310 1408 66 5 663 36 35 31 
White Oil with S-9 1264 1244 1455 69 78 75 29 31 34 
Oil 4 without S-9 1080 1568 1016 76 85 86 33 34 29 
Oil 4 with S-9 1144 1088 1245 92 95 99 26 31 30 
Oil N10 without S-9 784 1064 1204 66 75 78 38 35 36 
Oil N10 with S-9 1856 1542 1695 66 75 79 35 35 33 
Oil 8 without S-9 980 960 952 88 84 87 32 35 29 
Oil 8 with S-9 1608 1552 1547 120 152 114 31 33 32 
ALT 0 Oil without S-9 661 568 659 88 98 94 38 39 31 
ALT 0 Oil with S-9 1524 1425 1253 123 118 128 32 35 39 
ALT 1 Oil without S-9 960 944 945 85 88 79 32 31 34 
ALT 1 Oil with S-9 1254 1348 1578 124 152 128 36 34 38 
ALT 2 Oil without S-9 689 865 653 95 105 110 38 36 35 
ALT 2 Oil with S-9 1224 1205 1015 103 129 115 34 33 38 
ALT 3 Oil without S-9 702 652 625 99 109 105 38 35 31 
ALT 3 'Oil with S-9 1024 1058 1055 94 102 112 40 35 36 
GRIMMER WITH 80% S-9: REVERTANTS NUMBERS 
Sample on Plate Grimmer 5g Extract 
854 824 817 
845 855 835 
945 867 847 
986 984 934 
854 824 834 
1145 1178 1188 
1104 1236 1344 
1824 2150 3360 
1289 1279 1352 
1645 1520 1412 
1451 1245 1542 
1751 1542 1646 
1254 1264 1228 
1659 1547 1687 
1225 1365 1244 
1547 1547 1655 
Grimmer 0.5g Extract 
White Oil without S-9 
White Oil with S-9 
Oil 4 without S-9 
Oil 4 with S-9 
Oil N10 without S-9 
Oil N 10 with S-9 
Oil 8 without S-9 
Oil 8 with S-9 
ALT 0 Oil without S-9 
ALT 0 Oil with S-9 
ALT 1 Oil without S-9 
ALT 1 Oil with S-9 
ALT 2 Oil without S-9 
ALT 2 Oil with S-9 
ALT 3 Oil without S-9 
ALT 3 Oil with S-9 
276 147 123 
245 259 164 
154 176 198 
178 202 176 
256 345 256 
356 367 356 
278 193 167 
283 286 256 
165 167 130 
175 175 164 
167 156 129 
128 125 158 
167 111 132 
157 164 178 
68 171 131 
158 133 176 
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C18/SILICA/ISOLUTE PAH HC WITH 80% S-9 
Sample on Plate C 18/silica/isolute 
5 Extract 
C1 8/silica/iso lute 
2.5 g Extract 
C 18/silica/isolute 
0.5 Extract 
White Oil without S-9 39 32 41 47 35 36 29 34 32 
White Oil with S-9 45 42 39 45 43 39 38 39 45 
Oil 4 without S-9 32 34 31 31 32 31 35 35 39 
Oil 4 with S-9 59 64 61 59 58 55 45 49 48 
Oil N10 without S-9 39 34 40 30 31 35 32 34 31 
Oil N10 with S-9 73 63 77 52 58 69 48 43 41 
Oil 8 without S-9 32 35 42 29 30 32 31 30 31 
Oil 8 with S-9 99 93 107 89 93 87 55 51 48 
Blank Oil without S-9 35 35 32 31 32 31 35 32 34 
Blank Oil with S-9 104 96 86 89 85 97 58 51 52 
ALT I Oil without S-9 39 41 35 31 32 30 31 31 30 
ALT 1 Oil with S-9 102 90 89 95 90 88 52 56 54 
ALT 2 Oil without S-9 29 35 31 29 31 30 29 31 35 
ALT 2 Oil with S-9 97 96 95 97 96 86 52 58 54 
ALT 3 Oil without S-9 42 38 34 28 34 31 31 30 33 
ALT 3 Oil with S-9 116 107 95 89 85 91 52 51 58 
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APPENDIX D: ION CHROMATOGRAM PEAK AREA FOR 
ESTIMATING TOTAL PAH CONTENT 
TOTAL ION CHROMATOGRAM PEAK AREA 
Oil TIC Total Peak Integration Mean SD %CV 
1 1166817 1354264 1693607 1404896 267019.9 19.00638 
2 9242183 11415561 12434566 11030770 1630606 14.78234 
3 3382731 3648591 4542271 3857864 607437 15.74542 
4 2516881 3147789 3772303 3145658 627713.7 19.95493 
5 15269856 11535875 17108682 14638138 2839603 19.39866 
6 6933755 7965452 9738563 8212590 1418642 17.27399 
7 3717809 3209633 4501236 3809559 650671.3 17.07996 
8 32945630 31578886 32689544 32404687 726536.3 2.242072 
9 15900734 9960535 13564100 13141790 2992532 22.77112 
10 14911454 12360952 17360952 14877786 2500170 16.80472 
11 12656957 7424586 10615956 10232500 2637178 25.77256 
12 17795273 17256864 17165350 17405829 340358.2 1.955426 
SELECTIVE ION CHROMATOGRAM PEAK AREA 
Oil Total Peak integration of SIC Mean SD %CV 
1 639972 587904 678890 635588.7 45651.1 7.182492 
2 194524 206954 184216 195231.3 11385.49 5.831795 
3 435983 493903 284894.5 404926.8 107909.7 26.64918 
4 179725 152816 202678.5 178406.5 24957.38 13.98906 
5 2260732 1998219 2538585 2265845 270219.3 11.92576 
6 1689805 1865972 1544903 1700227 160788.3 9.456872 
7 1602865 1628666 1650098 1627210 23650.15 1.453418 
8 4458392 4141791 4234987 4278390 162701.9 3.802877 
9 1581507 1241518 1959714 1594246 359267.4 22.53525 
10 4259110 5271253 5136808 4889057 549676.1 11.24299 
11 1007150 1184153 1011728 1067677 100897.1 9.450156 
12 1451025 1234518 1729030 1471524 247892.5 16.84597 
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